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An important aspect of bionanotechnology is the utilization of biomolecules to prepare 
controlled and defined arrangements of multiple components with nanoscale order. Bacteriophage M13 
is a filamentous phage composed of five different coat proteins: with the minor coat proteins p3, p6, p7 
and p9 each having five copies at the ends of the phage. The major coat protein p8 is a small alpha-
helical protein and is present in approximately 2700 copies encapsulating the M13 ssDNA genome. The 
goal of this thesis research was to further develop methodologies for utilizing bacteriophage M13 as a 
scaffold for the purpose of binding multiple enzymes with nanoscale order to p8. The cellulase, Cel8A, 
was selected as the model protein to explore this system, as it exists as part of a multi-enzyme complex 
known to form in nature: the cellulosome.  
Several different methodologies to load the bacteriophage with Cel8A were explored in order to 
determine the optimal way to prepare multi-enzyme complexes that were uniformly and densely loaded. 
In Chapter 2, an enzyme-mediated approach was taken to prepare an M13 construct with cohesin, a 
cellulosomal protein capable of binding to dockerin-containing cellulase, reacted to the p8 major coat 
proteins. The cohesin modules could then be used to bind the model protein, Cel8A. Under the 
conditions required for this enzyme-mediated reaction, cohesin was found to efficiently undergo a 
cyclization side reaction and an adduct to M13 could not be detected.  
Of the approaches tested, the most successful approaches utilized highly efficient protein-
ligand interactions. Streptavidin (a tetrameric protein which binds tightly to the small molecule biotin) 
served as an adaptor protein which could be bound to biotinylated p8. Two main strategies were 
explored for interacting Cel8A with the bacteriophage scaffold. In Chapter 3, a protocol for producing 
monovalent SA (single biotin-binding site) with three functional groups capable of binding to His6-
tagged Cel8A was devised. However, dense enzyme loading was limited by the interaction between 
these functional groups and the His6-tagged protein.  
v 
 
In Chapter 4, covalently biotinylated Cel8A was utilized. The main challenge of this approach 
was binding all of the components (M13-biotin, SA and Cel8A) in a way that avoided aggregation. 
Surprisingly, it was found that under the appropriate conditions, SA on its own could efficiently coat 
the biotinylated bacteriophage without considerable crosslinking side interactions. It was furthermore 
found that the ionic strength of the solution impacted the stability of these SA-coated M13 complexes. 
Lastly, the constructs were tested for cellulase activity and were found to be active against both simple 
and complex cellulosic substrates. Over the course of this thesis, challenges which were encountered 
for each explored strategy are highlighted in order to improve future endeavors in preparing multi-
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Chapter 1 Introduction 
 
Viruses are particles composed of proteins and nucleic acids capable of replication within a 
host organism. There exists a wide diversity of virus on Earth, with the oceans alone containing an 
estimated 200,000 different species of virus (Gregory et al. 2019). This variety, in addition to being 
important for understanding the role of viruses in different ecosystems, provides us with a plethora of 
viral architectures ranging in size and composition. Given the variety of virus species, future work on 
developing viruses as materials, or components in nanotechnologies, is one area that is expected to 
continue to evolve with the discovery of new viral architectures.  
1.1 Bionanotechnology 
 
Nanotechnology encompasses a very wide and interdisciplinary space that has been used to 
address a number of medical and technological challenges (Doll et al. 2013; Jinjun Shi et al. 2017). 
Nanotechnology deals with components or assemblies of components with features in the nanoscale. 
The types of research falling under the umbrella of nanotechnology might include those dependent on 
the positioning of just a few atoms (Eigler and Schweizer 1990) up to relatively “large” assemblies of 
components into nanoscale machines capable of self-assembling and performing a particular task 
(Douglas, Bachelet, and Church 2012; Ma et al. 2019). The types of materials that find use in various 
nanotechnological applications are wide-ranging, including: nanoparticles (NP), quantum dots (QD), 
organic polymers, and biological materials, such as DNA and RNA (Chidchob and Sleiman 2018), 
liposomes (Barile and Vassalli 2017; Malam, Loizidou, and Seifalian 2009), capsule proteins (He and 
Marles-Wright 2015; B.-R. Lee et al. 2016), structural proteins such as spider silks (L. Xu et al. 2013; 
Karan et al. 2018), nanocellulose (W. Chen et al. 2018; Kargarzadeh et al. 2018) and viruses (Molek 
and Bratkovič 2015; Petrescu and Blum 2018). Where the material components are biological in nature, 
the field can be more specifically referred to as bionanotechnology. 
2 
 
While there is considerable overlap in the types of applications to which these different 
biological materials find themselves applied, the structures and properties of each biomolecule allow 
them to fill different roles (Figure 1.1). Many of these materials have been applied to medical 
applications, including cell-targeting, drug delivery, diagnostic imaging and vaccination (Doll et al. 
2013). In the context of drug delivery, there exist a number of FDA approved or clinical trials of 
systems of drug delivery based on liposomes as the vehicle (Jinjun Shi et al. 2017). The application of 
DNA is varied, given the massive design space made possible by being able to program precise shapes 
and geometries in an algorithmic way (Chidchob and Sleiman, 2018). In this way, DNA can be 
essentially “tailor-made” for a particular application. Specifically, nucleic acids with a designed or 
evolved affinity interaction (aptamers) or DNAzymes (DNA with catalytic activity) allow the design of 
varied biosensors with specific activity toward a particular analyte (Du and Dong 2017; Zhou, Saran, 
and Liu 2017). Proteins, inclusive of capsule proteins, viruses and virus-like particles, encompass a 
wide-range of potential applications including medical imaging tools, drug delivery vehicles, 
biocatalysts, and components that can impart new functionality to materials (E. J. Lee 2018). The nature 
of the application depends again on the possible geometries of proteins presented by nature – though 
there has been some work on building exact protein architectures from design principles (King et al. 
2012; Glover and Clark 2016). Nanocellulose is a stable, biodegradable and renewable material that has 
found application to energy storage (W. Chen et al. 2018) or as a component in the preparation of 
nanomaterials (Hajian et al. 2017). There is much overlap in the applications of these biomaterials, and 
a thorough catalog of the nanoscale properties, and methodologies to properly incorporate these 




Figure 1.1: Overview of typical bionanomaterial applications. 
Viruses have been noted to have several properties that would be beneficial to their use in 
bionanotechnology (L. A. Lee and Wang 2006). Namely, that they have: defined architecture with a 
variety of shapes and sizes, they are monodisperse, many have resolved structures, they can be 
produced in large-scale quantities, the surface chemistries of the viral coats can be manipulated by 
genetic methods, and in addition to genetic methods, chemical modification enables extensive 
possibilities for particle design. To elaborate on these points made by Lee and Wang, viruses have 
found their way into a number of very interesting nanotechnology applications beyond just biomedical 
applications. As illustrated in the cited review, there have been a number of sensor applications prior to 
2014 (Hwang 2014). Further work on virus-based technological applications have continued since then 
(Petrescu and Blum 2018). While spherical viruses might share some common applications with 
capsule proteins and liposomes given their similar overall shape, filamentous viruses offer an 
interesting high-aspect ratio architecture to work from and has been taken advantage in a number of 




1.2 Bacteriophage M13 
 
1.2.1 Structure and properties 
 
A virus that has found extensive use in bionanotechnological applications is the filamentous 
bacteriophage, M13. Bacteriophage M13 is a filamentous virus that infects enteric bacteria, such as E. 
coli. This phage has dimensions of ~7 x 900 nm and encapsulates a single stranded DNA genome (Day 
et al. 1988). M13 has five copies of each of its minor coat proteins, with p3 and p6 at one end and p7 
and p9 at the other (Figure 1.2). Along the length of the phage is the major coat protein, p8, which is 
present in approximately 2700 copies (Day et al. 1988). The p8 coat protein has three general regions 
important to its assembly in the M13 coat: residues 1-20 consist of an amphipathic region, residues 21-
39 compose a hydrophobic transmembrane region, and residues 40-50 compose the DNA-binding 
region (Figure 1.3) (D. Marvin 1998; K. A. Williams et al. 1995). The amphipathic region is composed 
of an alanine-rich face responsible for hydrophobic interaction with other pVIII in assembled M13 (K. 
A. Williams et al. 1995). The hydrophobic transmembrane portion of the helix keeps pVIII bound in the 
inner membrane of E. coli until re-assembly and is important for interaction between pVIII units in 
assembled M13. The DNA-binding region is composed of positively charged amino acids which 
interact with the phosphate backbone of DNA (Rakonjac et al. 2011). 
 
 




Figure 1.3: Major coat protein p8 sequence and structure.  The sequence is of pro-p8 prior to removal of the 23 N-terminal 
residues by bacterial leader peptidase. Blue: basic residues, Red: acidic residues. PDB: 1IFJ (D. A. Marvin et al. 1994). 
1.2.2 Life cycle 
 
M13 is a non-lytic phage capable of sustaining its host while replicating in a controlled fashion 
that occurs without lysis or death of the host bacterium. This enables M13 to produce some of the 
highest occurring titers in nature (~1013 PFU/mL). The life cycle of M13 and the relevant experiments 
are very nicely summarized in the following two cited reviews (D. A. Marvin, Symmons, and Straus 
2014; Rakonjac et al. 2011). Initially, the minor coat protein p3 is responsible for infection of its 
bacterial host by binding to the tip of the pilus. Therefore, there is the additional requirement that the 
host strain contain the F-plasmid which codes for the production of pili. In the absence of phage, the 
role of the pilus is to bring bacterium in close proximity to exchange DNA through conjugation (Clarke 
et al. 2008). This periodically extends and retracts, bringing the phage in close to the bacterial 
membrane to bind its secondary receptors, the TolQRA membrane protein complex, and initiate 
injection of its DNA into the host cell. After the ssDNA positive strand is injected into the cytoplasm, 
the host E. coli proteins synthesize the complementary strand (negative strand) of the DNA and the 
translation of phage proteins begins. In addition, more copies of DNA are replicated until p5, a DNA-
binding protein, has been translated in sufficient quantity to bind up single stranded DNA for packing 
6 
 
into extruding M13 (Figure 1.4). The various membrane-bound M13 coat proteins assemble as the 
single-stranded DNA is extruded through a pore complex composed of M13 proteins p1, p4 and p11 
(Rakonjac et al. 2011). A detailed description of this life cycle can be found in the following two 
reports which model the assembly of phage in a mathematical manner – taking into account the 
extensive data for M13 assembly from various sources (Smeal et al. 2017a; 2017b). 
 
Figure 1.4: Life cycle of bacteriophage M13. Reproduced with permission from (Smeal et al. 2017a). 
The major coat protein p8 is initially synthesized as pro-p8, a 73 amino acid protein (Figure 
1.5). The N-terminal portion of pro-p8 destines the protein for transport to the inner membrane where it 
is then processed by leader peptidase to the mature coat protein with a single transmembrane helix; the 
N-terminus points toward the exterior of the cell (Rakonjac et al. 2011). Initially the protein is able to 
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associate with the inner leaf of the inner membrane by electrostatic attraction – its insertion into the 
inner membrane occurs without the requirement of the Sec translocase. Instead, the process occurs 
using the YidC invertase (Samuelson et al. 2001). However large p8 fusions have been observed to use 
the Sec translocase (Roos et al. 2001). After insertion into the inner membrane, there are two 
transmembrane domains with helices near to each other in the membrane (Eisenhawer et al. 2001). In 
the inner membrane, a leader peptidase cleaves the leader sequence, forming the mature p8 coat protein. 
By an unknown mechanism, p8 is able to associate with the extruded ssDNA of M13 as it passes 
through the p1/p4/p11 pore complex. Overall, much of the lifecycle of M13 has been well-studied – by 
having this level of detail on its assembly, it is possible to troubleshoot and better design engineered 
M13 bacteriophages for specific applications. 
 
Figure 1.5: Fate of p8 during processing from pro-p8 to mature p8. Reproduced with permission from (Merzlyak and Lee 




M13 has seen a great number of applications in the last few decades. These applications vary 
widely, including: application to medicine (Choi et al. 2014; DePorter and McNaughton 2014; J. Y. 
Lee, Chung, and Kim 2016; J. Wang et al. 2014; H.-S. Lee et al. 2018), energy (Nam 2006; B. Y. Lee et 
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al. 2012; P.-Y. Chen et al. 2013; Jeong et al. 2013; Shin et al. 2015), biosensor fabrication (H.-E. Lee et 
al. 2014; Oh et al. 2014; Adhikari et al. 2015; Brasino, Lee, and Cha 2015; Yan et al. 2016; J. H. Lee et 
al. 2017; Koh et al. 2018), functional materials (Niu et al. 2008; Courchesne et al. 2014; Jung et al. 
2017; Devaraj et al. 2018) and nanomaterial synthesis (Mao 2004; Park et al. 2014; Zaman and Haberer 
2014; Moradi et al. 2016; De Plano et al. 2018). These approaches have made use of different aspects of 
M13, including its architecture (7 x 900 nm slightly flexible rod) and surface properties (altering the 
major coat protein, given its high copy number, can greatly change the phage’s properties). A selection 
of these applications will be highlighted in the following section, though the examples presented here 
are not exhaustive but representative of some of the different ways M13 has been utilized. 
An early and still widely used technique utilizing M13 is phage display. Namely, by making 
modifications to the DNA genome of the virus, it is possible to produce fusion proteins of several of the 
virus’s five mature coat proteins. This was initially demonstrated on p3 minor coat protein with the 
fusion of a protein fragment  (G. P. Smith 1985). The ability to isolate phage bearing the fused protein 
by affinity interaction was demonstrated. The production of fusion proteins to p3 has been the most 
extensive and well known genetic manipulation of M13. Furthermore, gene libraries can instead be 
inserted producing a library of M13 phages with randomized stretches of amino acid sequences. This 
allows variants with a particular property to be isolated, amplified, and then sequenced to determine the 
identity of the insert (Figure 1.6). While it is possible to produce M13 with only coat proteins present 
as fusion proteins, by encoding the fusion protein on a phagemid and infecting with a helper phage 
(which provides the wildtype coat proteins), an M13 phage with a mix of wildtype and fusion coat 
protein can be obtained (Henry, Arbabi-Ghahroudi, and Scott 2015). Lowering the frequency of fusion 
protein can be useful in reducing avidity effects when performing selection (Chappel, He, and Kang 
1998; Tsunoda, Tsutsumi, and Imai 2008). This results in higher affinity binders that can be isolated by 
biopanning. There are examples of phage display on all five of its coat proteins, though p3 and p8 




Figure 1.6: Schematic overview of biopanning using M13 phage display libraries. 
 Early applications of phage display envisioned the development of libraries of M13 fusions to 
isolate strong binding peptides to antibodies (G. P. Smith 1985). However, this technology has 
expanded and found utility beyond biological binding processes; quite interesting is its application to 
inorganic biological materials and non-biological materials – allowing a bridging of biological 
components and materials through affinity interactions (Seker and Demir 2011). For example, phage 
display against gold has led to the discovery of several gold-binding peptides (Huang et al. 2005; 
Jungok Kim et al. 2010; D. J. Lee et al. 2019; Tamerler et al. 2006). These could be used to target a 
complex to a gold surface, or allow gold nanoparticles (GNP) to bind to the viral surface. Related to the 
topic of interfacing biological components with materials was the discovery of a semi-conductor 
binding peptide (Whaley et al. 2000). Also related to nanomaterials was the discovery of a peptide with 
an affinity for single wall carbon nanotubes (CNTs) – also through phage display (Su, Leung, and 
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Honek 2006). At this point in time, there are many examples of p3-fusions that have been identified 
against a range of materials making for a substantial toolbox of phage variants to choose from in 
preparing engineered nanoscale constructs composed of M13 bacteriophage. Indeed, the idea of 
utilizing p3 as a targeting component, and p8 bound to a “cargo” molecule is an interesting one. 
However, with the major coat protein of M13, p8, there exist limitations to the extent with 
which a fusion can be made. While fusions to p3 can be quite large, protein fusions made on p8 must be 
short (limited to 5 - 8 amino acids) (Henry, Arbabi-Ghahroudi, and Scott 2015). One approach to 
address this limitation has been to produce hybrid M13 with a mix of wildtype and fusion-p8; however, 
these typically yield low display rates at <1 protein/M13 (Sidhu, Weiss, and Wells 2000). Furthermore, 
even short amino acid fusions to p8 can produce non-viable phage if they interfere with the processing 
of pro-p8 protein (Merzlyak and Lee 2009). In particular, the bacterial leader peptidase can have trouble 
with processing p8 if there is too much positive charge near the mature N-terminus (Figure 1.5). This 
can cause the external loop to associate to the negatively charged extracellular leaf of the E. coli inner 
membrane which makes it difficult for leader peptidase to cleave pro-p8. Despite the difficulties of 
genetic fusion to p8, there exist libraries of p8 fusions that allow for different sorts of interactions to be 
discovered due to the different mode of binding to an antigen. In particular, the multiple p8 interactions 
that result from the many copies of p8 can result in lower affinity interactions that can be enhanced by 
avidity (Knez et al. 2013). Furthermore, the display of short peptides on p8 can greatly change the 
properties of the entire phage, as there are 2700 copies and these proteins make up the majority of the 
mass of M13.  
Despite the limitations of p8 display, chemical modification of the major coat protein is a good 
alternative with a great deal of work done with characterization and application. A thorough 
examination of native p8 has found reactivity from several exposed amino acids: Gly1 (amine), Glu2, 
Asp4/5, Lys8, Tyr21 and Tyr24 were all capable of chemical modification (K. Li et al. 2010). 
Furthermore, the incorporation of orthogonally reactive, non-canonical amino acids for phage display, 
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or for the purpose of utilizing M13 as a nanoscale scaffold has expanded its reactivity (Tian, Tsao, and 
Schultz 2004; Urquhart, Daub, and Honek 2016). The filamentous structure of M13 was used to prepare 
a light-responsive nanowire by modifying Tyr residues with a photo-reactive component (Murugesan et 
al. 2013). Building up on the idea of M13 as a scaffold for adding components onto, this has been 
carried out with several minerals. 
A number of different approaches have been taken to accomplish controlled mineralization or 
formation of nanoparticles with M13. M13 without any kind of modification has been shown to be 
suitable for the reduction of metal salt solutions directly onto the filamentous phage (Avery, Schaak, 
and Schaak 2009). The electrostatics of M13 have been further tuned in a number of cases by 
engineering several glutamates on the N-terminus of p8 – aiding the electrostatic attraction of cationic 
metals for nucleation along the length of intact M13. Nanodimensional MnO2 nanowires formed on E4-
M13 was employed in a novel glucose oxidase biosensor (Han et al. 2016). E3-M13 phages were used 
to form TiO2 nanowires in solution, which were then formed into a network (P.-Y. Chen et al. 2015). 
E4-M13 with bound Co3O4 in solution, which was reduced with NaBH4, was used to form the anode of 
a flexible battery (Nam 2006). The M13 used for this was a hybrid formed with a mixture of p8 
displaying the EEEE (E4) motif, and some p8 showing a specific gold-binding motif. M13 with defined 
metal-binding properties has also been used – taking advantage of the capability of displaying short 
peptides along the length of M13 (on the p8 major coat protein). Several different peptides selected for 
binding to ZnS, CdS, FePt and CoPt have been used to form different crystalline nanowires (Mao 
2004).  
One of the most intriguing and surprising applications of M13 has been its utilization in 
technological applications. Elaborating upon the fundamentals of how one could prepare mineralized 
M13 phages, these concepts have been further applied to more elaborate device designs. M13 has been 
used in the construction of energy producing materials using a few different strategies which both 
utilize the architecture of the virus in unique ways. In one example, the filamentous structure of the 
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virus was useful as a template for the mineralization of BaTiO3 which allowed the material to be better 
dispersed and utilized more efficiently as a flexible generator (Figure 1.7A) (Jeong et al. 2013). Again, 
using the architecture of the phage itself to template the mineralization of a material, this time the 
formation of gold clusters and dye molecules were utilized for a dye-sensitized solar cell design 
(Figure 1.7B) (P.-Y. Chen et al. 2013). Further exploring the use of M13 in energy devices, energy 
generation was realized by using the piezoelectric properties of the p8 major coat proteins to create a 
material which would generate a current when flexed (B. Y. Lee et al. 2012). These applications of 
M13, a scaffold which can been separately and controllably modified by genetic and chemical methods, 
demonstrate some of the potential that a precisely manipulated and designed nanoscale scaffold can 
have. 
 
Figure 1.7: Examples of M13 utilizing in device designs.  A) M13 used to template mineralization of BaTiO3 in a flexible 
nanogenerator design. Reproduced with permission from (Jeong et al. 2013). Copyright (2013) American Chemical Society.  
B) M13 utilized as a component in a dye-sensitizes solar cell design. Reproduced with permission from (P.-Y. Chen et al. 
2013). Copyright (2013) American Chemical Society. 
 
1.3 Multi-enzyme complexes 
 
A number of important industrial applications such as biofuel production, production of 
pharmaceuticals or precursors, and sensing devices can be aided or made possible through the use of 
multi-enzyme biocatalysts. Furthermore, enzyme-based catalysts are considered a green technology 
since they are biodegradable (Sheldon 2007). Considerable research into the development of such 
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biocatalysts has involved the use of nanoscale architectures to alter and improve the function of these 
enzymes. Some advantages of enzymes immobilized onto scaffolds include improved stability, the 
ability to more easily remove and recycle enzyme catalysts, and the capability of carrying out more 
efficient multistep reactions (Lin, Palomec, and Wheeldon 2014). In this field of research many 
different types of nanoscale architectures have been utilized to immobilize enzymes of interest. Some of 
these different types of scaffolds, which will be elaborated on in the following sections, include 
nanomaterials, DNA scaffolds, and protein-protein interactions. Concepts such as changes to enzyme 
stability and how the rates of multi-enzyme reactions change when bound to a nanoscale architecture 
are highlighted below with specific examples.  
1.3.1 Nanomaterial scaffolds 
 
Nanoparticles (NPs) include a wide range of carbon-based and inorganic nanomaterials, such as 
quantum dots and silica NPs. For physical adsorption of proteins to NPs, both the properties of the 
protein and the surface are important in explaining protein adsorption behavior. For example, protein 
adsorption to increasingly chemically reduced graphene oxide surfaces showed varying structural 
changes (Y. Zhang et al. 2012). As the hydrophobicity of the surface was increased, protein structure 
determined by circular dichroism and relative activity both decreased (Figure 1.8). Therefore, for 
physical adsorption, understanding how proteins interact with a particular surface is important for 




Figure 1.8: Horseradish peroxidase (HRP) binding to graphene oxide (GO) and chemically reduced graphene oxide (CRGO) 
surfaces.  A) Contact angles of different GO and CRGO surfaces. Higher contact angles indicate greater hydrophobicity. B) 
Top: Circular dichroism spectra of HRP adsorbed to different GO/CRGO surfaces. Bottom: Residual HRP activity after 
adsorption onto CRGO surfaces. Adapted with permission from (Y. Zhang et al. 2012). 
Predicting the orientation of a protein on a surface is difficult by physical adsorption. A mass 
spectrometry based approached was used to determine the orientation of RNase A physically adsorbed 
to silica surfaces and highlighted factors important for protein adsorption to a NP surface. At low 
protein concentrations of RNase A, the orientation of the enzyme on silica indicated a role of arginine 
residues in adsorption (Wei et al. 2014). At high protein concentrations, though, the orientation of 
RNase A on the surface suggested that the enzyme underwent considerable rearrangement as the 
previously surface bound arginine residues became solvent accessible. For a biocatalyst design, 
orientation of the enzyme component is important as blocking of the active site, or denaturation of the 
protein would greatly reduce activity. So not only do the properties of the protein and the surface need 
to be considered, but protein-protein interactions of adsorbed proteins can further change the orientation 




 Controlled methods for modifying a surface with proteins are valuable to biocatalyst designs. A 
peptide-mediated approach to enzyme binding to NPs could be used to better control orientation on the 
surface. Histidine tags commonly used in protein purification can also serve to provide affinity 
interactions with CdSe-ZnS quantum dots (Kang et al. 2014). Alternatively, Zbasic2, a 7 kDa protein 
tag, binds to silica surfaces (Bolivar and Nidetzky 2012). It was rich in arginine residues which were 
expected to interact with the negatively charged silica surface. Additionally, covalent attachment of an 
enzyme to a surface can allow orienting the enzyme active site such that it is still accessible upon 
surface attachment (Y. Liu et al. 2013). In comparison to the physically adsorbed enzyme, they found 
that covalent attachment afforded nearly the same activity as in solution. 
The use of nanomaterial-based scaffolds offers several approaches for stabilizing enzyme(s). 
There have been results reported on enzymes that have been encapsulated within inorganic NPs or 
polymers having increased stability (Sheldon 2007). Penicillin G amidase encased in polymerized 
acrylamide followed by mesoporous silica encapsulation retained more activity after incubation at 37 
oC for 24 hours than non-encapsulated enzyme (Figure 1.9A) (F. Zhang et al. 2014). In another 
example, alcohol dehydrogenase (ADH) was encapsulated within silica nanoparticles (Figure 1.9B) 
(Jiafu Shi and Jiang 2014). The evidence of encapsulation was the absence of leeching of enzymatic 
activity even in the presence of high salt. Salt titration can help to determine the extent to which protein 
interaction with a surface is from electrostatic interactions (Boulos et al. 2013). It is possible though, 
that electrostatics are only responsible for a percentage of the total free energy change of a protein 
adsorbing to the surface. Therefore, this single experiment of incubating silica NPs with 1M KCl might 
not rule out other non-electrostatic contributions to protein adsorption (Xia, Monteiro-Riviere, and 
Riviere 2010). Despite this, their silica NP-enzyme constructs did have greater stability over one month 
than the free enzyme in solution and had comparable activity to the free enzyme (Jiafu Shi and Jiang 
2014). They showed evidence that the silica-NP microcapsules could be recycled with less loss of 




Figure 1.9: Examples of enzyme/nanomaterial complexes with altered properties.  A) Penicillin G amidase was modified with 
N-acryloxysuccinimide. Monomers of acrylamide and bis-acrylamide were added and polymerized to Penicillin G amidase 
with N’-tetramethylethylenediamine and ammonium persulfate initiators. Mesoporous silica was encapsulated around the 
acrylamide Penicillin G amidase. This biocatalyst retained ~80% activity after 24 hours at 37 oC whereas free Penicillin G 
amidase only retained ~5% activity at 24 hours. (B) Synthesis scheme for the fabrication of enzyme-silica NPs. (i) Silicate, 
alcohol dehydrogenase and polyethyleneimine were reacted forming enzyme-silica NPs. (ii) Aggregates of polyallylamine 
hydrochloride were mixed with (iii) enzyme-NPs to form hollow catalytic microcapsules. After 30 days the catalytic 
microcapsules had ~90% activity while free enzymes did not have activity after 30 days. The image in panel A) was adapted 
from (F. Zhang et al. 2014) under a Creative Commons Attribution 3.0 Unported License( 
http://creativecommons.org/licenses/by/3.0/). The image in panel B) was reproduced from (Jiafu Shi and Jiang 2014) with 
permission from The Royal Society of Chemistry. 
A study evolving from work on NPs grown in the presence of an enzyme was the co-
encapsulation of two enzymes, glucose oxidase and horseradish peroxidase, to catalyze a cascade 
reaction for a glucose sensor (J. Sun et al. 2014). Both higher stability and glucose sensitivity were 
observed in this biocatalyst. The improvement of sensitivity over free enzymes was attributed to the 
closer proximity of co-embedded enzymes. In another study using these two enzymes, they were 
encapsulated within a polymer matrix, and the increased stability of the enzyme pair was attributed to 
the reduction of entropy in the unfolded state (Zore et al. 2015). This reasoning might be extended to 
enzymes captured within an inorganic NP to explain the high stability observed in those studies. 
Overall, enhanced stability of enzymes prepared within or on NP scaffolds is a common theme and can 
be a potential advantage with this type of scaffold. 
1.3.2 DNA-based scaffolds 
 
DNA origami technology has enabled many biocatalyst designs and fundamental studies of 
their kinetics by allowing the design of a diverse set of architectures. DNA origami involves folding a 
strand of circular ssDNA using small DNA oligonucleotides called “staple strands” (Figure 1.10). 
These can be designed using an algorithmic approach to create a particular geometry (Rothemund 
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2006). Recent research in this field demonstrates the high level of precision possible with this 
technology by developing a DNA scaffold capable of tunable separation of two molecules with up to 
0.04 nm displacement (Funke and Dietz 2016). Given the ability to easily design different shapes from 
DNA origami the ability to precisely position proteins is quite high.  
 
Figure 1.10: Overview of DNA origami.  A) Schematic of a finalized DNA origami design. Single-stranded, circular template 
DNA is shown in black and staple strands are shown in colour. B) Several examples of different folded DNA origami designs. 
Adapted with permission from (Rothemund 2006). 
Interfacing proteins with DNA scaffolds can be achieved in a few different ways. By modifying 
the protein with a DNA oligonucleotide one can use the base complementarity of DNA bases to 
position the protein. The DNA origami structure would then have to contain staple strands with the 
complementary sequence as an overhang. Alternatively, producing a protein or enzyme of interest as a 
fusion with a DNA-binding protein, such as the Zif268 and PE1A zinc-finger proteins, is another 
approach (Q. Sun et al. 2014). A weakness of this approach is the relative low affinity of this DNA-
protein interaction. RNA-binding domains that bind to specific RNA aptamers were used in a different 
approach to attach proteins of interest to nucleic acid scaffolds (Sachdeva et al. 2014). Interestingly, 
this approach could be used in vivo and showed association of a split fluorescent protein in cells. DNA 
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offers an easily tunable framework that one would expect to be ideal in studying the parameters that 
affect the enhancement of enzyme activity on scaffolds. 
The programmable nature of DNA makes it particularly suitable toward the development of 
nanoscale devices and in-depth exploration on how physically constrained enzymes or co-factors with 
very exact positioning impacts enzyme rates. A DNA tweezer, for example, was designed to separate 
glucose-6-phosphate dehydrogenase (G6pDH) from nicotinamide adenine dinucleotide (NADH) under 
certain conditions (M. Liu et al. 2013). The presence of appropriate strands of ssDNA can open or close 
the device, therefore bringing G6pDH in contact with its NADH cofactor and causing a detectable 
signal (Figure 1.11A). The authors were able to further optimize their design in a more recent paper 
where they redesigned the scaffold to have more complete closure and increase the activity in the 
closed state by an additional 3-fold (Dhakal et al. 2016). In a different example, the separated domains 
of P450 BM3, which catalyzes monooxygenation reactions when assembled, were attached to a DNA 
scaffold to reconstitute enzymatic activity (Erkelenz, Kuo, and Niemeyer 2011). Proximity of the two 
domains was required for electron transfer between domains and therefore, successful catalysis. Using 





Figure 1.11: Schematics of DNA-based sensors and devices.  (A) A DNA tweezer-based device utilizing glucose-6-phosphate 
dehydrogenase (G6pDH) and NAD+. When fuel strand oligonucleotides are added, the tweezers close allowing oxidation of 
glucose-6-phosphate (G6P). Adding the set strand oligonucleotide opens up the structure again, reducing catalysis. (B) 
Different configurations of a DNA scaffold with a tethered NAD+ cofactor. DNA scaffold bound to G6pDH and tethered NAD+ 
cofactor with lactate dehydrogenase (LDH) and malate dehydrogenase (MDH) in solution (unchannelled NAD arm; left). In 
this configuration, the hydrides from NADH are preferentially transferred to LDH. A DNA device bound to G6pDH and MDH 
with a tethered NAD+ cofactor (right). In this configuration, the hydrides from NADH are preferentially transferred to MDH. 
Panel A was adapted with permission from (M. Liu et al. 2013). Panel B was adapted with permission from (Fu et al. 2014). 
In another example of spatially-constrained enzymes and cofactors, a DNA origami scaffold 
was used to explore the creation of a biocatalyst utilizing a tethered NADH that could transfer hydrides 
between the active sites of two different enzymes, G6pDH and malate dehydrogenase (MDH) (Fu et al. 
2014). The rate enhancement of tethered NADH cofactor compared to freely diffusing NADH was an 
impressive 91-fold increase. Further optimization was carried out by adjusting the stoichiometry of 
NADH to enzyme. Noting that G6pDH activity continued to increase linearly with additional NADH it 
was found that the most optimal configuration had G6pDH:NADH as 4:1 and MDH:NADH as a 1:1 
ratio. An interesting part of their work was that having the enzymes tethered together in proximity with 
their cofactor greatly increased the specificity of the reaction (Figure 1.11B). When in competition 
with freely diffusing lactate dehydrogenase (LDH), the reaction proceeded down the MDH pathway 
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preferentially only when MDH was spatially confined near NADH. This could potentially be an 
approach to channel or detect a substrate from a complex mixture of molecules down a particular 
pathway of interest in the presence of competing enzymes.  
1.3.3 Protein-based scaffolds 
 
Designing protein-based scaffolds to have a desired architecture is a challenge given the 
complexity of protein-protein binding interfaces. Although protein scaffolds are far behind the level of 
design of DNA scaffolds (Chidchob and Sleiman 2018) there is some work on design principles for 
creating novel protein scaffolds (King et al. 2012; Glover and Clark 2016). Protein-based scaffolds 
found in nature offer another source of stable and well-defined architectures. An excellent naturally 
occurring example of this is the cellulosome which is produced by cellulose-degrading bacteria for the 
purpose of breaking cellulose down to simpler sugars (Bayer, Setter, and Lamed 1985; Fontes and 
Gilbert 2010; Yael Vazana et al. 2013). The biological role and more detailed concepts concerning the 
cellulosome and its function will be discussed in the following section, Section 1.4. For this particular 
discussion on multi-enzyme scaffolds, the scaffolding proteins of the cellulosome are of particular 
relevance and will be introduced here first. The cellulosome is composed of a mixture of non-catalytic 
scaffolding proteins, called scaffoldins, and various cellulases (Figure 1.12A). Artificial cellulosome 
scaffolds were developed to understand how the cellulosome functions in nature and for biofuel 
applications (Borne et al. 2013; Stern et al. 2015; Yael Vazana et al. 2013). By improving the rate of 
cellulose hydrolysis down to simpler sugars for fermentation, one can access the energy found in 




Figure 1.12: Cellulosome structural features.  A) Schematic showing cellulosome structural organization. CipA is a scaffoldin 
from Clostridium thermocellum. B) Schematic showing domains on chimeric scaffoldin. “c” refers to the cellulose binding 
module, “A” is the cohesin from A. cellulolyticus, “T” is the cohesin from C. thermocellum, and “B” is the cohesin from B. 
cellulosolvens. C) Molecular dynamics simulation of cohesin:dockerin interface in the absence or presence of an applied 
force. Cohesin is shown in blue and dockerin is shown in red. Panel A was reproduced with permission from (Fontes and 
Gilbert 2010). Panel B is modified from (Yael Vazana et al. 2013) under Creative Commons Attribution License 2.0 
(http://creativecommons.org/licenses/by/2.0). Panel C is modified from (Schoeler et al. 2014) under Creative Commons 
Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/). 
In the course of artificial cellulosome research, a useful nanoscale scaffold was developed due 
to the nature of orthogonal dockerin and cohesin proteins. The orthologs from Clostridium 
thermocellum, Bacteroides cellulosolvens and Acetivibrio cellulolyticus do not bind to the orthologs of 
the other species (Yael Vazana et al. 2013). It was found that the two major areas of the binding 
interface that were crucial for specificity were a hydrophobic patch and H-bonding network (Slutzki et 
al. 2015). Chimeric scaffoldin combines these orthogonal cohesin domains into a single protein scaffold 
(Figure 1.12B). In addition to the specificity of the interaction, cohesin bound to dockerin has 
considerable mechanical strength (Schoeler et al. 2014). In this study, researchers found that the 
mechanical strength of the intermolecular interaction was about 600 pN. This is approximately half the 




in response to applied force by rearrangement of several residues (Figure 1.12C). This factor could 
make such a scaffold very suitable for application in the construction of continuous flow devices or 
biosensors. 
There are several good examples of multi-enzyme complexes employing protein scaffolds that 
demonstrate higher catalytic rates through substrate channeling. Substrate channeling is the concept of 
enhancing the efficiency of a pathway of multiple enzymes by having an intermediate diffuse directly to 
the next active site without entering the bulk solvent (Miles, Rhee, and Davies 1999). To examine the 
effects of spatial configuration on substrate channeling, chimeric scaffoldins have been used to spatially 
confine pathway-related enzymes. These biocatalysts were reported to enhance rate through substrate 
channeling (F. Liu, Banta, and Chen 2013; You, Myung, and Zhang 2012). In a particular example, 
chimeric scaffoldin was used to explore effects on rate using a model system of glycolysis enzymes 
(Figure 1.13A). Triosephosphate isomerase (TIM), aldolase (Ald) and fructose 1,6-bisphosphatase 
(F1,6BPase) were arranged on this scaffold by expressing them as dockerin fusion proteins to control 
their spatial positioning relative to each other (You, Myung, and Zhang 2012). Rate enhancement as 
high as 21.1-fold greater compared to freely diffusing enzymes was observed. The authors noted that by 
dynamic light scattering that the size of the assembled complex was larger than expected. A mechanism 
pointed out by the authors for larger aggregate formation could involve TIP, Ald and F1,6BPase, which 
can exist as dimers and tetramers. By virtue of this fact, there may be additional factors that contribute 





Figure 1.13: Examples of protein-based nanoscale scaffolds.  A) Glycolysis pathway enzymes bound to a protein scaffold 
using divergent cohesin:dockerin interactions. Triosephosphate isomerase (TIM), aldolase (Ald) and fructose 1,6-
bisphosphatase (F1,6BPase) are shown bound to cohesin domains from C. thermocellum (CTCoh), Clostridium cellulolyticum 
(CCCoh), and Ruminococcus flavefaciens (RFCoh). B) Mevalonate biosynthesis pathway enzymes bound to a scaffold 
comprised of three different protein-protein interaction domains. The image in panel A was adapted with permission from 
(You, Myung, and Zhang 2012). The image in panel B was adapted with permission from (Dueber et al. 2009). 
Another example which utilized protein-protein interactions was the design of a scaffold with 
three distinct modules to bind up three different pathway-related enzymes. In particular, expressing 
these components such that they assembled onto a designed scaffold in E. coli was found to greatly 
enhance the formation of mevalonate, a precursor for several types of therapeutic molecules (Dueber et 
al. 2009). The scaffold utilized three different protein domains with specific and distinct protein-protein 
interactions separated by flexible glycine linkers (Figure 1.13B). Peptides with affinity to each of the 
different domains on the scaffold were fused to pathway related enzymes: acetoacetyl-CoA thiolase 
(AtoB), hydroxy-methylglutaryl-CoA (HMGS) and methylglutaryl-CoA reductase (HMGR). By 
altering the number of times each domain on their scaffold was repeated, the number of recruited 
enzymes could be tailored – a single AtoB and two each of HMGS and HMGR was found to be the 
optimal arrangement. This system expressed in E. coli and mevalonate biosynthesis was enhanced by 
up to 77-fold through better flux of metabolites through substrate channeling (Dueber et al. 2009). 
Thus, unlike nucleic acids which are particularly well-suited to rationally designed interactions, there 
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exists a palette of protein-protein interaction pairs in nature that can be selected for a particular 
application.  
1.3.4 Rate enhancement in multi-enzyme complexes 
 
As already highlighted in some of the examples above, binding multi-enzymes to a nanoscale 
scaffold can improve their catalytic activity. Simply having small aggregates of pathway-related 
enzymes may in and of itself may be enough for rate enhancement through substrate channeling; a 
theory-based study showed that small clusters of enzymes may be kinetically advantageous with respect 
to substrate channeling occurring (Castellana et al. 2014). The proximity of enzymes gives more 
potential targets for a diffusing intermediate to react with before escaping to the bulk solvent (Figure 
1.14A). The model constructed included enzyme clusters of two or three pathway-related enzymes of 
defined radius, within a basin of larger volume (Figure 1.14B). For two enzymes, the optimized effect 
of clustering was a 6-fold improvement compared to evenly distributed enzymes. For three related 
enzymes the expected increase in pathway efficiency was calculated to be 110-fold. In contrast to 
engineering studies that place importance on defined spatial positioning of pathway components, this 
study suggested the relative unimportance of precise spatial positioning but rather that dense clustering 




Figure 1.14: Schematic representations of substrate channeling.  A)(i) Channeling of substrates through a physical channel. 
(ii) Legend; E1 represents enzyme 1 and E2 represents enzyme 2. (iii) Channeling of substrates by proximity. This only occurs 
when the active sites are sufficiently close to each other. (iv) Substrate channeling within clusters of enzymes. B) Model used 
to simulate rate enhancement from dense clusters of enzymes. Clusters of enzymes of radius r* were separated at a defined 
distances. These clusters are separated by basins of radius, R (dashed lines). Adapted with permission from (Castellana et al. 
2014). 
Another theory-based study on substrate channeling set up two enzymes at fixed distance and 
carried out simulations of diffusion from one enzyme to the other (Figure 1.15A) (Idan and Hess 
2013). It was found that spatially constraining the enzymes only improved the rate for a limited time. At 
a certain point the intermediate product will accumulate sufficiently in the container that the 
concentration gradient will dissipate (Figure 1.15B). Therefore, only in a system where an intermediate 




two enzymes. Additionally, when an attractive force was included between the target protein and 
substrate, acceleration due to channeling was observed. In theory, it seems that proximity without a 
physical tunnel or mechanism for channeling should not be expected to allow for substrate channeling. 
Indeed, when three pathway related enzymes were covalently crosslinked to each other no rate 
enhancement observed despite their spatial configuration (Schoffelen et al. 2013). Therefore, it may be 
important to look critically at cases where substrate channeling by proximity is used as the reason for 
rate enhancement as other mechanisms may be involved in the rate enhancements observed. 
 
Figure 1.15: Simulations used to model substrate channeling between two enzymes from just diffusion effects.  A) Histograms 
of 10000 random walk simulations from a point at (left) 100 nm or (right) 10 nm from a red sphere which represents a 
hypothetical reference. Red bars represent trajectories that collided with the red sphere and black bars represent trajectories 
that reached the limits of the basin. B) Diffusion simulations of a reaction at time-points (1 ms, 33 ms and 1 s) after initiating a 
reaction at point “1”. Colours indicate the concentration of diffused intermediate. At t=1s the diffusion gradient dissipates. 
Adapted with permission from (Idan and Hess 2013). Copyright (2013) American Chemical Society. 
 Electrostatics are known to play an important role in substrate channeling for enzymes 
proximal to each other. In vivo crosslinking of citric acid cycle enzymes gave evidence of multi-enzyme 
structures in nature and a model was constructed (Wu and Minteer 2015). In this model, there was a 




research based upon computational modelling suggested that electrostatic effects could contribute 
considerably to substrate channeling effects (Elcock and McCammon 1996). In a more recent study of 
thymidylate synthase, which has a history of research regarding electrostatic channeling, pulse-chase 
type kinetics suggested channeling occurs (Sharma et al. 2013). In this experiment the channeled 
intermediate had a radiolabel which was expected to be detected in the absence of channeling. In 
combination with the structure of the enzyme, the authors suggested that electrostatic channeling 
occurred and does not necessarily require a continuous pathway of charge from one active site to the 
next and that a concentration of appropriate charge near the active site may be sufficient. In contrast to 
this, the human version of the enzyme may have such a pathway according to docking simulations (N. 
Wang and McCammon 2016). Given these additional experiments and the various studies predicting 
the kinetics of scaffolded enzymes, it seems that for substrate channeling to occur, that close proximity 
of enzymes may not be sufficient to cause channeling. Therefore, in the cases where several pathway-
related enzymes are bound together on a scaffold, other factors such as electrostatic effects and 
aggregation should also be considered. 
1.3.5 Conclusions 
 
For the different types of scaffolds discussed, each have their own advantages and it might not 
be correct to say that a single type of scaffold would be optimal for all applications. Protein scaffolds, 
for example, are not as expensive to produce as DNA origami scaffolds, whose assembly requires the 
synthesis or purchase of hundreds of different oligonucleotide staple strands. On the other hand, the 
ease of designing a particular architecture from DNA with precision might make it particularly useful 
for more fundamental studies on how different parameters affect biocatalyst designs. Lastly, the 
properties of NP scaffolds of enable biocatalyst recovery by centrifugation and improved stability, 
which would be valuable to industry. Different NPs or materials though, vary in how they impact 
enzymatic activity depending on both surface and protein properties. In the following section, a 
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naturally occurring multi-enzyme system for which there is a good theoretical understanding of the 




Cellulose is a polymer of glucose monomers joined by β(1 → 4) glycosidic linkages (Figure 
1.16). The repeating unit is cellobiose, which is composed of two β-D-glucose units. Cellulose polymer 
chains have two distinct ends depending on the placement of the anomeric carbon of the terminal sugar. 
In the case where the anomeric carbon is a hemi-acetal, and not a acetal, then the end is considered the 
“reducing end”. Conversely, the other end of the cellulose chain is the non-reducing end. These 
polymers are roughly linear and strands of about 10000 – 15000 glucose units (depending on the 
source), which are assembled into large, super-molecular arrangements with intra and inter-chain 
hydrogen-bonding. These form fibrils which are 5 – 50 nm in diameter (Moon et al. 2011). These fibrils 
contain regions of high crystallinity, termed crystalline regions, and amorphous regions which contain 
more disordered arrangements of fibrils. Some of the important characteristics of cellulose from 
differing sources have been summarized in the following reference, which include: the crystallinity, 
length of cellulose chains, exposed surface area, pore distribution on surface and dimensions of 
cellulose fibrils (Mansfield, Mooney, and Saddler 1999). Cellulose comes from a variety of sources 
including the cell wall of plants and bacteria, where these factors vary (Langan et al. 2011).  
 
Figure 1.16: Structure of repeat unit of cellulose, cellobiose, which is composed of two β-D-glucose units. 
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Cellulose encompasses a large quantity of energy bound up in the biomass of plants but due to 
its nature, being recalcitrant to hydrolysis, it is difficult to liberate that energy (Langan et al. 2011). 
Enzymes capable of the hydrolysis of cellulose exist naturally and are referred to as cellulases. These 
enzymes exist in a large category with many varieties, and different types of activity. Overall these 
enzymes catalyze the release of glucose or oligomers of glucose as shown in the overall reaction 
presented in Figure 1.17. Since cellulose is not a simple, soluble substrate, there exists a large space for 
cellulases with different modes of action against this substrate. In reality, the liberation of simpler 
sugars from biomass has an additional complexity, that of additional cell-wall components that are not 
cellulose which need to be removed by some pre-treatment step followed by the more specific digestion 
of cellulose by added cellulases (Chundawat et al. 2011). 
 
Figure 1.17: Simplified scheme of cellulose breakdown by various cellulases.  Adapted with modifications from (Arora, 




1.4.1 Cellulosome structure 
 
In particular, a complicated arrangement of cellulases exists in nature – cellulosomes. In 1983, 
a cellulase-containing complex with cellulose binding functionality was discovered in Clostridium 
thermocellum (Lamed, Setiter, and Bayer 1983). This was later discovered to be a multi-cellulase 
complex bound in nodules on the surface of the organism that was named the cellulosome (Figure 
1.18A) (Bayer, Setter, and Lamed 1985). The cellulosome is a multi-enzyme complex produced 
naturally by cellulose-digesting bacteria, such as C. thermocellum (Artzi, Bayer, and Moraïs 2017). The 
multi-enzyme complex has attracted the attention of biofuels researchers looking to harness its very 
high cellulolytic activity, and better understand the principles through which such high conversion can 
be achieved, in order to access the massive energy stored in the world’s biomass waste.  
 
Figure 1.18: Structural organization of the cellulosome.  A) Micrograph of cellulosome anchored on C. thermocellum cell 
surface. B) Structural organization of the cellulosome highlighting the scaffolding proteins, scaffoldin, and modular enzymatic 
components. Images were reproduced with permission from (Fontes and Gilbert 2010). 
The cellulosome is composed of a mixture of scaffolding proteins and cellulose-degrading 
enzymes (Artzi, Bayer, and Moraïs 2017). The main protein-protein interaction that allows for 
hierarchical ordering of the various cellulosome components is the cohesin-dockerin interaction 
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(Figure 1.18B). In the C. thermocellum cellulosome, there are two main types of Coh and Doc that are 
distinct and play different roles. Type 2 Coh and Doc are responsible for binding of the whole 
scaffoldin complex to the cell-surface and type 2 Coh bind type 2 dockerin domains present on various 
cellulosomal cellulases. The specificity of the Coh-Doc interaction has been taken advantage of for 
further tailoring and engineering of cellulolytic assemblies. In particular it has been noted that Coh and 
Doc homologs from different species bind specifically to the same-species homologs, which has had 
important implications for synthetic biology applications of cellulosomal proteins (Pagès et al. 1997; 
Slutzki et al. 2015). Furthermore, the Coh-Doc interaction has been found to be particularly tight, with 
a Kd of less than 1 x 10-9 M (H.-P. Fierobe et al. 2005). As highlighted previously, this interaction is 
speculated to further tighten under externally applied force (Schoeler et al. 2014). This may have been 
an evolutionary adaptation to the shear forces found in the environments these bacteria grow in.  
There exist several arrangements of cellulosomal components which depend on the species of 
cellulolytic bacterium, with varying levels of complexity. These may be free cellulosomes or those 
which are tethered to the bacterial membrane (Artzi, Bayer, and Moraïs 2017). Typically, there is some 
kind of scaffolding protein, called scaffoldin. The role of this is structural in nature, and allows for 
several dockerin-bearing enzymes to be brought into close vicinity to each other. In the case of the C. 
thermocellum scaffoldin, CipA, there is also a single cellulose-binding module (CBM – also called, 
carbohydrate-binding module – other papers refer to cellulose-binding domain CBD) that is responsible 
for interacting and binding to cellulose. The complexity and arrangement of components is specific to 
the number of cohesion modules present (and whether any secondary scaffoldins are included in the 
complex). In the case of C. thermocellum, CipA scaffoldin is capable of binding up to 9 dockerin-
bearing components with a Type 2 dockerin present to bind to the cell surface (Krauss, Zverlov, and 
Schwarz 2012). In particular, an important aspect of the cellulosomes high degree of catalytic activity 
against cellulose is the presence of cellulases with differing modes of action which allow for synergistic 
processing of the cellulosic substrate (Hirano et al. 2016).  
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Having several types of cellulases in close proximity has been shown to be a critical factor in 
the function of the cellulosome. In particular, researchers have identified several core concepts that are 
important to the rate enhancement observed. These are synergism between enzyme types and 
adsorption to cellulose (Mansfield, Mooney, and Saddler 1999). Specifically, the synergism is that 
between endo- and exo-cellulases on cellulose, and beta-glucosidases, which act on produced cellobiose 
and prevent inhibition of other cellulases. Several theoretical models have been put forth to describe the 
nature of this synergy (Asztalos et al. 2012; Kostylev and Wilson 2013; Kumar and Murthy 2013). 
Given the complex nature of the substrate, there is a continuous evolution of concepts and parameters 
considered in such models. The basic concept is that endoglucanases act internally on cellulose chains, 
increasing the concentration of cellulose chain termini that exoglucanases act on, liberating cellobiose 
in a processive manner; the freed cellobiose, which is known to inhibit many cellulases, is acted upon 
by a β-glucosidase. Then, with respect to adsorption, since cellulose is insoluble, the enzymes must 
adsorb onto the cellulose surface – this is facilitated by CBM. The role of these components is to 1) 
increase local concentration of cellulase, and 2) liberate the cellulose chains from the surface of the 
substrate in a non-hydrolytic manner that makes the chains more accessible for hydrolysis (Shoseyov, 
Shani, and Levy 2006). There are many factors that contribute to the high rate of cellulose hydrolysis in 
cellulosomal systems, and in understanding this, one might be able to better tailor or enable more 
efficient cellulose hydrolysis for biofuel applications. 
1.4.2 Artificial cellulosomes 
 
 Building upon the concepts that have been learned while studying the mechanisms behind the 
efficient cellulolytic activity of the cellulosome, several groups have applied these concepts to 
developing artificial cellulosomes – mixtures of scaffolding components and select cellulases of 
varying types. Some of the goals set out to meet using artificial cellulosomes include mimicking, or 
improving, the high activity of the natural cellulosome against cellulose. Alternatively, some groups 
have envisioned constructs more precisely tailored to hydrolyse cellulose for a particular application – 
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favoring certain types of cellulases over others (Fontes and Gilbert 2010). The basic strategy involves 
the careful design of a scaffold that may then be further applied for the specific binding or arranging of 
different cellulases: typically a combination of exocellulases, endocellulases and CBMs. 
 The types of scaffolds that have been explored are varied and extend beyond just the natural 
components that typically make up the cellulosome. These types of scaffolds include synthetic/chimeric 
scaffoldins, multimeric proteins, DNA, inorganic nanoparticles, and protein-coated nanoparticles 
(Figure 1.19). Some of the cellulases that have been employed in artificial cellulosome designs are 
summarized in Table 1-1. Often, these consist of a mixture of endo- and exo-cellulases in order to 
obtain synergy between the two components as discussed above. Furthermore, CBM domains are also a 




Figure 1.19: Types of scaffolds that have been commonly used to prepare artificial cellulosomes.  Chimeric scaffoldin example 
– chimeric scaffoldin to bind dockerin-bearing cellulases from (Yael Vazana et al. 2013) under Creative Commons Attribution 
License 2.0 (http://creativecommons.org/licenses/by/2.0). Protein scaffold example – model of cohesin-rosettasome adapted 




Table 1-1: Cellulases employed in artificial cellulosome designs.  CMCase activity denotes activity against carboxymethylcellulose (CMC). pNPase activity denotes activity 
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 There have been several designs that have utilized native-like cellulosomal scaffolding proteins 
(i.e. scaffoldin, predominantly) or variants of those proteins (highlighted in Figure 1.19). In some 
cases, this has been to dissect and understand the behavior of the cellulosome, for example, using 
divalent (H.-P. Fierobe et al. 2002) or trivalent (H.-P. Fierobe et al. 2005) chimeric scaffoldin scaffolds 
to highlight important synergistic effects. Alternatively, these have been used to head toward 
optimizing many different parameters, such as: spacing of the cellulase components and relative 
positioning (Yael Vazana et al. 2013). This chimeric scaffoldin included an exo-cellulase, an endo-
cellulase and a processive endo-cellulase and the positions were shuffled by preparing 56 different 
scaffoldins. Thus, the positioning of the cohesin module determined the final positioning of the 
components. The presence of a linker was found to be the main factor affecting activity, with longer 
linker lengths producing the highest activities. These studies utilizing chimeric scaffoldin have been 
very informative; getting away from native-like proteins, a number of scaffolds have been tested in 
preparing artificial cellulosomes. 
 Other stable proteins have been used in place of scaffoldin variants for the purpose of preparing 
artificial cellulosomes. The rosettasome – an 18-mer protein (protein structure highlighted in Figure 
1.19) – was engineered as a genetic fusion to cohesin such that the final assembled protein would be a 
multimer capable of binding up to 18 dockerin-containing enzymes (Mitsuzawa et al. 2009). Four 
different cellulases from C. thermocellum were used in this study. For single components, there was 
only a minor increase in activity when complexed to rosettazyme scaffold; however, there was an 
approximately 2.4-fold increase of activity against Avicel® when different cellulase types were bound 
to the complex. In a further elaboration of this scaffold, more “naturally-occurring” amounts of 12 
different cellulases were used to further enhance degradation of crystalline cellulose (Chundawat et al. 
2016). These complexed cellulases showed enhanced activity on crystalline cellulose – though the 
authors noted some possible reasons for slightly lowered activity including limited flexibility and 
geometry of the scaffold not permitting optimal orientation of all cellulase components. 
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 Transitioning from protein-only scaffolds, there has been some work over the years on using a 
protein coating on NPs. Instead of utilizing the native Coh-Doc interaction of cellulosomal cellulases, 
the specific interaction is now mediated by a different ligand pair. In this design, cellulolytic 
components expressed with a biotin-acceptor peptide were bound to a streptavidin-coated CdSe QDs 
(D.-M. Kim et al. 2011). Notably, this study found rate enhancement against cellulosic substrates with 
only a fungal endoglucanase, and CBM domain complexed together. A later study using this platform 
explored a slightly more elaborate setup with an endocellulase, processive endocellulase and two 
different types of CBMs (Nakazawa et al. 2013). In an alternate approach to complexation of enzymes 
to CdSe QDs, an oligo-His tag on an endo- and exocellulase was used to bind both components to NPs 
of differing sizes (Tsai, Park, and Chen 2013). The oligo-His tag was used to directly bind the 
components to the NP surface. It was found that the size of the NPs did not matter as much as having 
the two different types of enzymes complexed together. Finally, a magnetic NP used to template the 
binding of a endocellulase and β-glucosidase was explored (Honda, Tanaka, and Yoshino 2015). The 
authors combined two orthologous cohesins to a protein that could bind to the magnetosome – a 
membrane-bound magnetic particle produced by certain bacteria. Due to the magnetic nature of the 
complex, the construct was capable of several cycles where the enzyme-bound particles could be reused 
(shown for 5 cycles). 
 Several designs have utilized DNA as the scaffolding component. In contrast to NP designs, 
DNA has additional flexibility and can be very easily tailored to space and bind components at specific 
positions. Furthermore, DNA differs from some of the protein and NP-based scaffolds in the flexibility 
of the scaffold – which could be a factor important for orienting cellulases on the cellulose surface. In 
an early design, an endocellulase/CBM fusion protein was joined to a DNA scaffold by a 
transglutaminase reaction (Mori et al. 2013). Despite only having an endocellulase and CBM 
component (no exo-cellulase), there was observed rate enhancement upon complexation – presumably 
the rate enhancement was from targeting effects. The authors furthermore found that there existed an 
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optimal amount of cellulase bound to their DNA scaffold – and that further complexation hindered 
activity. Later, a method using Zn-finger proteins was used to position cellulolytic components to the 
DNA scaffold (Q. Sun et al. 2014). This artificial cellulosome similarly found rate enhancement, 
though assembled cellulases were only tested against phosphoric acid swollen cellulose (PASC) – not 
more recalcitrant cellulosic substrates, such as Avicel®. Lastly, an approach using DNA base pair 
complementarity to exactly position components was used to bind 4 components: endocellulase, 
exocellulase, β-glucosidase, and CBM (Q. Sun and Chen 2016). Though again, activity was only tested 
against more digestible substrates, carboxymethylcellulose (CMC) and PASC. 
 Overall, there have been modest enhancements to the rate of hydrolysis of various cellulose 
substrates using different scaffolds for binding of cellulolytic components. Of the different cellulases 
that have been used, they vary in both mode of action (exo- or endo-) and source organism. 
Interestingly, while it has been shown that synergy between different cellulase functionalities is an 
important factor to enhanced hydrolysis of cellulose, a few of these designs have included only 
endocellulase activity, and a targeting component (CBM). Even so, the authors reported a rate 
enhancement, possibly due to the proximity effect imparted to a cellulase when complexed to the 
cellulose-targeting component. The endo-1,4-β-D-glucanase from C. thermocellum (Cel8A; 
UniProt: A3DC29) has ended up in many of these designs as a component. The enzyme has been 
crystallized and had the structure of its catalytic domain determined (Guérin et al. 2002). Given the 
wealth of information available for this enzyme, and evidence of its effectiveness in artificial 
cellulosomes, this enzyme was chosen as a model protein for developing an M13-based nanoscaffold in 
this thesis work. 
1.5 Streptavidin 
 
Streptavidin (SA) is a tetrameric protein originally discovered as a synergistic component for 
an antibiotic factor produced by the Streptomyces avidinii (Chaiet and Wolf 1964). The protein was 
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named in part after the organism it was discovered in and its similar activity to avidin, a protein that 
was discovered previously (Tausig and Wolf 1964). SA binds very tightly to the vitamin, biotin, with 
one of the strongest non-covalent interactions known in nature (Figure 1.20). The dissociation constant 
for the biotin/SA interaction is about 4 x 10-14 M (Chilkoti and Stayton 1995). Its biotin-binding activity 
is approximately an order of magnitude weaker than the interaction of avidin with biotin (~1.3 x 10-15 
M) (Green 1963). Some additional differences - apart from avidin being purified from chicken eggs, 
and SA being isolated from a bacterial source - is that avidin is heavily glycosylated (~10% by MW) 
(Hiller et al. 1987; Spolaore et al. 2014). Several systems for producing SA recombinantly have been 
realized enabling the production and study of variants produced of the protein (Gallizia et al. 1998; 
Sano and Cantor 1990a). There has been some work tailoring the activity of avidin, for example: 
through nitration of binding site residues producing a pH-sensitive avidin called “captavidin” (García-
Aljaro, Muñoz, and Baldrich 2009). The ability to produce SA recombinantly allows further 
engineering of SA leading to the development of multiple strategies to change the nature of the tight 
biotin-binding interaction of this protein. This has led to the development of several SA variants: 
“traptavidin” (Chivers et al. 2010; 2011), dimeric SA (Sano et al. 1997), and “switchavidin” (Taskinen 
et al. 2014). A more complete description of variants of SA/avidin produced are summarized here 
(Laitinen et al. 2006). Namely, the high specificity and tightness of binding to its ligand has enabled SA 




Figure 1.20: Overview of the structure of streptavidin (SA).  A) SA (ribbon structure) showing biotin (spheres) bound in each 
of the four monomers shown. B) Close-up of biotin-binding pocket showing residues within 0.5 nm of biotin (green). 
The unique tight-binding nature of biotin to SA/avidin has enabled many applications utilizing 
this protein. The following cited review highlights several applications of SA/avidin: engineered 
variants, SA-based enzymes, live cell imaging, proteomics applications, targeted drug delivery, and SA-
based sensors (Dundas, Demonte, and Park 2013). Particularly interesting variants of SA include 
“monovalent SA” (SA with a single “active” biotin-binding site) which is particularly beneficial for 
applications where the multivalent nature of SA could be a hinderance. Studies on the quaternary 
structure of SA have highlighted that the tetrameric form of the protein is essential for high affinity, as 
the biotin-binding site is found at the interface between subunits, thus ruling out the possibility of 
producing a truly tight-binding, monomeric form of SA. Indeed, a monomeric variant of SA can be 
produced from two mutations, T90A and D128A, resulting in a protein with a Kd of 1.3x10-8 M 
(Qureshi and Wong 2002). In particular, a useful modification of SA was developed making the protein 
essentially “monomeric” for biotin binding (Howarth et al. 2006). This was initially done to solve a 
fluorescence microscopy artifact that resulted from the multivalent nature of SA biotin binding. In 
particular, the protein of interest, a neuronal membrane protein, would “crosslink” as a side reaction. In 
their approach, the authors were able to utilize a mutation that abolished biotin-binding – this was 
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denatured and allowed to refold in the presence of active monomers such that SA with a single active 
subunit, and three “dead” subunits could be isolated (Howarth et al. 2006). However, when it comes to 
stable surface attachment (e.g., to a biotinylated surface), a single, high-binding site may be inadequate 
for a long-lived interaction with such a surface (Dubacheva et al. 2017). It was found that SA bound to 
the surface with only a single ligand-binding site could be washed away under the flow conditions used 
in their experiment. Thus, the optimal valency of a particular SA variant is very much dependant on the 
application. 
 In addition to affinity staining techniques (biotin blotting, microscopy) SA itself has been used 
as a scaffold for organizing protein components on the nanoscale. In particular, one of the highlighted 
artificial cellulosome designs included SA, as well as SA-coated QDs used to bridge the NP scaffold to 
the cellulase and CBM components (D.-M. Kim et al. 2011; Nakazawa et al. 2013). Further elaborating 
on SA-based scaffold designs, modification of SA subunits themselves were designed such that 4 
tetramers could self-assemble into a construct with 12 available biotin-binding sites in order to prepare 
a 56 component nanoscale assembly of a signalling protein of interest (Fairhead et al. 2014). To 
accomplish this, 1 of 4 SA monomers were fused to the SpyCatcher/SpyTag affinity pair. In another 
example of this, crosslinking of SA with a tag that permits HRP-mediated Tyr coupling was done to 
produce SA capable of both biotin-binding and further “dual-modification” using sortase-mediated 
coupling (Matsumoto et al. 2016). Binding an endo- and exo-cellulase on crosslinked SA variants was 
done, though rate enhancement was only modest. Using SA as a mediator to bind a protein of interest to 
a scaffold (virus) has been done using biotinylated tobacco mosaic virus (TMV; 2130 coat protein per 
virus) (M. L. Smith et al. 2006; Klug 1999). The SA was produced as a genetic fusion to the protein of 
interest and up to 2200 copies of the protein displayed (~710 tetramers of SA were estimated to be 
loaded).  
The ability to precisely build and position components, allowing bottom-up fabrication 
schemes, can be useful in the fabrication of devices. One approach is to use a biotinylated surface to be 
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functionalized with SA covalently attached to some biomolecule component. For example, biotinylated 
TMV was used as a component in a field-effect transistor device for detecting penicillin G (Poghossian 
et al. 2018). The TMV served the role of being a mediator to which a penicillinase-SA fusion protein 
was indirectly bound to the sensor surface to avoid issues with direct enzyme adsorption. In the reverse 
case, surfaces modified with SA might be used to bind biotinylated components. A pH-sensitive SA 
variant was used to bind molecules of interest for capture of an analyte to a biosensor chip (Pollheimer 
et al. 2013). The surface could be regenerated by a combination of low pH and detergent for re-use. In 
summary, SA is a particularly useful addition to the nanoscale assembly “toolbox” as it can act as a sort 
of molecular glue for the positioning of components in devices, sensors or nanoscale assemblies in 
general. 
1.6 Summary 
 Bionanotechnology has a wide selection of biological materials with which new technological 
designs can be brought forth from. The different biological building blocks outlined in Section 1.1 each 
have their own benefits and optimal uses. To reiterate, the interest in viruses as biological building 
blocks stems from their monodispersity, variety of architectures, high production and exact positioning 
of reactive functional groups. The fact that the particles are composed of DNA and protein packaged 
together enables modification of the coat proteins themselves through molecular biological techniques. 
Knowledge of virus structure and positioning of reactive amino acids furthermore enables chemical 
modification – opening up many possibilities for designs in the context of using viruses as nanoscale 
scaffolds. 
 It is the goal of this thesis to further explore and enable the application of viruses to 
bionanotechnological designs through exploring methods with which large multi-enzyme assemblies 
may be prepared using filamentous bacteriophage as a nanoscale scaffold. In a broader context, multi-
enzyme complexes may be applied to the fields of technology and synthetic biology. With respect to 
technology, having methodologies whereby dense arrangements of enzymes can be prepared and 
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directed to a surface (refer to phage display Section 1.2.3) may expand upon available “bottom-up” 
device fabrication strategies in which biological components are required. With respect to synthetic 
biology, methodologies for preparing large multi-enzyme complexes may be useful in creating model 
systems which may be used to study naturally occurring multi-enzyme complexes (such as the 
cellulosome, referred to in Section 1.4). Several approaches have been explored with respect to this end 
goal. In exploring these approaches several design challenges and concepts important to controllable 
nanoscale assembly on this platform were found. In preparing a multi-enzyme complex on M13, a 
cellulosomal cellulase was chosen to examine the effects of high-density enzyme loading on the 
platform. Given the large amount of literature exploring the assemblies of cellulases, and how the 
cellulolytic activity of such enzymes can be affected by targeting and synergy effects, this was a 
relevant enzyme to explore. Cel8A from C. thermocellum was chosen as the model enzyme given its 
prevalence in artificial cellulosome designs (Chundawat et al. 2016; Q. Sun and Chen 2016; Q. Sun et 
al. 2014; Tsai, Park, and Chen 2013; Yael Vazana et al. 2013). 
 A number of approaches were taken to preparing enzyme modified M13. As highlighted in the 
section on the M13 lifecycle and p8 display methods, direct fusions to the major coat protein are poorly 
displayed (Sidhu, Weiss, and Wells 2000). Given the difficulties in preparing direct genetic fusions, 
alternate means were explored. Briefly, a sortase-mediated platform was tested to see if a Coh-bearing 
M13 could be produced and then used to bind Cel8A via the Coh-Doc interaction (Figure 1.21). 
Further approaches utilized a combination of other affinity interactions to prepare multi-enzyme 
complexes on M13. SA was utilized as a mediator to complex Cel8A onto biotinylated-M13. Though 
initially a simple concept, experimentation with this approach highlighted several important design 
principles that were not initially evident and uncovered over the course of exploring the preparation of 
this multi-enzyme platform. Model systems exhibiting cellulolytic activity were discovered and the 
design principles elucidated herein should provide critical information for the future fabrication of 














 The first strategy used to prepare a multi-enzyme complex on M13 was to utilize the native 
Coh-Doc interaction in the cellulosome (Section 1.4) to load Doc-bearing cellulase onto M13. Given 
the limitations of directly displaying genetic fusions of large proteins on p8, the proteins were joined 
enzymatically. The target M13 nanoscale scaffold was an M13 displaying Coh subunits along its length 
(Figure 2.1). The bound Coh modules would then be used to bind enzymes that have Doc domains, 
such as Cel8A. CipA, the scaffoldin from C. thermocellum, contains nine Coh domains with similar 
sequence identity (Jindou et al. 2004). The second Coh domain of CipA (Coh2), has been well-studied 
and characterized, and was selected as the Coh to be used in preparing this complex (Caspi et al. 2009; 
Yaron et al. 1995). Therefore, preparation of this complex would be done in two steps: first the M13-
Coh2 scaffold must be prepared, and 2) the docking of Cel8A would be carried out in a second step. 
Therefore, the preparation of the initial M13-Coh2 construct should be done in a way that efficiently 




Figure 2.1: Concept image of Coh2 fused to the N-terminus of the p8 major coat protein of M13.  To the Coh2 module is a 
dockerin-containing protein shown bound. M13 – PDB: 2MJZ (Morag et al. 2015), Coh2/Doc complex – PDB: 2B59 (Adams 
et al. 2006). 
One method that has been cited in literature for post-translationally preparing p8 fusions 
utilizes the enzyme, sortase (Hess et al. 2012). Natively, sortase is responsible for taking proteins with a 
C-terminal signal peptide and attaching them to the bacterial cell wall peptidoglycan layer (Marraffini, 
DeDent, and Schneewind 2006). Specifically, the enzyme initially reacts with a recognized peptide to 
form a covalent acyl-enzyme intermediate in the first step, followed by reaction with an appropriate 
nucleophile to liberate the peptide from the enzyme. In particular, two sortases have found use in 
protein engineering applications: sortase from S. aureus (SauSrtA) which is Ca-dependent and 
recognizes a LPXTG motif, and sortase from S. pyogenes (SpySrtA) which has no calcium requirement 
and recognizes a LPXTA motif (Guimaraes et al. 2013; Theile et al. 2013). The development of an M13 
p8 variant with the ability to act as a nucleophile in the SpySrtA reaction has been demonstrated with 
small molecules and model proteins (Hess et al. 2012). To make this possible, this p8 variant has a 
mutated N-terminus with an insertion of AAGGGG (p8-A2G4). Therefore, in adapting this 
methodology for preparing a multi-M13-Coh2 scaffold, the following scheme was devised (Figure 
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2.2). Coh2 with a C-terminal LPETAG motif will be prepared and reacted with SpySrtA in the presence 
of A2G4-p8 to covalently join the two proteins with a native peptide bond.  
 
Figure 2.2: Reaction schematic for SpySrtA reaction with Coh2-LPETAG substrate. 
As this methodology involved the purification of several proteins, the different proteins that 
were produced and used will be introduced first (Figure 2.3). Following this, initial experiments with a 
model fluorescent SpySrtA substrate were carried out to confirm that all purified components were 
active. Furthermore, the importance of SpySrtA concentration is illustrated. Then, moving on to the 
reactions with the Coh2-LPETAG substrate, several methods were explored for detecting a p8-Coh2 
adduct. Lastly, it was observed that a cyclization side-reaction was occurring – further modifications to 
the Coh2-LPETAG variant were made to try and reduce this side reaction. While this methodology was 
unable to produce an efficiently modified M13 scaffold, the efforts to utilize this approach highlight 





Figure 2.3: Chapter 2 overview. 
2.2 Materials and methods 
 
2.2.1 General methods 
 
 General M13 amplification and purification 
 
M13 (M13KE strain from New England Biolabs, Whitby, Canada) was amplified by 
inoculating a 1:100 diluted overnight culture of E. coli K12 ER2738 (New England Biolabs, Whitby, 
Canada) in Luria Broth (LB) media (1% (w/v) peptone, 0.5% (w/v) yeast extract, 1% NaCl (w/v)) 
supplemented with 8 µg/mL tetracycline. M13 was inoculated to a final titer of ~106 plaque-forming 
units (PFU) per mL and amplified for 4.5 – 5.5 h at 37 oC with shaking for aeration. E. coli were 
pelleted by centrifugation at 12000 g for 10 min and 4 oC. 
 M13 was concentrated by polyethylene glycol with 8000 Da average MW (PEG-8000) 
precipitation with PEG-8000/NaCl solution (20% PEG-8000 Da, 2.5 M NaCl). The resulting 
supernatant was mixed with a 1/5 volume of PEG-8000/NaCl solution and precipitated for 18 h at 4 oC. 
The precipitated M13 was centrifuged at 12000 g for 15 min at 4 oC. The pellet was resuspended in a 
solution of 1x phosphate-buffered saline (PBS; 10 mM Na2HPO4, 1.8 mM KH2PO4, 137 mM NaCl, 2.7 
mM KCl) pH 7.4 that was 1/20 the volume of the initial culture volume. A 1/6 volume of PEG-
8000/NaCl solution was added for a second round of precipitation for 30 min on ice. The phage was 
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pelleted by centrifugation at 15000 g for 10 min. The final pellet was resuspended in a volume of 1x 
PBS that was 1/100 the initial culture volume. If the solution was cloudy, it was centrifuged at 15000 g 
for 1 min to clear the supernatant. The resulting phage solutions were flash frozen in liquid nitrogen and 
stored at -80 oC. 
The M13 stocks were quantified by measuring the absorbance at 269 nm. The absorbance at 
320 nm is included to account for light scattering. This can be converted to a measure of M13 
concentration in particles/mL using Equation 2.1. Nbases is the number of bases in the M13 ssDNA 
genome which is 7222 bp for M13KE. The 6 x 1016 coefficient can be derived from the literature 






         (2.1) 
 
2.2.2 Materials preparation 
 
 Coh2 variants 
 
 The initial construct for Coh2 (Coh2-LPETG) was cloned in a pET28b(+) vector (Genscript, 
Piscataway, USA). This construct was cloned with a LPETG C-terminal tag to act as a SpySrtA 
substrate. Several modifications were made to this plasmid to improve its role as a SpySrtA substrate. 
These modifications were made using standard molecular biological techniques (Table 2-1). To clone 
Coh2-LPETAG, Ala was inserted into the C-terminal tag to produce Coh2-LPETAG by site-directed 
mutagenesis (SDM).  
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Table 2-1: Mutagenesis strategies for preparing variants of Coh2 for use as a SpySrtA substrate. 





5’ – CCT GCC GGA AAC CGC AGG 
CTA ACT CGA GC – 3’  
5’ – GCT CGA GTT AGC 
CTG CGG TTT CCG GCA 






5’ – GGA GAT ATA CCA TGT CGC 
ACC ACC ATC AC-3’ 
5’ – GTG ATG GTG GTG 








5’ – GTG AAT GTG GGT GGA TCC 
GGT GGT GGC GGT TCT CTG 
CCG GAA AC-3’ 
 
5’ – GGA TCC ACC CAC 
ATT CAC GCC ACC ATC 
AAT AAA GC-3’ 
 
 
Expression and purification conditions were the same for each variant. The plasmid was 
transformed in BL21 E. coli which were grown to 0.4 – 0.5 OD at 37 oC in LB media with 40 µg/mL 
kanamycin. Protein expression was induced at 23 oC with 1 mM isopropyl-B-D-1-
thiogalactopyranoside (IPTG) for 18 h, at which point the cells were collected by centrifugation at 
5000 g for 15 min at 4 oC.  
To 1 L of cell pellet, 30 mL of lysis buffer (50 mM tris(hydroxymethyl)aminomethane (Tris) 
pH 7.5, 150 mM NaCl, 10 mM imidazole) supplemented with 1 mM phenylmethylsulfonyl fluoride 
(PMSF) was added. The resuspended pellet was passed three times through a high-pressure 
homogenizer to lyse the cells. The lysate was centrifuged at 15,000 g for 30 min at 4 oC. The protein 
was purified by immobilized metal affinity chromatography (IMAC). The cleared lysate was loaded 
onto a 1 mL HisTrap™ (GE Healthcare, Chicago, USA), washed with 5 mL of wash buffer (50 mM 
Tris-HCl pH 7.5, 150 mM NaCl, 10 mM imidazole), and eluted over a 5 mL gradient from 20 to 300 
mM imidazole. The eluted fractions were dialyzed 3 x 2 L into 200 mM HEPES pH 7.5. The purified 
protein was flash frozen in liquid nitrogen and stored at -80 oC. Coh2 was quantified by measuring its 
absorbance at 280 nm and using its theoretical extinction coefficient of 7450 M-1 cm-1 calculated by 





The SpySrtA was expressed from pET28a-SpySrtA (Addgene plasmid # 51139) from Hidde 
Ploegh (Guimaraes et al. 2013). The plasmid was transformed in BL21 E. coli which was grown to 0.5 
– 0.6 OD at 37 oC in LB media with 40 µg/mL kanamycin. Protein expression was induced at 23 oC 
with 1 mM IPTG for 18 h, at which point the cells were collected by centrifugation at 5000 g for 15 
min at 4 oC.  
To the cell pellet from 1 L of culture, 30 mL of lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM 
NaCl, 10 mM imidazole) supplemented with 1 mM PMSF was added. The resuspended pellet was 
passed three times through a high-pressure homogenizer (>10,000 psi) to lyse the cells. The lysate was 
centrifuged at 15,000 g for 30 min at 4 oC. The protein was purified by IMAC. The cleared lysate was 
loaded onto a 1 mL HisTrap™ (GE Healthcare, Chicago, USA), washed with 5 mL of wash buffer (50 
mM Tris-HCl pH 7.5, 150 mM NaCl, 10 mM imidazole), and eluted over a 5 mL gradient from 10 to 
300 mM imidazole. The eluted fractions containing SpySrtA were pooled and concentrated with a 10 
kDa molecular weight cut-off (MWCO) spin concentrator. The concentrated sample was loaded onto a 
Superdex® 75 size-exclusion column and eluted with 50 mM Tris-HCl pH 7.5, 150 mM NaCl. The 
purified protein was flash frozen in liquid nitrogen and stored at -80 oC. SpySrtA was quantified by 
measuring its absorbance at 280 nm and using its theoretical extinction coefficient of 10430 M-1 cm-1 
calculated by ProtParam (Gasteiger et al. 2005). 
 A2G4 M13 
 
 M13 double stranded DNA was prepared by inoculating a 1:100 diluted overnight culture of E. 
coli K12 ER2738 (New England Biolabs, Whitby, Canada) in Luria Broth (LB) media (1% (w/v) 
peptone, 0.5% (w/v) yeast extract, 1% NaCl (w/v)) supplemented with 8 µg/mL tetracycline. M13 was 
inoculated to a final titer of ~106 plaque-forming units (PFU) per mL and amplified for 4.5 – 5.5 h at 37 
oC with shaking for aeration. Aliquots of 1 mL were centrifuged at 15000 g for 1 min to collect the cell 
pellet which was processed with GenElute™ Plasmid Miniprep Kit (Millipore Sigma, Oakville, Canada) 
according to manufacturer’s protocol. 
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 Mutagenesis of M13KE DNA to prepare M13-A2G4 for SpySrtA reactions was carried out 
using primers synthesized at Millipore Sigma (Millipore Sigma, Oakville, Canada). For insertion of 
sequences to the N-terminus of p8, the M13KE vector was prepared by mutating T1372A and C1381G 
to introduce PstI and BamHI sites respectively (Table 2-2) (Petrenko et al. 1996). Additionally, there 
was a PstI site that was removed from M13KE by mutation of A6249T. M13-A2G4 (M13 p8 variant 
for reaction with SpySrtA) was prepared by insertion of A2G4 with complementary oligos according to 
(Hess et al. 2012). Amplification and purification were carried out using general M13 amplification and 
purification (Section 2.2.1.1). 
Table 2-2: Primers used in preparing M13-A2G4 as described in the Methods. 
Variant Method Forward Primer Reverse Primer 
A6249T SDM  5’ – GCT TGC ATG CCT GCT GGT 
CCT CGA ATT CAC – 3’ 
5’ – GTG AAT TCG AGG 
ACC AGC AGG CAT GCA 
AGC – 3’ 
C1381G SDM 5’ – CTG CAG AGG GTG AGG ATC 
CCG CAA AAG – 3’  
5’ – CTT TTG CGG GAT 
CCT CAC CCT CTG CAG – 
3’ 
T1372A SDM  5’ – CTG TCT TTC GCT GCA GAG 
GGT GAC GAT CC – 3’ 
5’ – GGA TCG TCA CCC 
TCT GCA GCG AAA GAC 




5’ – (phos)GCT GGC GGG GGA GGG 
– 3’ 
5’ – (phos)GAT CCC CTC 
CCC CGC CAG CTG CA – 
3’ 
 
2.2.3 SpySrtA reaction conditions 
 
 Reaction with SpySrtA substrates 
 
The synthetic peptide FITC-LPETGG(N2) (Figure 2.4) was purchased from GenScript (95.9 % 
purity; GenScript, Piscataway, USA). The peptide was prepared as a 10 mg/mL working stock in 




Figure 2.4: Structure of FITC-LPETGG-N2. 
Typical reaction conditions with SpySrtA were prepared with 50 µM p8-A2G4, 500 µM 
substrate (FITC-LPETGG or Coh2 variant), 25 µM SpySrtA in 1x sortase reaction buffer (50 mM Tris-
HCl pH 7.5, 150 mM NaCl) incubated at 37 oC up to 18 h. The reaction conditions and 1x sortase 
reaction buffer were adapted from (Theile et al. 2013). Aliquots of the reaction were removed and 
mixed with sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) loading buffer 
(containing β-mercaptoethanol) to stock the reaction. The gels were analyzed in a gel imager with 534 
nm excitation source and 537 nm filter to image FITC fluorescence. For detection of adducts by 
Western blotting, the primary antibody used was a mouse monoclonal antibody against the M13 major 
coat protein (RL-ph1; Santa Cruz Biotechnology, Dallas, USA). The secondary antibody was goat anti-
mouse conjugated to horseradish peroxidase (Santa Cruz Biotechnology, Dallas, USA). The HRP was 
detected using 3,3′,5,5′-Tetramethylbenzidine (TMB) substrate for membranes (Millipore Sigma, 
Oakville, Canada).  




In the initial design for a multi-enzyme complex built from bacteriophage M13, native 
cellulosomal proteins were used. By coating bacteriophage M13 with Coh from the C. thermocellum 
scaffoldin protein, a nanoscale scaffold with the capability of binding multiple Doc-bearing enzymes 
(such as native cellulases) could be accomplished. There are a number of ways that a Coh-bearing M13 
could be prepared. One of the main difficulties in displaying large proteins onto p8 is that this occurs 
very inefficiently (Sidhu, Weiss, and Wells 2000). In particular, large genetic fusions on p8 likely 
interfere with the assembly of phage particles. When preparing genetic fusions, it has been necessary 
for groups to grow hybrid phage with genes coding for wildtype p8 and the p8-fusion protein (Sidhu, 
Weiss, and Wells 2000). However, display of proteins in this way is still very inefficient – leading to <1 
displayed protein per M13. A group developed an enzyme-mediated approach to preparing fusion 
proteins attached to M13 p8 protein using sortase (SpySrtA) – a bacterial cell-wall sorting enzyme 
(Hess et al. 2012). This method has been demonstrated to be useful for the display of a model protein, 
green fluorescent protein (GFP), onto p8. Thus, this approach was used here for the attachment of Coh 
to M13. 
2.3.1 Component purification 
 
 Three components needed to be prepared to carry out this procedure: Coh2-LPETAG, SpySrtA 
and M13-A2G4. Coh2-LPETAG was expressed and purified with a N-terminal His6-tag for IMAC. 
SpySrtA was also expressed with a His6-tag for IMAC – however, IMAC was not adequate to purify 
the protein and subsequent size-exclusion chromatography (SEC) was required. Lastly, M13-A2G4 was 
purified by typical methods using PEG-8000 precipitation. 
 In order to be recognized by sortase from S. pyogenes LPETAG was fused to the C-terminal 
end of the construct (this construct will be referred to as Coh2-LPETAG). Coh2-LPETAG was 
separated solely by IMAC, eluting as expected over the course of the imidazole gradient (Figure 2.5A). 
Based on the intensity of the bands, the protein expressed very well. Coh2-LPETAG was purified only 
using IMAC with an initial wash of 10 mM imidazole. The purified Coh2 was analyzed by electrospray 
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ionization mass spectrometry (ESI-MS) and the resulting deconvoluted spectrum showed a 
reconstructed mass slightly lower than the theoretical MW of 16734.88 Da (Figure 2.5B). However, 




Figure 2.5: Purification of Coh2-LPETAG starting material.  A) SDS-PAGE of IMAC separation of Coh2-LPETAG as 
described in the Methods. FT is the flowthrough, and E1-6 are fractions eluted during the imidazole gradient. B) 
Deconvoluted ESI-MS of purified Coh2-LPETAG in 1:1 MeOH:H2O + 0.1% FA run on a ThermoFisher Q-Exactive and 
deconvoluted using BioPharma Finder™ (ThermoScientific, v.3.0). 
Initially, the concentration of Coh2-LPETAG was estimated using the Bradford assay; 
however, it was found that the assay grossly underestimated the concentration of Coh2-LPETAG. The 
concentration estimated by the Bradford assay was 338 µM (~5.6 mg/mL). The concentration estimated 
from the calculated extinction coefficient (ProtParam) and UV-Vis spectroscopy was found to be 7.72 
mM (129.2 mg/mL). The Bradford assay therefore underestimated the concentration by more than 20-
fold. The yield ended up being about 60 mg of protein per liter. Typically, differences between the 
protein being assayed and the protein used for the standard curve (bovine serum albumin (BSA)) can 
result in such inaccuracies (Kruger 1994). Though the Coh construct used has 4 Arg and 8 Lys residues, 
which should facilitate binding to the dye, thermostable proteins tend to have a network of ionic 
interactions on their surface stabilizing the protein (Chan et al 2011). Perhaps these make basic residues 
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unavailable for interaction with the Bradford dye. Regardless, this ended up being one of those 
cautionary examples where the protein being studied is poorly assayed with this method. 
SpySrtA was purified initially by IMAC, however the resulting protein was inadequately 
purified by this method alone. This has been noted in the literature, and SEC following IMAC was 
recommended (Guimaraes et al. 2013). Therefore, fractions collected from IMAC were concentrated 
and then applied to SEC to further clean-up the protein (Figure 2.6A). The yield of this protein was 
quite poor, as only 3 mg/L of culture was ultimately purified. This protein was also analyzed by ESI-
MS and the reconstructed mass was consistent with the expected mass of 20556.35 Da (Figure 2.6B). 
Ultimately, this protein would also be tested with a model substrate in the following section to confirm 
that it was indeed active. 
 
Figure 2.6: Purification of SpySrtA.  A) SDS-PAGE of SEC of SpySrtA fractions pooled from IMAC on Superdex® 75 as 
described in the Methods. B) Deconvoluted ESI-MS of purified SpySrtA in 1:1 MeOH:H2O + 0.1% FA run on a ThermoFisher 
Q-Exactive and deconvoluted using BioPharma Finder™ (ThermoScientific, v.3.0). 
 Lastly, M13-A2G4 was cloned according to the Methods and then amplified using standard 
M13 purification protocols. Typically, the yields from these preparations were around 1 – 2 x 1013 
particles/mL, as estimated by their absorbance spectra (Equation 2.1). The solutions were centrifuged 
until they were clear to remove any aggregated protein (15,000 g for 5 min). As a side observation, this 
variant of M13 was more prone to aggregation than M13KE, as the phage tended to settle to the bottom 
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of tubes when stored at 4 oC after a few days. Furthermore, when preparing this variant for ESI-MS it 
was particularly sensitive to dilution into the ESI-MS solvent (50% MeOH) and tended to precipitate at 
higher concentrations. However, diluting M13-A2G4 to a p8 concentration of ~1 µM was suitable for 
preparing the sample without visible precipitates.  
 Interestingly, the ESI-MS did not show the major coat protein to be the expected monoisotopic 
mass. The major peak observed on the spectrum was at 5274.75 Da (Figure 2.7A). The expected 
monoisotopic mass for p8-A2G4 was 5232.77 Da based on its expected mature sequence (Figure 
2.7B). The difference between the observed mass and expected mass corresponded to the mass change 
expected for acetylation. Furthermore, the sequence was confirmed to be the correct one by DNA 
sequencing of the M13-A2G4 stock. While acetylation of proteins is typically thought to be a 
eukaryotic phenomenon, it has been observed extensively in bacteria such as E. coli (Kuhn et al. 2014). 
Based on the consensus sequence published, the altered p8 sequence in A2G4 does make the protein 
appear as a suitable substrate for acetylation of Lys (Figure 2.7C). This was not noted in the original 
paper for the M13-A2G4 framework; however, no intact mass spectra of p8-A2G4 were included in this 
report (Hess et al. 2012). As liquid chromatography tandem mass spectrometry (LC/MS-MS) spectra of 
digested p8-adducts were analyzed in their work, an acetylated fragment may have gone unnoticed. 
Regardless, it is not expected that N-acetylation of the Lys residue would affect the role of p8-A2G4 as 
a nucleophile in the sortase reaction. It is also unlikely that N-terminal acetylation occurred, as 




Figure 2.7: Characterization of M13-A2G4 starting material by ESI-MS.  A) Deconvoluted ESI-MS of M13-A2G4 run in 1:1 
MeOH:H2O + 0.1% FA on a ThermoFisher Q-Exactive. B) Sequence of mature p8-A2G4 with expected monoisotopic masses 
of protein and acetyl modification. C) Consensus sequences for acetate kinase (ackA) Lys acetylation in E. coli from (Kuhn et 
al. 2014) under a creative commons license (https://creativecommons.org/licenses/by/4.0/). 
2.3.2 Reactions with FITC-LPETGG 
 
There are several sets of conditions that have been successfully used to perform reactions using 
sortase. One such publication presents a protocol for the use of sortase (both S. pyogenes and S. aureus 
sortases) to join a peptide-containing probe to the N-terminus of a protein (Theile et al. 2013). They 
provide a range of component concentrations to set up reactions: 0.5 – 1 mM peptide, 10 - 50 µM target 
protein, 20 – 150 µM sortase A in 1x sortase buffer and 37 oC. The final concentrations for the reaction 
buffer are 50 mM Tris pH 7.5 and 150 mM NaCl (CaCl2 can be omitted for SpySrtA). What is 
particularly noticeable is the recommended high enzyme concentration.  
 The purified components were first tested to confirm that they were indeed reactive and that the 
reactions would proceed as described in the literature. To test the SpySrtA enzyme and the A2G4-M13 
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strain that were prepared as described in the Methods, the fluorescent peptide FITC-LPETGG was used. 
This particular substrate had an amidated “C-terminus”, rather than the usually carboxy-terminus. Such 
small molecule substrates have previously been reported as successful sortase substrates (Nelson et al. 
2010). It was necessary to use high concentrations of both the substrate, FITC-LPETGG, and SpySrtA. 
At 500 µM FITC-LPETGG and 2.5 µM SpySrtA, there was very little product detected by denaturing 
PAGE at several time points (Figure 2.8A). However, at 25 µM SpySrtA labelling of p8 was observed. 
The acyl-enzyme intermediate (SpySrtA/FITC) could also be detected throughout the reaction. The gel 
was stained and imaged to confirm the bands ran at their expected MW (Figure 2.8B). Overall, the 
components were active – however, the reaction was inefficient and proceeded slowly. It was clear 
from these tests that high substrate concentrations and enzyme concentration would be necessary for 
effective reaction. High substrate concentration is typically recommended to offset the hydrolysis side 
reaction that can occur (Levary et al. 2011). More specifically, it is recommended to have the sortase 
enzyme at 1/10th the concentration of the substrate. 
 
 
Figure 2.8: Monitoring reaction of SpySrtA, M13-A2G4 and FITC-LPETGG fluorescent substrate over time.  Aliquots were 
taken at 0 and 1, 3 and 21 h. Tricine-PAGE gel of FITC-LPETGG/M13-A2G4 reactions with variable amounts of SpySrtA 
under A) fluorescence imaging, and B) after staining with Coomassie stain. The red arrow indicates the location of the p8 
band. The blue arrow indicates the location of the SpySrtA band. 
Based on the observed reactions with the small, fluorescent peptide FITC-LPETGG, the 
purified SpySrtA was indeed active and the M13-A2G4 capable of being modified by SpySrtA as 
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described in literature. These conditions would be used to inform on those necessary for reaction with 
the protein substrate, Coh2-LPETAG.  
2.3.3 Reactions with Coh2-LPETAG and M13-A2G4 
 
 After testing the SpySrtA enzyme preparations with FITC-LPETGG, reactions with M13-A2G4 
and Coh2-LPETAG were tested. Unlike FITC-LPETGG which was easily detected by its fluorescence, 
identification of the Coh-p8 adduct by denaturing PAGE was not possible due to the similar MW of 
some of the components (Table 2-3). In particular, the expected MW of the Coh2-p8 adduct and 
SpySrtA enzyme were similar – 21.9 and 20.6 kDa respectively. As it was unlikely that the adduct 
would be confirmed by denaturing PAGE only, some alternate methods were tested. 
Table 2-3: Average molecular weight of components used as substrates for SpySrtA-mediated reactions and estimated masses 






SpySrtA acyl-enzyme intermediate 37.3* 
 
 In the purification of M13, the filamentous phage is typically precipitated by PEG-8000 and 
NaCl. This method has been used in several literature approaches to purify M13 reacted with various 
small molecules (Chung, Lee, and Yoo 2014; Jinsu Kim et al. 2015). This was tested here to determine 
the extent to which the M13 and any formed adducts might be separated from unreacted components. 
Reactions were carried out with a 10-fold excess of substrate to SpySrtA (500 µM Coh2-LPETAG). As 
determined from initial testing with FITC-LPETGG test substrate, an excess of substrate was required 
in addition to a high enzyme concentration. Prior to PEG precipitation, the excessive amount of 
substrate required for reaction made the reactions difficult to analyze directly by SDS-PAGE (Figure 
2.9A). To clean-up the reaction mixtures and make it clearer to identify possible products, the reaction 
mixtures were fractionated by PEG precipitation and the supernatant and pellets analyzed by SDS-
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PAGE (Figure 2.9B). The precipitation method did not adequately remove unreacted Coh2-LPETAG, 
though the M13 p8 band was clearly separated to the pellet fraction. While the SpySrtA band was 
effectively removed by PEG precipitation according to the control lane, there was no clear band that 
might correspond to the p8-Coh2 adduct.   
 
Figure 2.9: Monitoring reaction progress of M13-A2G4 and Coh2-LPETAG via the SpySrtA-catalyzed transpeptidation 
reaction.  A) Tricine-PAGE gel of sortase reaction of 500 µM Coh2, 25 µM SpySrtA and 50 µM p8-A2G4 at 0 and 4 h with 
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control lacking M13-A2G4. B) Tricine-PAGE gel of precipitated SpySrtA reactions in A). Aliquots were taken of the 
supernatant and resuspended pellets after overnight precipitation. C) Western blot of precipitated SpySrtA reactions in B) 
using anti-p8 primary antibody and HRP-conjugated secondary antibody. The arrows correspond to the positions or expected 
positions of SpySrtA (blue), Coh2-LPETAG (green) and p8-A2G4 (red). 
 
It was briefly tested whether the adduct (containing p8) might be a suitable antigen for an anti-
p8 antibody, as a possible way to distinguish the Coh2-p8 adduct from other components. Western 
blotting to try and detect attached p8 was not possible given that the antibody did not recognize p8 with 
the N-terminal modifications (p8-A2G4) (Figure 2.9C). Several other bands in M13-containing 
samples were reactive toward the anti-p8 antibody. In the control lanes for WT M13 and A2G4-M13, 
the inability to detect A2G4-p8 was most obvious – showing that M13-A2G4 is not antigenic toward 
antibodies prepared for WT M13. Overall, there was no clear evidence of Coh2-LPET-p8 having 
formed. It would therefore be recommended that in designing substrates for this procedure that they be 
designed with an additional specific tag for the purpose of antibody detection in order to avoid the 
complication of similar MW components.  
It was furthermore apparent that the expected yield of adduct (if formed) would be quite low. 
Even assuming that levels of adduct formation comparable to those observed in the literature were 
obtained, this would not be suitable for preparing a large, densely clustered multi-enzyme complex on 
M13. In particular, the literature values estimate about 3.4 % of p8 subunits reacted with GFP-LPETG 
to form an adduct via the sortase-mediated reaction (Hess et al. 2012). If considering this an 
approximate expected yield for the reaction, there would need to be a sensitive method to detect the 
adduct. While mass spectrometry is highly sensitive, direct analysis of reaction mixtures with intact 
proteins was later shown to be inappropriate for detecting an adduct, as the major coat protein of M13-
A2G4 suppressed the ionization of other components (see Section 2.3.4).  
In summary, the p8-LPET-Coh2 adduct was not easily detected, and the following two 
considerations should be taken: 1) that the substrate, for the purpose of confirming successful reaction, 
should be designed with a specific immunoreactive tag, as direct identification of p8-adducts are 
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unlikely given their expected low yields and, 2) as an alternate means to ESI-MS of intact proteins, it is 
likely necessary that more elaborate methods, such as LC-MS/MS following digestion of the proteins 
be done to reduce ionization suppression from p8. Given the low expected yields, the approach was not 
extensively pursued to use as the main method for assembling multiple cellulases on the surface of M13 
– however, a few aspects were investigated further.   
 
2.3.4 Cyclization of Coh2-LPETAG by SpySrtA 
 
 Over the course of trying to detect a p8-Coh2 adduct, it became apparent that there was also a 
side-reaction occurring in the reaction mixtures containing Coh2 and SpySrtA (presence or absence of 
M13). Initial reactions containing SpySrtA, p8-A2G4 and Coh2-LPETAG resulted in the formation of a 
lower MW band over time (Figure 2.10). Initially it was hypothesized that this might be a hydrolysis 
(or reaction with Tris buffer) side-reaction at an internal amino acid sequence that resembled a sortase 
substrate close enough to react. To test for cross-reaction of Tris with the acyl-enzyme intermediate, the 
FITC-LPETGG test substrates were reacted in either Tris, or HEPES buffer – however, no difference of 
in-gel fluorescence was noted (not shown). However, it was later confirmed by ESI-MS that the mass 
of a reaction mixture consisting of both SpySrtA and Coh2-LPETAG was instead consistent with a 
cyclization reaction occurring with the N-terminus of the Coh2-LPETAG protein (Figure 2.11). This 
was identified by a mass peak corresponding to Coh2-LPET without its N-terminal Met1 and 
furthermore, missing mass corresponding to water (18 Da). The formation of a cyclized protein was 
consistent with the formation of a lower MW band on denaturing PAGE in figure 10, since the cyclized 





Figure 2.10: Tricine-PAGE gel of 50 µM Coh2-LPETAG, 50 µM p8-A2G4 or 500 µM FITC-LPETGG reactions and control 
without 25 µM SpySrtA.  Aliquots were taken at 0 and 20 h. The arrows correspond to SpySrtA (blue), Coh2-LPETAG (green), 
cyclized Coh2-LPETAG (yellow) and p8-A2G4 (red). 
 
Figure 2.11: ESI-MS evidence of Coh2-LPETAG cyclization catalyzed by SpySrtA.  A) Deconvoluted ESI-MS of Coh2-
LPETAG only. B) Deconvoluted ESI-MS of Coh2-LPETAG in the presence of SpySrtA. Also shown are the expected sequences 
of the highlighted primary peaks in the spectra. 
This has been seen with other proteins where Ala is the second residue and the N- and C-
termini are in close proximity. In fact, for many of the proteins for which there are structures available, 
about 2/3 have N- and C-termini in close proximity (Antos et al. 2009). Inspection of the structure of 
Coh2 indicates that the N- and C-termini are indeed close to each other and could conceivably react 
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(Figure 2.12). The exact distance cannot be estimated due to the missing portions of the sequence in the 
structure shown. It has been suggested that in the case of proteins with Ala2 as the residue following the 
N-terminal Met that it be mutated to Ser to reduce the potential for this occurring (Guimaraes et al. 
2013). The mutation Ala2Ser was planned for a future Coh2 construct to eliminate this side-reaction 
that could be reducing the amount of p8-adduct forming. Though, it has been shown that addition of a 
small peptide (i.e.. GGG (Antos et al. 2009)), can shift the equilibrium back to a linear product, p8-
A2G4 on intact M13 would be considerably more hindered as a nucleophile compared to a small 
peptide and may not effectively do so. 
 
Figure 2.12: Structure of Coh2 with the C-terminal residue indicated.  The sequence shown has the amino acids not included 
in the structure underlined. Additionally, Coh2-LPETAG has the following N-terminal residues that are not present in this 
structure: “AHHHHHHAAG”. Structural data comes from PDB:1ANU (Shimon et al. 1997). 
In addition to the planned Ala2Ser mutation to reduce cyclization, an additional mutation was 
made to the C-terminus in an effort to make the substrate more likely to react with p8-A2G4. Recall, 
the reactions with the test substrate, FITC-LPETGG, confirmed that the purified SpySrtA was active, 
and that p8-A2G4 was capable of reaction with it. As mentioned above, the approach of p8-A2G4 to 
liberate Coh2 from the covalent SpySrtA intermediate would be more hindered in comparison to its 
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approach to react with a FITC/SpySrtA covalent intermediate (Figure 2.13). Therefore, the ability of 
M13-A2G4 to be positioned to react with the acyl-enzyme intermediate might be further improved with 
an additional extension to its C-terminal linker. With this in mind, a GGGGS spacer was also added by 




Figure 2.13: Steric considerations for reaction of Coh2-LPETAG to M13 using SpySrtA.  Comparison of (right) experimental 
structure of Coh2 and (left) computational structure of SpySrtA with a LPSTG peptide docked into its active site (shown in 
green; from (Race et al. 2009)). The Coh2 structure is coloured such that it goes from blue to red for N- to C-terminus. 
 Mutation of Coh2 N-terminus to reduce cyclization 
 
Ala2 was mutated to Ser in order to reduce the extent to which the protein could react with 
itself via SpySrtA. Furthermore, Coh2-LPETAG was further modified to have an extended GGGGS 
linker added to the C-terminus. Despite the modification to the N-terminus, the Coh2 construct was still 
quite capable of cyclization (Figure 2.14A). ESI-MS confirmed that the product could still cyclize. 
Formation of cyclized product was also apparent by SDS-PAGE analysis of SpySrtA and A2S-Coh2-
GGGGS-LPETAG over time (Figure 2.14B). Approximately 15 % of the Coh2 was cyclized at 3 hours 
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when reacted at 37 oC, according to densitometry. In one source, A2S mutations have been 
recommended suggested to prevent cyclization reaction from occurring (Guimaraes et al., 2013). From 
these results, it was apparent that this is not adequate to completely prevent the cyclization side 
reaction. A more drastic change in the second amino acid from the N-terminus should be considered 
instead. Val has been used to prevent this cyclization side reaction; the authors mutated the N-terminus 
such that the 2nd amino acid after Met would be Val and found that hydrolysis of acyl-enzyme 
intermediate could be detected, but not cyclization (Antos et al., 2009). However, with the 
modifications here, it was possible that cyclization was reduced and so it was briefly examined whether 
M13-A2G4 could react with a higher efficiency and be more easily detected. 
 
Figure 2.14: Reaction of 25 µM SpySrtA with 50 µM A2S-Coh2-GGGGS-LPETAG to check for cyclization.  A) Deconvoluted 
ESI-MS of mixture at 3 h reaction time. B) SDS-PAGE gel of reaction mixture at indicated time points. 
 Again, without re-engineering the substrate to contain a specific tag for immunodetection, 
formation of an adduct could not be unambiguously identified. Indirectly, there was indication that the 
mutations were favorable in aiding the formation of p8-LPET-Coh2 product. A sortase reaction with the 
new substrate was set up and aliquots were removed during the course of the reaction to analyze 
possible products by SDS-PAGE (Figure 2.15A). If M13-A2G4 was included as a competing 
nucleophile, any reduction in the formation of the cyclized Coh2 band could be an indication of some 
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kind of competing reaction – such as p8-Coh2 adduct formation. When M13-A2G4 was present in the 
reaction, the formation of cyclized Coh2 was reduced by about 33% by densitometry. 
The reactions were also analyzed by ESI-MS of the intact proteins. An aliquot was removed at 
3 h and desalted for ESI-MS. It should be noted that intact protein analysis by ESI-MS was not an 
appropriate method for analysis of the products of this reaction with M13. When complete reactions 
were desalted and analyzed by ESI-MS, it became apparent that M13-A2G4 signal suppressed 
ionization of Coh2 and SrtA signals (Figure 2.15B). When comparing the signal of Coh2 and SpySrtA 
without M13-A2G4 present – the charge envelope in the raw spectrum was clearly visible. However, 
with M13-A2G4, only a signal corresponding to the major coat protein could be seen in the raw 
spectrum despite having the same concentration of Coh2 variant. No signal corresponding to a p8-Coh2 
adduct could be detected. 
 
Figure 2.15: Testing reaction with of modified Coh2 variant with M13-A2G4 to compete with cyclization.  Reaction conditions 
were 25 µM SpySrtA with 50 µM A2S-Coh2-GGGGS-LPETAG with 25 µM p8-A2G4 at 37 oC. A) SDS-PAGE gel of reaction 
with or without p8-A2G4. Raw ESI-MS of reaction B) without M13-A2G4 or C) with M13-A2G4. The m/z species that were 
relevant to either A2S-Coh2-GGGGS-LPETAG or p8-A2G4 are highlighted. 
2.4 Conclusions 
 
A desirable nanoscale multienzyme scaffold is one that is uniformly and highly concentrated 
with some binding or adhesive moiety on the surface to ensure uniform distribution and high loading of 
enzyme. It became apparent while working with this enzyme-mediated approach that it would likely be 
insufficient in meeting these goals. In particular, the efficient cyclization of Co2-LPETAG (with A2S 
70 
 
mutation as well), and the expected low yields of adduct based on literature values describing the same 
system, indicated that alternate methods should be pursued. Though the SrtA reaction has seen broad 
and effective applicability over the years (Dai, Böker, and Glebe 2019), it seems as though the approach 
of the SrtA enzyme to the phage surface might be too hindered to achieve the high and uniform degree 
of labelling desired for this particular nanoscale scaffold. Furthermore, as the reaction progresses one 
might expect the surface to become even more difficult for the enzyme-substrate intermediate to 
approach. In the following sections, a re-design of the nanoscale scaffold was instead pursued to reduce 
the potential steric limitations of enzymatic modification: M13 was instead modified densely with a 
small molecule via bioconjugate techniques that could bind a high affinity adaptor protein.
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Chapter 3 Multi-enzyme assembly using streptavidin as an adaptor 




 In the previous chapter, an enzyme-mediated approach was used to prepare multi-enzyme 
complexes on M13. In exploring that approach however, it was determined that the resulting scaffold 
would be unlikely to be densely loaded with protein. This chapter will cover the approaches taken 
utilizing streptavidin (SA) as an adaptor molecule to bind multiple enzymes to the major coat protein 
(p8) of M13. The main interaction used in the approaches discussed in this chapter then, is the tight 
binding between SA and biotin (Section 1.5). In all cases, the approaches in this chapter utilize 
covalently biotinylated M13 which was then used to bind to SA (Figure 3.1). This was then further 
complexed with the cellulase, Cel8A from C. thermocellum, utilizing a non-covalent interaction 
between the His6-tag present on the enzyme and a biotin analogue attached to three of the four SA 
ligand-binding sites. 
 
Figure 3.1: Schematic representation of multi-enzyme complex assembly using biotinylated enzyme and SA as an adaptor 
molecule. 
M13 was covalently labelled with biotin which was used to bridge the p8 coat protein with the 
SA adaptor molecule. It has been demonstrated that acylation of primary amines of the major coat 
protein p8 (Ala1 and Lys8) with an activated ester is an efficient strategy. With N-hydroxysuccinimidyl 
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5(6)-carboxytetramethylrhodamine (NHS-TAMRA), as high as ~1600 5(6)-
carboxytetramethylrhodamine (TAMRA) per M13 phage was obtained when reacted (K. Li et al. 
2010). The authors found that both Lys8 and Ala1 were modified, though Ala1 was modified more 
readily. This approach was therefore deemed appropriate for preparing multiply and efficiently 
biotinylated M13. Thus, M13 was labelled by acylation of primary amines with an activated ester of 
biotin to serve as a connector between the intact bacteriophage and SA (Figure 3.2). This would serve 
as one of the main components used in building M13 complexes in this chapter and Chapter 4. 
 
Figure 3.2: Structure of activated ester, TFP-PEG12-biotin, used to biotinylated M13 at the primary amines of p8. 
 As alluded to, an affinity interaction between the His6-tag on Cel8A and a chelated metal was 
used to attach Cel8A to the SA adaptor. Loading Cel8A onto SA in this way was done to make this 
approach generally applicable to any His-tagged protein/enzyme of interest. Although this introduced 
an additional step in preparing this complex, the general applicability would make the resulting scaffold 
far more useful. In this design, SA was complexed to His6-tagged Cel8A via biotin-X-NTA (BXN; Nε-
(N-(+)-Biotinyl-6-aminohexanoyl)-Nα,Nα-bis(carboxymethyl)-L-lysine) bound to SA (Figure 
3.3). The nitrilotriacetic acid (NTA) group is able to mediate binding to the His6-tagged protein via a 
chelated metal which results in a coordination complex between the protein of interest and the biotin 
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moiety on BXN. In this design, Co(II) is bound to the NTA and His6-tagged Cel8A; however, this can 
be further oxidized to Co(III) resulting in a kinetically stable complex (Wegner and Spatz 2013). In 
their work, Wegner and coworkers demonstrated that by oxidizing Co(II) to Co(III) after equilibration 
with a His-tagged protein, the off-rate of the resulting coordinated complex was decreased by many 
orders of magnitude down to 1.1 x 10-6 s-1. As a reference point, this is the same order of magnitude as 
the off-rate of the SA/biotin interaction. The metal affinity interaction was therefore used here to form a 
stable arrangement of Cel8A onto the SA adaptor protein. Mentions in this chapter to complexes 
prepared via the “Co(III)-mediated approach” are in reference to this methodology, adapted for His6-
tagged Cel8A. 
 
Figure 3.3: Schematic representation of M13/SA(BXN):Co(III):Cel8A complexes.  A) Cartoon representation of 
M13/SA(BXN):Co(III):Cel8A complex showing intended stoichiometry. The interaction shown between SA and Cel8A is the 
molecule, biotin-X-NTA (BXN) shown above. B) Relative size of components with M13-PEG12-biotin (green; PDB: 1IFJ, (D. 
A. Marvin et al. 1994)), SA (white; PDB: 3RY2, (Le Trong et al. 2011)), and three Cel8A (rainbow; PDB: 1CEM, (Alzari, ne 
Souchon, and Dominguez 1996)) attached via BXN coordinated to Co(III) and His6-tag of Cel8A (built using Maestro 
(Schrödinger)). 
The sections in this chapter will be presented as outlined in the chapter overview. A 
commonality to the various approaches in this chapter (and the following chapter) is the utilization of 
the SA/biotin non-covalent interaction as the primary interaction holding the complex together. 
Therefore, the first topic that will be discussed are some experiments and considerations regarding the 
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binding of biotin to SA for the purpose of forming multi-protein complexes (Figure 3.4). These include 
the formation, stability and dynamic nature (at higher temperatures) of the biotin/SA bond. This is 
presented early on in the chapter such that some of the behaviors observed when preparing M13 
complexes with a SA adaptor can be discussed within that context. 
 
Figure 3.4: Organization of topics in Chapter 3.  
Next, given the very defined arrangement of each component in the design, the main challenge 
was in devising a methodology that directed the self-assembly of each component toward the final 
structure depicted in Figure 3.3. Initially, the interaction between just Cel8A and BXN via the Co(III)-
mediated interaction was tested to ensure it would function correctly and that Cel8A would still be 
active under the conditions used to oxidize Co(II) (Figure 3.4). After confirming that the Co(III)-
mediated approach was suitable for Cel8A and BXN, further complexation to SA was explored –
producing SA with a single open biotin-binding site remaining to allow binding to M13-biotin. 
However, given that SA has four biotin-binding sites, it was expected that a mixture of SA species with 
differing valencies (of unoccupied biotin-binding sites) would form.  
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There were two main strategies tested for preparing the M13/Cel8A complex with a single free 
biotin-binding site: 1) preparing a mixture of SA(BXN:Co(III):Cel8A)N complexes and separating 
species by size-exclusion chromatography (SEC), and 2) preparing SA(BXN)N and separating species 
by ion exchange chromatography (IEC) followed by complexation with Cel8A using the Co(III)-
mediated approach (Figure 3.5). The former approach was not viable as individual 
SA(BXN:Co(III):Cel8A)N species could not be resolved; however, the latter approach was able to 
successfully isolate the SA(BXN)3 species for further complexation with M13-biotin. Then in a final 
step, the complexation of Cel8A to this scaffold via the Co(III)-mediated approach was examined in a 
series of transmission electron microscopy (TEM) experiments. Though ultimately, there were some 
drawbacks to utilization of the Co(III)-mediated approach for docking Cel8A onto the scaffold, some of 
the methodologies involved in isolating a “monovalent” SA highlight successful strategies to ensure 
multi-valent adaptors (i.e.. SA) have the desired arrangement of components. Furthermore, the efficient 
docking of SA(BXN)3 to M13 highlights the interesting interplay of how viral subunit symmetry and 




Figure 3.5: Overview of schemes for isolating SA(Cel8A-biotin) of the desired stoichiometry from the chelated metal affinity 






SA (>95% purity according to the supplier; Cedarlane, Burlington, Canada) was supplied as a 
lyophilized protein (from 10 mM potassium phosphate buffer pH 6.5) and was resuspended up to 5 
mg/mL in ultra-pure (18 MΩ·cm resistivity) water (MQH2O). The concentration of SA was 
determined by its estimated monomer extinction coefficient at 280 nm of 41940 M-1 cm-1 (ProtParam, 
ExPASy). Low viscosity carboxymethylcellullose (CMC) sodium salt (Millipore Sigma, Oakville, 
Canada) was prepared freshly as a 1% (w/v) solution in 0.1 M sodium citrate pH 5.8. 
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3.2.2 Phage amplification and protein expression 
 
 M13 amplification 
 
 M13KE was amplified by inoculating a 1:100 diluted overnight culture of E. coli K12 ER2738 
(New England Biolabs, Whitby, Canada) in Luria Broth (LB) media (1% (w/v) peptone, 0.5% (w/v) 
yeast extract, 1% NaCl (w/v)) supplemented with 8 µg/mL tetracycline. M13KE was inoculated to a 
final titer of ~106 plaque-forming units (PFU) per mL and amplified for 4.5 – 5.5 h at 37 oC with 
shaking for aeration. E. coli were pelleted by centrifugation at 12000 g for 10 min and 4 oC. 
 M13 was concentrated by PEG precipitation with PEG/NaCl solution (20% PEG-8000, 2.5 M 
NaCl). The resulting supernatant was mixed with a 1/5 volume of PEG/NaCl solution and precipitated 
for 18 h at 4 oC. The precipitated M13 was centrifuged at 12000 g for 15 min at 4 oC. The pellet was 
resuspended in a solution of 1x phosphate-buffered saline (PBS; 10 mM Na2HPO4, 1.8 mM KH2PO4, 
137 mM NaCl, 2.7 mM KCl) pH 7.4 that was 1/20 the volume of the initial culture volume. A 1/6 
volume of PEG/NaCl solution was added for a second round of precipitation for 30 min on ice. The 
phage was pelleted by centrifugation at 15000 g for 10 min. The final pellet was resuspended in a 
volume of 1x PBS that was 1/100 the initial culture volume. If the solution was cloudy, it was 
centrifuged at 15000 g for 1 min to clear the supernatant. The resulting phage solutions were flash 
frozen in liquid nitrogen and stored at -80 oC. 
The M13 stocks were quantified by measuring the absorbance at 269 nm. This can be converted 
to a measure of M13 concentration in particles/mL using Equation 3.1. Nbases is the number of bases in 
the M13 ssDNA genome which is 7222 bp for M13KE. The 6 x 1016 coefficient can be derived from the 










 Cel8A expression and purification 
 
The sequence of Cel8A from C. thermocellum was cloned in a pET28b(+) vector (GenScript, 
Piscataway, USA). The cellulase was cloned with a C-terminal His6-tag as has been done previously in 
the literature (Anbar et al. 2012). The protocol for expression and purification was adapted from the 
literature for this enzyme (Anbar et al. 2012). Briefly, the protein was overproduced from transformed 
BL21 E. coli which was grown to ~0.8 OD at 37 oC in LB media with 50 µg/mL kanamycin. Protein 
expression was induced at 37 oC with 1 mM IPTG for 3 h, at which point the cells were collected by 
centrifugation at 5000 g for 15 min at 4 oC. 
To 1 L worth of cell pellet, 30 mL of lysis buffer (25 mM Tris, 137 mM NaCl, 2.7 mM NaCl, 5 
mM imidazole) supplemented with 0.5 mM phenylmethylsulfonyl fluoride (PMSF). The resuspended 
pellet was passed three times through a high-pressure homogenizer (>10,000 psi) to lyse the cells. The 
lysate was incubated at 60 oC for 30 min and then centrifuged at 20,000 g for 30 min at 4 oC. The 
protein was purified by immobilized metal affinity chromatography (IMAC). The cleared lysate was 
loaded onto a 1 mL HisTrap™ (GE Healthcare, Chicago, USA), washed with 5 mL of wash buffer (25 
mM Tris, 137 mM NaCl, 2.7 mM NaCl, 10 mM imidazole), and eluted over a 5 mL gradient from 5 to 
250 mM imidazole. The sample was dialyzed against 50 mM sodium acetate pH 6 using a 12400 Da 
MWCO dialysis membrane (Millipore Sigma, Oakville, Canada). The purified protein was flash frozen 
in liquid nitrogen and stored at -80 oC. Cel8A was quantified by measuring its absorbance at 280 nm 
and using its theoretical extinction coefficient of 104420 M-1 cm-1 calculated by ProtParam (Gasteiger et 
al. 2005). 
3.2.3 Bioconjugation methods 
 




Tetrafluorophenyl-PEG12-biotin (TFP-PEG12-biotin) was first prepared as a 10 mM stock in 
anhydrous dimethyl formamide (DMF). The final reaction concentrations were 100 µM p8, 1 mM TFP-
PEG12-biotin in 1x PBS pH 7.46 with 20% DMF. Reactions were carried out over 18 h at 4 oC. These 
were then dialyzed 6 times against 2 L of 1x PBS pH 7.46 in 12.4 kDa MWCO regenerated cellulose 
dialysis tubing (Millipore Sigma, Oakville, Canada). M13-PEG12-biotin were flash frozen with liquid 
nitrogen and stored at -80 oC. The concentration of M13-PEG12-biotin was determined according to its 
A269 absorbance as described in Section 3.2.2.1. 
 Reaction of Cel8A with TFP-PEG12-biotin  
 
Cel8A was diluted to 160.8 µM in 100 mM sodium phosphate buffer pH 7.46. To this solution, 
800 µM TFP-PEG12-biotin was added to initiate the reaction. The total amount of DMF present in the 
reaction was 10% (v/v). The reaction was carried out for 18 h at 4 oC. After reaction, the labeled Cel8A 
samples were dialyzed for a total of three 2 L dialysis exchanges (6 h minimum, 23 oC) in 12400 kDa 
MWCO dialysis tubing (Millipore Sigma, Oakville, Canada) against 1x PBS pH 7.4. Labelled protein 
was flash frozen with liquid nitrogen and stored at -80 oC. The protein was quantified as described in 
Section 3.2.2.2. 
 Reaction of Cel8A with NHS-TAMRA 
 
 Cel8A was diluted to 80.4 µM in 100 mM sodium phosphate buffer pH 7.9. To this solution, 
400 µM NHS-TAMRA in DMSO was added to initiate the reaction. The total amount of DMSO 
present in the final reaction mixture was 10 % (v/v). The reaction was carried out for 3 h at 23 oC. After 
reaction, the labeled Cel8A samples were dialyzed for a total of three 2 L dialysis exchanges (6 h 
minimum, 23 oC) in 12400 kDa MWCO dialysis tubing (Millipore Sigma, Oakville, Canada) against 1x 
PBS pH 7.9. Labelled protein was flash frozen with liquid nitrogen and stored at -80 oC. The quantity of 
Cel8A-TAMRA recovered was calculated using the theoretical extinction coefficient of 104420 M-1 cm-
1 with an additional correction factor (CF) of 0.3 to account for the absorbance of the dye at 280 nm. 
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The extinction coefficient of the dye used was 65000 M−1 cm−1 (Meadows, Shafer, and Schultz 1991). 
The correction factor was calculated from the ratio of (280/517) nm absorbances for the free dye. 
3.2.4 Characterization of SA/biotin binding 
 
 Desthiobiotin exchange 
 
Desthiobiotin (dtb) stock was prepared as a 40 mg/mL dimethyl sulfoxide (DMSO) stock. This 
was further diluted to a working concentration of 1 mM in water. SA at a tetramer (SAtet) concentration 
of 10 µM was mixed with 40 µM desthiobiotin in 1x phosphate-buffered saline (PBS: 10 mM 
Na2HPO4, 1.8 mM KH2PO4, 137 mM NaCl, 2.7 mM KCl) pH 7.4. This was further diluted to a working 
stock concentration of 2.5 µM SAtet. In preparing each displacement experiment, SA/desthiobiotin was 
first added to 1x PBS pH 7.4 buffer in a quartz fluorescence cuvette to final concentrations indicated in 
the relevant figures. Biotin-4-fluorescein (B4F; Figure 3.6) was then added to a final concentration 
ranging from 25 to 300 nM and the exchange was monitored using 490 nm excitation, 525 nm emission 
with a 515 nm cut-off filter at 23 oC. Controls without SA present were similarly prepared and 
monitored for a shorter time (~2 min) to determine fluorescence of B4F at t = 0 h. Fluorescence data 
was collected on a SpectraMax® M5 (Molecular Devices, San Jose, USA) with the photomultiplier 
tube sensitivity set to high. 
 
Figure 3.6: Structure of biotin-4-fluorescein (B4F). 
Conversion of fluorescent data in relative fluorescence units (RFU) to molar amounts of B4F 
was done by creating a standard curve of fluorescence over a range of 0 – 544 nM B4F. A standard 
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curve was prepared for each experiment using the same prepared buffers. Concentrations of B4F stocks 
were determined in 1x PBS pH 7.4 by measuring the absorbance at 494 nm and literature extinction 
coefficient of 68000 M-1 cm-1 (Ebner et al. 2008). 




Figure 3.7: Competing equilibria used to model desthiobiotin (dtb)/B4F exchange process. 
 This model is simplified, in that the four biotin-binding sites per SA tetramer are treated as 
equal. This follows from literature evidence which shows all four sites are equivalent and that there is 
no cooperative binding (Deng, Kitova, and Klassen 2013). The equilibria were therefore described by 
the following system of ordinary differential equations (Equations 3.2 – 3.6) that were solved by 
numerical methods using DynaFit4 to perform the analysis (Kuzmič 2009). 
𝑑[𝑆𝐴:𝑑𝑡𝑏]
𝑑𝑡
= 𝑘1[𝑆𝐴][𝑑𝑡𝑏] −  𝑘−1[𝑆𝐴: 𝑑𝑡𝑏]        (3.2) 
𝑑[𝑆𝐴]
𝑑𝑡
=  𝑘−1[𝑆𝐴: 𝑑𝑡𝑏] − 𝑘1[𝑆𝐴][𝑑𝑡𝑏] − 𝑘2[𝑆𝐴][𝐵4𝐹] + 𝑘−2[𝑆𝐴: 𝐵4𝐹]     (3.3) 
𝑑[𝐵4𝐹]
𝑑𝑡
= 𝑘−2[𝑆𝐴: 𝐵4𝐹] −  𝑘2[𝑆𝐴][𝐵4𝐹]        (3.4) 
𝑑[𝑑𝑡𝑏]
𝑑𝑡




= 𝑘2[𝑆𝐴][𝐵4𝐹] − 𝑘−2[𝑆𝐴: 𝐵4𝐹]        (3.6) 
 
 B4F/BXN thermal exchange 
 
This experiment was to test dynamic binding and rebinding of biotin to SA by competitive 
binding between pre-bound biotin analogue, BXN, with fluorescent analogue, B4F. First, 10 µM SAtet 
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was mixed with 40 µM BXN in 1x PBS pH 7.4 to form 10 µM SA(BXN)4. This was further diluted 
down to 100 nM SA(BXN)4 in 1x PBS pH 7.4. B4F was added to a final concentration of 400 nM to 
initiate the exchange in separate tubes (obscured from light) which were incubated at either 23 oC or 50 
oC in a temperature-controlled water bath. The fluorescence was read in 96-well opaque (black) plates 
at 490 nm excitation, 525 nm emission (515 nm cutoff) at 0, and 18 h incubation time at each 
temperature. 
3.2.5 Cobalt-mediated approach to prepare multi-enzyme complexes 
 
 Co(II):NTA complexes with Cel8A 
 
 This protocol was adapted for complexation of Cel8A and NTA with Co(II) followed by 
oxidation to Co(III) (Wegner and Spatz 2013). CoCl2 and biotin-X-NTA were mixed at a 1:1 ratio at 
2.5 mM in MQH2O. Cel8A at a final concentration of 20 µM and BXN:Co(II) at 100 µM were 
incubated together in 1x PBS pH 7.4 for 2.5 h to equilibrate. A working stock solution of 500 mM H2O2 
was prepared fresh from a 30% (9.8 M) stock solution and added to a final concentration of 10 mM to 
the Cel8A:Co(II):BXN solution above. A control without H2O2 was also prepared. 
 To assess complexation, the resulting solutions were separated by IMAC. Samples were loaded 
onto a 1 mL HisTrap™ column in wash buffer (25 mM Tris, 137 mM NaCl, 2.7 mM KCl, 10 mM 
imidazole pH 7.4). The samples were eluted with a 10 – 100 mM imidazole gradient over 10 mL at 0.5 
mL/min. Afterward, the individual fractions of Cel8A which were recovered were assayed using the 
Bradford assay with purified Cel8A for the standard curve using Bradford 1x dye reagent (Bio-Rad, 
Hercules, USA) according to the manufacturer. 
 Collected fractions from IMAC were assayed for endocellulase activity against model cellulose 
substrate, CMC. A CMC stock solution was first prepared at 1 % (w/v) in 0.1 M sodium citrate pH 5.8. 
These solutions were stored no longer than a week at 4 oC. Hydrolysis of CMC was monitored by end-
point analysis with a dinitrosalicylic acid reagent (DNS; Millipore Sigma, Oakville, Canada) to detect 
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the reducing ends present in solution. The DNS reagent was prepared in the proportions described 
(Aiba, Kitai, and Imanaka 1983). First, 25 mL of a 60% w/v solution of sodium potassium tartrate 
(gently heated to dissolve). Separately, 0.5 g DNS solution was prepared in 15 mL water. The tartrate 
solution was added slowly to this solution (a yellow precipitate forms). Upon adding 10 mL 2 M 
NaOH, the precipitate will dissolve, and the resulting orange solution is brought up to 50 mL with water 
and stored at 23 oC. To assay for reducing ends, an equal volume of this solution was added to CMC 
reactions at the end points of the reaction. The solutions were boiled 5 min to develop the colour, and 
absorbance was read at 540 nm. These were compared to a standard curve of D-glucose to determine 
the reducing ends present in the solution. 
 Separating SA(NTA):Co(III):Cel8A complexes by SEC 
 
SA was bound with BXN followed by Cel8A via the Co(III)-mediated interaction to prepare 
complexes of SA and Cel8A. CoCl2 and biotin-X-NTA (BXN) were mixed at a 1:1 ratio at 2.5 mM in 
MQH2O. BXN:Co(II) at 20 µM was bound to SAtet at 20 µM in 1x PBS pH 7.4. Cel8A at a final 
concentration of 80 µM and SA(BXN:Co(II))4 at 20 µM were incubated together in 1x PBS pH 7.4 to 
equilibrate. A working stock solution of H2O2 of 500 mM was prepared from a 30% (9.8 M) stock 
solution and added to a final concentration of 10 mM to the SA(BXN:Co(II))4/Cel8A solution above. A 
control with 4 µM SAtet and 12 µM Cel8A-biotin (prepared as described in Section 3.2.3.2) was 
assembled in 1x PBS pH 7.4. The samples were separated on either a Sephacryl® S-300 or Superdex® 
75 SEC column. Fractions were collected from SEC and assayed for endocellulase activity as described 
in Section 3.2.5.1.  
 Separating SA(BXN)N by IEC 
 
SAtet at 20 µM was mixed with 0 – 80 µM BXN in 20 mM Tris pH 8.0. The samples prepared 
this way were loaded onto a MonoQ® anion exchange column with 20 mM Tris pH 8.0 running buffer. 
An elution gradient of 0 – 200 mM NaCl was applied to elute SA(BXN)N species. Collected fractions 
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were concentrated using 10 kDa MWCO spin concentrators (Millipore Sigma, Oakville, Canada) and 
the concentration of SA estimated using its theoretical monomer extinction coefficient of 41940 M-1 
cm-1 calculated by ProtParam (Gasteiger et al. 2005). The number of biotin-binding sites per tetramer 
was determined by B4F titration as described below in Section 3.2.6.1. 
3.2.6 Analysis methods 
 
 B4F forward titration 
 
B4F titrations were carried out for two main purposes: to determine the number of biotin-
binding sites present in a solution of SA, and to determine the extent of biotinylation of labelled 
biomolecules. First, determining the number of biotin-binding sites in solution was carried out 
according to the “forward titration” technique for determining the biotin-binding sites present in a 
solution of strept(avidin) (Ebner et al. 2008). B4F was diluted 250-fold from a 4 mM DMSO stock into 
1x PBS pH 7.4 and standardized using its extinction coefficient of 68000 M-1 cm-1 at 495 nm (Ebner et 
al. 2008). B4F was protected from light as much as possible, as exposure to light has been observed to 
oxidize the biotin moiety of B4F (Haack et al. 2017). For titration, B4F was titrated into a quartz 
cuvette containing sample diluted down to approximately 100 to 400 nM biotin-binding sites. The 
fluorescence of this mixture was measured at 490 nm excitation and 525 nm emission with a 515 nm 
cut-off filter after each addition of B4F. B4F was added until a breakpoint (intersection of two lines fit 
to the data) was clearly observed. 
 The breakpoint represents the point in the titration at which all available biotin-binding sites 
have been titrated (Ebner et al. 2008). The location of the breakpoint was determined by linear 
regression using R with the “segmented” library (Muggeo 2003; Vm 2008). An example of a B4F 




Figure 3.8: Example B4F titration and linear regression using “segmented” module in R.  Titrations are carried out with SA 
only (open squares) and with SA mixed with biotinylated sample (open circles). The difference between the location of the 
breakpoints gives the amount of biotin present in the sample. Produced in R (v.3.5.1). 
B4F titrations were also carried out to estimate the extent of biotinylation of biomolecules. The 
procedure used here was adapted from a “forward titration” technique for estimating the amount of 
(strept)avidin in unknown samples, with some modifications (Ebner et al. 2008). In particular, rather 
than determining the concentration of an unknown sample of SA, this titration was used to determine 
the total number of biotin present by measuring the total number of biotin-binding sites in a known 
solution of SA before and after adding biotinylated sample. The estimated amount of biotin present in 
the sample is determined by the straightforward relation: 
[𝑏𝑖𝑜𝑡𝑖𝑛 𝑖𝑛 𝑠𝑎𝑚𝑝𝑙𝑒] = 𝑏𝑟𝑒𝑎𝑘𝑝𝑜𝑖𝑛𝑡𝑐𝑜𝑛𝑡𝑟𝑜𝑙 − 𝑏𝑟𝑒𝑎𝑘𝑝𝑜𝑖𝑛𝑡𝑠𝑎𝑚𝑝𝑙𝑒 
 
For the titration, M13-PEG12-biotin samples were first mixed with SA at a concentration of 2.5 
µM SAtet and 5 µM p8 (or 2.5 µM for Cel8A-PEG12-biotin) in 1x PBS pH 7.4. The complexed protein 
was further diluted into 1x PBS pH 7.4 to a SAtet concentration of 25 nM at a final volume of 500 µL in 
a quartz cuvette. The fluorescence of this mixture was measured at 490 nm excitation and 525 nm 
emission with a 515 nm cut-off filter after each 5 µL addition of 1 µM B4F. B4F was added until a 
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breakpoint was clearly observed. A control titration with just SA to determine the number of open 
biotin-binding sites in the absence of biotinylated protein was also carried out as described above. 
Along with the total concentration of p8 in the titration, the extent of biotinylation can be estimated. 
 TEM staining conditions (regular staining with PTA) 
 
Phosphotungstic acid (PTA) stain was prepared fresh before each experiment by diluting PTA 
in water to 1% (w/v) and then adding 1.12 mL 2 M NaOH per 1 g of PTA that was weighed out to 
neutralize the stain (Phillips 1950).  
M13 phage containing samples were typically adhered to transmission electron microscopy 
(TEM) grids at a concentration of 1.5 – 4.5 x 1011 M13 particles/mL in sterile MQH2O (M13 typically 
exchanged into MQH2O from 1x PBS buffer by dilution of ~100-fold). Grids used were carbon/formvar 
400 mesh (Ted Pella, etc.) or ultrathin carbon film supported by lacey carbon 400 mesh (Ted Pella, etc.) 
where indicated. Grids were prepared by placing grids onto prepared drops of sample/wash solution. A 
typical grid preparation is as follows: a 10 µL drop of M13 was adhered to the grid for 1 min, followed 
by two brief washes (a few seconds) on 50 µL drops of sterile MQH2O, and lastly, staining for 20 sec 
on a 20 µL drop of 1% PTA. Excess solution was wicked away with filter paper after each step. Grids 
were dried overnight. TEM samples were imaged at 60 kV using a CM10 Philips microscope modified 
with an Advanced Microscopy Techniques image capturing CCD camera. 
 TEM staining conditions (TEM immunostaining procedure) 
 
This staining procedure was carried out to specifically bind 5 nm gold nanoparticles (GNP) to 
the TAMRA reacted to Cel8A (Section 3.2.3.3). The primary antibody was an anti-TAMRA 
monoclonal mouse IgG antibody (Abcam, Toronto, Canada). The stock solution was at 1 mg/mL. The 
secondary antibody was goat anti-mouse IgG 5 nm GNP conjugate (Cytodiagnostics, Burlington, 
Canada). The stock solution was at 3 OD (~1.64 x 1014 particles/mL according to the manufacturer). 
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The protocol for immunogold staining was adapted from literature methods with some changes 
(X. Li et al. 2016). The TEM grids used were carbon/formvar 400 mesh. In order to adhere phage 
samples to the grid, M13 was diluted down to 1.5 – 4.5 x 1011 M13 particles/mL in sterile MQH2O, and 
a 10 µL droplet to each grid and let sit for 1 min before removing the excess with filter paper. The grid 
was touched to 50 µL water droplets (~2 sec) to wash and the excess was removed with filter paper. 
The grid was blocked by incubation of the grid with 50 µL droplet of blocking buffer (0.1 % BSA in 1x 
TBS pH 7.4) for 10 min to prevent non-specific binding of antibodies. The excess solution was 
removed with filter paper. The grid was incubated on 50 µL droplet containing primary antibody 
(diluted 1:20 into blocking buffer) for 60 min. This was washed 5 x 3 min on 50 µL droplets of 
blocking buffer. The grid was incubated on 50 µL droplet containing the secondary antibody GNP 
conjugate (diluted 1:30 into blocking buffer) for 60 min. This was washed 3 x 3 min on 50 µL droplets 
of blocking buffer, followed by 3 x 3 min on 50 µL droplets of 1x TBS pH 7.4, and lastly, with 4 x 30 s 
on 50 µL droplets of sterile MQH2O. The excess solution was removed with filter paper. Lastly, the 
grids were stained on 20 µL droplets of 1% (w/v) PTA for 1 min and then the excess stain was removed 
with filter paper. 
3.3 Results and discussion 
 
3.3.1 General considerations for SA/biotin complexation 
 
 As mentioned, some general considerations for SA/biotin complexation will be discussed in 
this chapter. The results in this section are applicable to both this chapter, and Chapter 4, where the 
SA/biotin interaction is again employed. The purpose of presenting this here is to provide some context 
on the distribution of SA(biotin)N species (SA with biotin bound at N ligand-binding sites) that form 
when mixing SA and BXN (or biotin-Cel8A; particularly in Chapter 4). Binding of biotin to SA, due to 
its slow off-rate, results in a distribution of occupied biotin-binding sites that is not statistical in nature 
(Jones and Kurzban 1995). Initially it was thought that binding of biotin to SA was cooperative since 
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the resulting mixture of SA(biotin)N species appeared biased toward the SA(biotin)0 and SA(biotin)4 
species (Sano and Cantor 1990b). In fact, there have been several papers disagreeing on whether the 
nature of biotin-binding to SA was cooperative or not. However, several experiments have since shown 
that binding to SA is not cooperative, and the non-statistical distribution of species is due to the slow 
off-rate and limits of mixing quickly enough (Deng, Kitova, and Klassen 2013; Jones and Kurzban 
1995). Regardless, this context highlights one of the subtleties involved in working with biotin and SA 
– that is, it is very difficult to mix biotin with SA without biasing the distribution of biotin-bound 
species toward either the fully bound, or fully unbound SA(biotin) species. 
 Desthiobiotin Exchange Kinetics 
 
 To overcome a non-statistical mixture of species resulting from mixing biotin (or biotinylated 
enzyme), desthiobiotin has been used here to slow the binding of biotin (requiring that desthiobiotin 
first dissociate from SA) and therefore, make the distribution closer to what one would statistically 
expect. For binding of biotin to SA with four equivalent sites, the resulting mixture of SA(biotin)N 
should have a binomial distribution. However, because of the slow off-rate of SA this is typically not 
the case (Jones and Kurzban 1995). Furthermore, by reducing the need for rapid mixing, the resulting 
mixture of species should be more predictable between experiments. In order to test the feasibility of 
this approach with biotinylated enzyme, a model system using desthiobiotin-saturated SA and a 
fluorescent biotin was used to monitor this exchange process over time. In this section, some of the 
details of the exchange of desthiobiotin with biotin will be discussed. 
The goals of these experiments were to: 1) determine the time-frame that exchange of 
desthiobiotin for biotin would expected to occur over, and 2) show that desthiobiotin can indeed be 
used to form a more statistically predictable distribution of SA(biotin)N species. In order to probe this 
ligand exchange process, the fluorescent biotin analogue biotin-4-fluorescein (B4F) was used as the 
biotin-containing probe for these experiments. The fluorescence of the attached fluorescein is quenched 
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upon binding to SA (Kada, Falk, and Gruber 1999). Therefore, upon adding B4F to desthiobiotin-
saturated SA, the initial fluorescence of free B4F should decrease over time as it binds to SA. 
Pre-incubation of SA with desthiobiotin slows the binding of B4F. Binding of 300 nM B4F to 
100 nM SAtet either without or with pre-bound desthiobiotin at 400 nM was carried out at 23 oC. SAtet 
binds B4F more quickly when not already bound to desthiobiotin, as expected (Figure 3.9A). The 
binding was reduced when SA was pre-saturated with desthiobiotin, as expected. Importantly, even 
with desthiobiotin present, B4F does eventually displace the desthiobiotin completely. Binding was 
90% complete at 50 s for SA only and 480 s for SA pre-bound with desthiobiotin. As a side note, the 
binding of B4F to SA on its own was slower than expected in theory. For a protein/ligand pair with an 
on-rate on the order of 108 M-1 s-1 (Deng, Kitova, and Klassen 2013), complete binding is expected to 
be reached in under 1 second (Figure 3.9B). There was likely a limit in how rapidly the solution could 
be mixed manually that reflects this discrepancy. Regardless, this served as an initial indication that 
pre-binding with desthiobiotin could indeed slow biotin-binding.  
 
Figure 3.9: Relative time to reach equilibrium for SA mixed with B4F using desthiobiotin pre-incubation.  A) 100 nM SAtet 
mixed with 300 nM B4F either (black circles) SA without pre-bound desthiobiotin, or (open circles) with 400 nM pre-bound 
desthiobiotin (average of three trials). B) Simulated data for binding of 300 nM B4F to 100 nM SAtet using an association rate 
constant of 130 x 106 M-1 s-1 (Deng, Kitova, and Klassen 2013) and dissociation rate constant of 5.5 x 10-6 s-1 (Deng, Kitova, 
and Klassen 2013) and simple protein-ligand binding model (described by equilibrium 2 in Section 3.2.4.1). 
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To get a better sense of the amount of time that should be given to allow a biotin analogue or 
biotinylated-protein to displace desthiobiotin (dtb) from SA(dtb)4, several B4F/desthiobiotin exchange 
experiments were carried out at different concentrations of B4F. The purpose here was to qualitatively 
capture the time frame of incubation required for this exchange process to occur, not to extensively 
characterize the kinetics of the process; however, some kinetic considerations were included to 
determine if the results produced were reasonable within the wealth of kinetic data available for 
biotin/SA kinetics. The exchange rate was quite fast and the very first seconds of the exchange were 
missed during mixing and placing the cuvette in the fluorimeter (Figure 3.10A - C). At the higher 
concentrations of B4F, it took longer for complete binding of B4F, while the lower concentrations 
tested were rapidly bound over the course of a few minutes.  
In order to better understand the process of desthiobiotin exchange, the data was fit to a model 
considering the dissociation of desthiobiotin from SA:dtb and binding of B4F to SA (as described in the 
Methods Section 3.2.4.1.). Only the 100 nM B4F trace was able to capture enough of the initial portion 
of the exchange process to fit the desthiobiotin binding and dissociation parameters (Figure 3.10A). 
Using the parameters for the on-rate and off-rate of desthiobiotin estimated from this fit, some 
simulated data sets were run to get an idea of the trend expected for differing B4F concentrations 
Figure 3.10D). The decreased time it took to completely bind the biotin probe in the simulated data 
followed a similar trend to that observed in Figure 3.10 traces A – C, where decreasing initial [B4F] 
resulted in the system more rapidly reaching equilibrium. This makes sense if one considers that as 
more B4F binds to SA (forming SA(B4F) which dissociates from SA very slowly), the concentration of 
SA(dtb) with which to exchange with decreases; this is more apparent when the [B4F] is stoichiometric 
to the number of biotin-binding sites. This would be expected to be less impactful where the initial 
[B4F] << [SA(dtb)], as even when the majority of B4F has bound, there would still be considerable 




Figure 3.10: Displacement of desthiobiotin from SA active site by B4F.  SAtet (25 nM; 100 nM biotin-binding sites) was mixed 
with 100 nM B4F and the exchange was monitored reading the fluorescence at 490 nm excitation and 525 nm emission with a 
515 nm cut-off filter at 23 oC. B) SA (100 nM biotin-binding sites) was mixed with 75 nM B4F. C) SA (100 nM biotin-binding 
sites) was mixed with 50 nM B4F. D) Simulated data using parameters fitted from A), Kon = 24.09 µM-1 s-1 Koff = 0.009505 s-1. 
Kd = ~3.95 x 10-10 M. Single traces (n = 1) were done to qualitatively explore the time-frame necessary for the exchange to 
reach equilibrium. 
The kinetics of biotin binding to SA has been well-established and studied. The Kd of SA is on 
the order of 10-15 – 4 x 10-14 M (Chilkoti and Stayton 1995; Hofmann et al. 1982). A fairly recent 
estimate utilizing ESI-MS to study the dissociation of biotin from SA determined the on- and off-rates 
to be 1.3 x 108 M-1 s-1 and 5.5 x 10-6 s-1 at 22.1 oC (Deng, Kitova, and Klassen 2013). There were 
relatively fewer estimates available for the dissociation constants of desthiobiotin from SA, though 
several papers have cited a value of 10-11 M for the dissociation constant (Wong et al. 2013; M. Zhang 
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et al. 2016). The values estimated (kon ~24 x 106 M-1 s-1, koff ~0.0095 s-1, KD ~4 x 10-10 M) to simulate a 
theoretical desthiobiotin/biotin exchange seem reasonable, in terms of magnitude, within the context of 
the 10-11 M literature estimates available. For the purposes of simulating the data and understanding the 
trends observed this was suitable; however, the estimate should not be taken to be a definitive 
determination of desthiobiotin/SA rate constants. The goal here was not to extensively characterize the 
exchange kinetics of biotin/desthiobiotin, but rather to obtain some reasonable values to simulate the 
exchange process and get a sense of the time frame required for subsequent experiments that utilized 
this approach for binding biotinylated proteins to SA. Importantly, the exchange occurs over a useful 
time frame (not requiring extensive incubation) and desthiobiotin was found to be completely displaced 
by B4F. 
Lastly, the question of whether the distribution of biotin-bound SA species changes as a result 
of using SA pre-saturated with desthiobiotin was tested. The electrophoretic mobility shift (EMS) that 
occurs between SA and SA(biotin)N can be taken advantage of to determine the resulting mix of SA 
species (Sano and Cantor 1990b). Biotin-X-NTA (BXN) was used because it gave a good EMS and was 
used in experiments later in this chapter. Thus, mixtures of SA with or without desthiobiotin bound 
initially were mixed with aliquots of BXN and run on native PAGE. The binding of desthiobiotin to SA 
itself induced a slight EMS initially (Figure 3.11A). There was an additional transition that occurred 
upon adding 3 – 4 equivalents to SA. Treating the 4:1 dtb:SA lane as a starting point, addition of 
equivalents of BXN induced a further EMS. The shift from the addition of desthiobiotin made it more 
challenging to identify individual bands as the migration range between 4:1 dtb:SA and 4:1 BXN:SA 
was shorter compared to SA only. However, in comparing SA with 2 equivalents of BXN added (either 
with or without pre-bound desthiobiotin), the distributions of species were visibly quite different 
(Figure 3.11B, C). In particular, adding BXN directly to SA biases the distribution toward fully 
occupied and fully unoccupied SA species, as seen previously (Sano and Cantor 1990b). The pre-
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saturation of SA with desthiobiotin appears to be a viable strategy for producing a more predictable 
distribution of SA(biotin)N species. 
 
Figure 3.11: Comparison of preparing SA/biotin complexes with or without pre-incubation with desthiobiotin (prepared at a 
[SA] = 20 µM).  Plotted lane profiles of B) 2:1 BXN:SA (with desthiobiotin) and C) 2:1 BXN:SA lanes fitted with a multiple 
Gaussian distribution in R (version 3.5.1). 
This desthiobiotin/biotin exchange approach offers an alternate method to fine tune the 
association of biotinylated molecules to a SA scaffold. While not explicitly used to affect the 
distribution of SA(biotin)N species, displacement of desthiobiotin has been used in other applications. 
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The reversibility of SA binding to desthiobiotin has been used for regenerating functionalized surfaces 
(Yoon, Hong, and Kim 2001), and for the purpose of gently dissociating SA from labelled proteins in 
affinity chromatography or labelling applications (Hirsch et al. 2002). The exchange of desthiobiotin 
and biotin bound to SA has also been utilized in a DNA tile designed to reveal a message after 
incubating with a “decoder molecule” (biotin) (Wong et al. 2013). While utilizing the reversibility of 
desthiobiotin is not a novel idea, the use of it to subtly alter the distribution of SA(biotin)N species 
immediately formed upon mixing offers a novel approach to controlling the self-assembly of 
components onto SA-based scaffolds. 
 SA/BXN thermal exchange 
 
 Cellulase assays for C. thermocellum enzymes are typically run at higher temperature (50 – 65 
oC). Though the SA/biotin interaction is relatively long-lived, the lifetime of the interaction is expected 
to be shorter at higher temperature. The following experiment was devised to quickly confirm whether 
there would be dynamic unbinding and rebinding of loaded Cel8A expected when utilizing the designed 
scaffold at higher temperature. To test whether this was occurring, SA was pre-saturated with a 
stoichiometric amount of biotin in the form of biotin-X-NTA (BXN) to form SA(BXN)4. If BXN 
dissociates from SA in the presence of a competing biotin-analogue, there will be competition between 
the two molecules to bind to open biotin-binding sites; in this case, B4F was used as the competing 
biotin reagent. The assay then measured the loss of B4F fluorescence from binding to SA at either 23 or 
50 oC. 
At the end of an 18 h incubation, the residual B4F fluorescence in the samples were compared. 
Firstly, the control (B4F only) in both cases showed a slight increase in fluorescence over time for the 
fluorophore by itself (Figure 3.12). This could be due to slight concentration due to evaporation of 
aqueous phase over 18 h. There was a clear decrease in measured fluorescence for the 50 oC samples 
incubated together suggesting displacement of BXN with B4F (~50 % displacement from the residual 
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fluorescence detected). That there was no detected loss of fluorescence for the 23 oC samples suggested 
that little exchange occurs at 23 oC over 18 hours. 
 
Figure 3.12: B4F exchange assay to examine whether there is significant exchange of biotin molecules bound to SA at 50 oC.  
B4F (400 nM) either with or without SA(BXN)4 at 100 nM incubated at A) 23 oC, or B) 50 oC. (average with standard 
deviation (SD) shown, n = 3). 
In summary, these results indicate that there is exchange of biotin analogues between SA 
binding sites at 50 oC showing that the system would be expected to be dynamic at this temperature. 
Therefore, any complexes formed on M13 utilizing the biotin/SA interaction should be expected to be 
dynamic at higher temperatures, though stable at 23 oC for longer periods of time. Given the dynamic 
nature of the SA/biotin bond at higher temperature, it should be expected that this also exists for M13-
biotin/SA/Cel8A complexes that are designed here. For comparison, the half-life (calculated from the 
cited off-rates) of SA/biotin interaction at 44.8 oC is roughly 46.2 min compared to 35 h at 22.1 oC 
(Deng, Kitova, and Klassen 2013). Despite dynamic unbinding and rebinding at higher temperature, it 
is expected that the SA mediator would increase the localized concentration of enzyme to the vicinity of 
the nanoscale scaffold. Consider that in the native cellulosome, the components are held together by 
non-covalent interactions via the Coh modules bound to Doc-containing cellulases; these interactions 
are likely to be much weaker than a SA/biotin interaction (KD ~10-10 M (Sakka et al. 2011)), yet this is 
adequate for cellulosome assembly and its resulting high cellulase activity.  




 One approach to preparing a multi-enzyme scaffold on M13 was to prepare a SA molecule with 
BXN which would further be complexed to a His-tagged protein via a metal affinity interaction. In this 
approach, the BXN serves as a mediator between the SA molecule and the protein of interest via the 
NTA moiety. This approach utilizes a metal affinity interaction whereby a coordination complex 
between the His-tag of the protein of interest, Co(II) and NTA is allowed to equilibrate (Figure 3.13). 
Oxidation to Co(III) by the addition of H2O2 results in a coordination complex with a very slow 
exchange rate (Wegner and Spatz 2013). In this way, Cel8A would be stably complexed onto SA, 
which itself is furthermore complexed onto M13 via biotin-binding. The result would be a nanoscale 
scaffold that could be generalized to any His-tagged protein/enzyme of interest. One of the main 
challenges to be addressed in this section is how one can effectively prepare these types of complexes 
in the stoichiometry shown, such that a single biotin-binding site is available to bind to M13. 
 
Figure 3.13: Representation of SA(BXN) scaffold to attach i) M13-biotin and ii) Cel8A via Co(III)-mediated interaction.  A) 
SA bound with 3 BXN molecules which can chelate Co(II)/Co(III). B) The His6-tagged protein of interest is complexed with 
the NTA-bearing SA scaffold via the Co(III)-mediated interaction. 
 Co-NTA Complexes with Histidine 
 
First, the applicability of this method to Cel8A was tested using BXN, Co(II), His6-tagged 
Cel8A (referred to as just “Cel8A”) and H2O2 to oxidize the Co(II) to Co(III). Oxidation of Co(II) to 
Co(III) requires incubation with 10 mM H2O2 – given the susceptibility of some proteins to oxidation, 
the activity of Cel8A was first determined before and after treatment with H2O2. One approach to 
confirm that stable complex has formed is to run the resulting mixture on IMAC (Wegner and Spatz 
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2013). They observed that earlier elution peaks corresponded to His6-tagged protein complexed to 
Co(III) and NTA – that methodology was used here as confirmation that complexation was successful. 
Thus, Cel8A:Co(III):BXN is expected to interact poorly with the IMAC resin as it would have two less 
His residues available with which to interact with the immobilized metal resin in contrast to free Cel8A. 
After incubating Cel8A with all components (including H2O2) for 3 hours, the samples were 
resolved by IMAC. For the Cel8A sample without H2O2 added, the protein eluted as a single peak 
during the imidazole gradient (Figure 3.14A). However, the sample that had been treated with H2O2 
had several peaks which eluted earlier (Figure 3.14B). The first peak to elute during the imidazole 
gradient (fraction 18) was expected to be Cel8A complexed to BXN via the Co(III)-mediated 
interaction, as complexation of the His6-tag in a coordination complex would reduce the interaction 
with the immobilized metal of the resin. Some of the Cel8A in this sample eluted later in the gradient 
where Cel8A eluted in the control without H2O2 (fraction 21). The sharp peaks early in the elution 
profile were from trapped air bubbles.  
 
Figure 3.14: Testing Co(III)-mediated BXN complex with Cel8A by IMAC.  IMAC chromatogram of 100 µM BXN and 20 µM 
Cel8A with 100 µM CoCl2 A) without and B) with the addition of 10 mM H2O2. The absorbance at 280 nm (green) and 260 nm 
(purple) are shown. The imidazole gradient starts at fraction 17. 
  
The first eluted peak in the Cel8A:Co(III):BXN chromatogram (fraction 6) was likely mostly 
composed of excess Co(III):BXN. It was found separately that BXN mixed with CoCl2 and treated with 
10 mM H2O2 absorbed at 260 nm, and more weakly at 280 nm (not shown). Also, when assayed for 
protein content by the Bradford assay, the low signal indicated that little protein was present (Table 
3-1). Thus, the higher A260 absorbance of this peak is consistent with elution of the unreacted small 
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molecules in the mixture. For the fractions containing Cel8A, it was found that approximately 50% of 
the protein applied to the column was recovered in total (20 nmol Cel8A applied). It is possible that the 
other protein can be found spread out throughout the rest of the fractions in low amounts to account for 
the missing 50% of protein. About 30% of the collected protein was recovered as Cel8A:Co(III):BXN 
(Table 3-1). In contrast, about 61% of the recovered protein was uncomplexed. It was not expected that 
there would be 100% complexation, as initially, it is necessary for Cel8A to equilibrate with Co(II) and 
BXN before oxidation to Co(III). The formation constants for His6-tag complexes with Co(II) are 
typically poorer than for the metals typically used for immobilized metal affinity interactions, such as 
Ni(II) or Zn(II) (Mehlenbacher et al. 2015). Overall, these results indicated that the complexation was 
not complete under these conditions, but that a fraction of Cel8A was complexed with BXN. This 
served as a positive indication that complexation with BXN and Cel8A would occur according to 
literature methods in further experiments employing SA(BXN) complexes. 
 
Table 3-1: Recovered components from IMAC of Cel8A complexed with BXN via Co(III)-mediated interaction (n=3). 
Component Without H2O2 (% recovery ± 
SD)* 
With H2O2 (% recovery ± 
SD)* 
Excess Co(III):BXN (F-6) - 0.06 
Cel8A:Co(III):BXN (F-18) 1.3 ± 1.5 15.2 ± 5.2 
Cel8A (F-21) 47.5 ± 6.7 30.5 ± 5.7 
*Percent recovery calculated by moles of recovered protein detected by Bradford assay divided by the total moles of Cel8A 
applied to the column. 
Lastly, to determine whether the Co(III)-mediated strategy would be appropriate for this 
particular enzyme, endocellulase activity was tested with the Cel8A fractions collected from the 
columns. Cel8A isolated from fractions 18 and 21 (with H2O2) and fraction 21 (without H2O2) were 
diluted to 100 nM and tested for endocellulase activity with 0.5% (w/v) CMC at 65 oC for 1 h. Over the 
course of 1 hour, a similar amount of reducing ends were produced for all fractions compared to the 
control (Figure 3.15A). This indicated positively that endocellulase activity was present; however, the 
reaction with CMC was found to be complete at this time point when a time course reaction was carried 
out under the same conditions with Cel8A (Figure 3.15B). Thus, this can only serve as an indicator that 
Cel8A treated in this way retained some activity– not as a diagnostic of the relative activity of the 
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samples. Overall, this was an adequate indicator that this treatment did not abolish endocellulase 
activity and that further experiments could be carried out. 
 
 
Figure 3.15: Endocellulase activity of Cel8A, BXN and CoCl2 treated with or without H2O2 after IMAC.  The reaction 
conditions were 0.5% CMC reacted with 100 nM Cel8A at 65 oC for 1 h. A) Activity of fraction eluted from IMAC (F1-18 
Cel8A:Co(III):BXN, F1-21 Cel8A (with H2O2), F2-21 Cel8A (no H2O2) (n = 1). B) Time course of CMC hydrolysis by Cel8A. 
Reducing ends were detected using DNS and comparing to glucose standard curve (n = 1). 
 Preparing and separating an ensemble of SA(NTA):Co(III):Cel8A complexes 
 
 The main goal was to ultimately prepare a stable arrangement of Cel8A onto SA which could 
be further complexed onto M13-biotin. One approach to prepare complexes onto M13 of defined 
stoichiometry is to first prepare a mixture of Cel8A bound to SA(BXN)N via the Co(III)-mediated 
interaction and separate SA(BXN)N with the desired stoichiometry as discussed in the introduction 
(Figure 3.16). SEC was used as a method to distinguish between the different components, and ideally, 




Figure 3.16: Schematic representation Cel8A assembly onto SA(BXN) followed by SEC.  SA(BXN:Co(III):Cel8A complexes 
are prepared and then separated by SEC to obtain a species with a single biotin-binding site for further complexation to M13-
biotin. 
 The SA(BXN:Co(III):Cel8A) complexes were prepared in the following way: first BXN:Co(II) 
was prepared at a 1:1 ratio in water, this was next incubated with SA at a ratio of 1:4 SAtet:BXN, 
followed by Cel8A at a ratio of 1:4 SAtet:Cel8A and then ultimately the entire mixture was reacted with 
10 mM H2O2. Note that for this procedure that all of the biotin-binding sites would be expected to be 
occupied (i.e., all SA should exist as SA(BXN)4 with some of this further complexed to Cel8A via 
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Co(III)). Though the end goal was to prepare a SA(Cel8A) complex with a single free biotin-binding 
site, fully saturated SA was tested here. Since the previous experiments with Cel8A and BXN separated 
on IMAC indicated that complexation would be incomplete, using SA fully occupied with BXN was 
expected to simplify the interpretation of the chromatograms.  
The separation of any formed complexes by size-exclusion was initially tested on a Sephacryl® 
S-300 resin but the resolution was poor and there was very little separation between SA and Cel8A 
components (Figure 3.17). There was an observed shift toward higher MW observed for the 
SA(BXN:Co(III):Cel8A) sample compared to either SAtet (52 kDa) or Cel8A (50 kDa) run on their 
own. The separation range of the Sephacryl® S-300 resin used was specified to be 10 – 1500 kDa and 
therefore any formed complexes (expected to range from 52 – 252 kDa based on the masses of the 
individual components) would be expected to be well within this range.  
 
Figure 3.17: SEC separation of SA(BXN)4 complexed to Cel8A via Co(III)-mediated interaction on a Sephacryl® S-300 
column.  Chromatogram of A) 20 µM SA(BXN:Co(II))4 complexed to 80 µM Cel8A followed by treatment with 10 mM H2O2, 
B) SA only and C) Cel8A only. 
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In order to get a better sense of how complexed samples should be expected to run on this 
particular column, a further control with biotinylated Cel8A (Cel8A-PEG12-biotin; prepared by 
acylation of Lys residues as described in the Methods) was used to provide an additional comparison 
between elution profiles. The main difference between the sample and this control is that the biotin is 
covalently reacted to Cel8A, and therefore, would be suitable as a positive control to see how these 
complexed components would be expected to separate. The chromatogram of SA and Cel8A-PEG12-
biotin was similar to the one performed with the Co(III)-mediated complex of Cel8A and SA above 
(Figure 3.18). The main eluted peak was shifted toward a higher MW and was presumed to be from 
complexation of Cel8A-biotin to SA. The first peak to elute was broader than that seen in the Co(III)-
mediated complex, perhaps indicative of a wider range of SA-complexed species of varied size (the 
larger of those species eluting earlier). Once again, any potential complexed species were poorly 
separated from their starting components (SA and Cel8A).  Given the poor resolution, a resin with a 
smaller fractionation range would be tested next. 
 
Figure 3.18: SEC separation of SA complexed to Cel8A-PEG12-biotin on a Sephacryl® S-300 column.  Chromatogram of A) 4 
µM SA complexed to 12 µM Cel8A-PEG12-biotin, B) SA only and C) Cel8A-PEG12-biotin only. 
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A Superdex® 75 column with a fractionation range of 3000-70,000 Da was next used. Though 
the assembled complex would be expected to be much larger than 70 kDa (SAtet = 52 kDa, Cel8A = 50 
kDa), Cel8A is composed of several small globular domains with flexible linker regions and therefore 
would be expected to run differently than a single globular protein of the same MW (Figure 3.19). 
Therefore, it was expected that an assembled complex might still elute within the fractionation range of 
the column. For a direct comparison the SA(BXN:Co(III):Cel8A) complexes run above on the S-300 
resin, the complexes were prepared the same way.  
 
Figure 3.19: Cel8A with linker region and dockerin domain.  Built from Cel8A cellulase domain (PDB: 1KWF), and dockerin 
domain (built from ModBase with template structure PDB: 4FL4) and sequence from Cel8A (UniProt A3DC29) (Pieper et al. 
2014). The linker was built in from the primary sequence of Cel8A in Maestro (Schrödinger). 
The Superdex® 75 column was able to better resolve the different species after complexation 
via the Co(III)-mediated interaction. Cel8A was run on its own and was found to elute latest of all the 
individual components (Figure 3.20A). As an additional control, Cel8A incubated with CoCl2 and 
BXN (but no SA), was then oxidized with H2O2 was run on this column as well. This was found to run 
at a slightly higher MW that Cel8A on its own (Figure 3.20B). This could be from a subtle change in 
conformation with how the cellulase and dockerin domains are positioned relative to each other. When 
complexed with SA, three peaks were observed – one with a very obvious shift to a higher MW (Figure 
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3.20). The first eluted peak was expected to be various complexes of SA(BXN:Co(III):Cel8A) eluting 
together at a higher MW. The third peak was Cel8A as determined from the controls. Therefore, the 
second (and largest peak) was likely SA(BXN) species eluting as a single peak. 
 
Figure 3.20: SEC separation of SA(BXN)4 complexed to Cel8A via Co(III)-mediated interaction on a Superdex® 75 column.  
Chromatogram of (top panel) Cel8A only, (middle panel) 80 µM Cel8A and 80 µM BXN:Co(II) followed by treatment with 10 
mM H2O2, (bottom panel) 20 µM SA(BXN:Co(II))4 complexed to 80 µM Cel8A followed by treatment with 10 mM H2O2. 
To further confirm the suspected assignments of these peaks, Cel8A-biotin was again used as a 
control to see what one should expect from the Superdex® 75 column for SA complexed to Cel8A. 
This could then be compared to the elution profile of the Co(III)-mediated complex to see if the 
assignment of peaks was reasonable. Like the complexes prepared using the Co(III)-mediated approach, 
when the SA(Cel8A-biotin) positive control was run, there was again a very obvious shift to higher 
MW (Figure 3.21A). As with the S-300 column, the first peak to elute was quite broad and likely 
consisted of various SA(Cel8A-biotin)N complexes. The suspected SA peak was not observed in this 
control, suggesting the complexation of Cel8A-biotin to SA does not leave much SA that is not 
complexed. Additionally, a protein MW standard was run on this column (Figure 3.21C). Of the 
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components in these mixtures, SA was the only protein with a single globular domain; therefore, it 
should be expected to run true to its MW. Indeed, when compared to the protein standards, the peak 
suspected of being uncomplexed SA(BXN)4 ran near to its expected MW of 52 kDa – suggesting that 
the assignment was reasonable. Noticeably, the Cel8A does not run true to its MW; however, this was 
discussed above as likely being due to the two domains and flexible linker present on the protein. 
Alternatively, the cellulase may have some affinity for the crosslinked agarose and dextran which 
compose the column resin which might alter the retention time. From the comparison of Cel8A 
complexed via the Co(III)-mediated interaction with Cel8A-biotin, it was apparent that some 
complexation does likely occur with the Co(III)-mediated approach; however, there was a considerable 




Figure 3.21: Comparison of SA(BXN:Co(II))4 with Cel8A complex with Cel8A-PEG12-biotin control on a Superdex® 75 
column.  Chromatogram of A) 4 µM SA and 12 µM Cel8A-PEG12-biotin, B) 20 µM SA(BXN:Co(II))4 complexed to 80 µM 
Cel8A followed by treatment with 10 mM H2O2, C) Bio-Rad gel filtration standard showing 280 nm absorbance. The purple 
traces show the absorbance at 260 nm, and the green traces show the absorbance at 280 nm. DNS detection of reducing ends 
after 15 min reaction of 0.5 % CMC in 0.1 M citrate pH 5.8 at 65 oC with SEC fractions corresponding to D) complexation of 
Cel8A-PEG12-biotin with SA (mean and SD shown; n = 2), E) Co(III)-mediated approach (mean and SD shown; n = 3). 
Fractions were either assayed directly (for D), or diluted 4-fold (E), before reacting with CMC. Values were converted to 
reducing ends by comparison to a DNS standard curve of D-glucose.  
 
To further confirm the assignment of the elution profile, the endocellulase activity of Cel8A 
was assayed as it eluted from the column to identify which eluted peaks might be associated with 
Cel8A (or some complex of Cel8A). The fractions were diluted at the same fold-dilution and assayed 
against CMC at 65 oC giving a measure of relative activity in each fraction. The first peak to elute for 
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both the SA(BXN:Co(III):Cel8A) mixture and the SA(Cel8A-biotin) positive control had endocellulase 
activity (Figure 3.21D, E). This would be consistent with that peak containing SA and Cel8A 
complexed together either through BXN:Co(III) or biotin (for the control). Some activity was detected 
in fraction 20 (which was suspected to be SA); however, this likely comes from slight overlap of the 
preceding and following peaks. The last peak eluted in each spectrum around fraction 22 was also 
consistent with the expectation that the peak corresponded to uncomplexed Cel8A. 
In summary, SEC was tested as a potential approach to separate individual species of 
SA(BXN:Co(III):Cel8A) for the purpose of later binding these complexes on M13-biotin in a 
controllable way. The Superdex® 75 resin did give better resolution than the S-300 column; however, 
the column was still only able to resolve the complexed species, and the individual components (SA 
and Cel8A). The lack of resolution could in part be due to the flexible linker on Cel8A giving a wide 
range of possible conformations that a formed complex might exist in, resulting in broad and 
unresolved peaks by SEC. Therefore, this approach was not considered viable for separation of a SA 
loaded with enzyme at a particular stoichiometry. As one of the goals of this project was to explore 
ways of producing defined, and well-ordered arrangements on the nanoscale, a second approach was 
pursued to obtain SA(Cel8A) complexes with the desired arrangement of components. 
 Isolating SA(BXN)N species of defined stoichiometry 
 
 In order to overcome the challenge of preparing a multi-enzyme complex with the kind of 
defined stoichiometry of components outlined in the design presented in Figure 3.3, Section 3.1, a 
different approach was taken where SA(BXN)3 was prepared and isolated first by IEC (Figure 3.22). 
As the NTA moiety has several negatively charged carboxylate groups, the interaction of SA(BXN)N 
with an anion exchange column would be expected to increase with additional bound BXN. The 
isolated SA(BXN)3 would have a single unoccupied biotin-binding site for further complexation to 
M13-biotin. Additionally, the NTA groups from the BXN bound to SA could be used for complexation 
with the His6-tag of Cel8A via the Co(III)-mediated interaction explored in the previous section. It was 
108 
 
found that this method was suitable for isolating the various SA(BXN) species that form from mixing 
the two. 
 
Figure 3.22: Schematic representation showing isolation of SA(BXN)3 prior to complexation with Cel8A.  A mixture of 
SA(BXN)N are first prepared and then separated by IEC to obtain a species with a single biotin-binding site and three bound 
BXN to complex with the His6-tag of Cel8A via the Co(III)-mediated interaction. 
Briefly, the ability to separate different species of SA bound to BXN was tested with two 
extremes: SA with nothing bound to it, and SA saturated with BXN to form SA(BXN)4. Due to the 
additional negative charge introduced by BXN, this separation was carried out on an anion exchange 
column. It was found that all species would be expected to elute over the range of 5 – 20 mS/cm when a 
NaCl gradient was used for elution (Figure 3.23). As expected, the SA fully saturated with BXN eluted 




Figure 3.23: IEC separation of SA complexed with BXN on a MonoQ® anion exchange column in 10 mM Tris pH 8.0 and 
eluted with a gradient of 0 – 1 M NaCl.  Chromatogram of A) 20 µM SA and 80 µM BXN, B) 20 µM SA. 
As discussed in Section 3.3.1, desthiobiotin can be used to alter the distribution of SA(BXN)N 
species that form by pre-incubation with desthiobiotin. However, it was also observed that desthiobiotin 
bound to SA itself resulted in an electrophoretic mobility shift on native PAGE. It was expected that 
pre-incubation in this specific case would not be suitable, as it might affect the resolution of the anion 
exchange chromatogram. Therefore, SA(NTA)N prepared at different ratios of BXN:SA tetramer (1:1 to 
4:1) were separated together by IEC. This was to ensure that there would be a good distribution of 
species to separate and identify once separated. When the prepared mixture of SA(BXN)N species was 
run on a MonoQ® IEC column, six potential SA(BXN)N peaks were observed (Figure 3.24A). It was 
expected that the SA species with more BXN bound would elute later based on the additional negative 
charge present from the NTA moieties.  
In order to confirm that the tentatively assigned peaks had the predicted stoichiometry of bound 
BXN, the unoccupied biotin-binding sites were assayed as described in the Methods (Section 3.2.6.1). 
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Briefly, a fluorescent biotin analogue, biotin-4-fluorescein (B4F), is titrated into a solution of SA and is 
quenched upon binding (Ebner et al. 2008). When an amount of B4F equivalent to the number of free 
biotin-binding sites is added, a sharp breakpoint is observed in the titration curve. A clear pattern 
identifying the different isolated peaks was observed (Figure 3.24B). The concentrations isolated from 
the column were low, making the accuracy a little lower, but the positioning of the breakpoints relative 
to each other qualitatively supported the peak fraction assignments made. Interestingly, the shoulder 
that elutes immediately after the SA(BXN)0 peak does appear to be SA-related, as it does bind four 
equivalents of biotin per tetramer (Figure 3.24B; orange trace). Each subsequent peak was confirmed 
to have an additional BXN bound. 
To confirm that each isolated fraction corresponded to a single SA(BXN)N species, they were 
analyzed by native PAGE (Figure 3.24C). For comparison, mixtures of SA and BXN were prepared 
without separation, alongside the fractions isolated by IEC. For the mixtures of SA and BXN, there was 
a clear shift in electrophoretic mobility upon each subsequent addition of a BXN equivalent. 
Importantly, the fractions isolated from IEC ran as single species, rather than a distribution of species. 




Figure 3.24: IEC separation of SA(BXN)N species on a MonoQ® anion exchange column in 10 mM Tris pH 8.0 and eluted 
with a gradient of 0 – 200 mM NaCl.  A) Chromatogram of equal volumes of SA(BXN) separately prepared at SA:BXN ratios 
of 1:0, 1:1, 1:2, 1:3 loaded together. B) B4F fluorescence (490 nm excitation, 525 nm emission) titration of SA(BXN)N 
fractions isolated from IEC. C) A 7% native PAGE gel of prepared mixtures of SA and BXN and fractions eluted from IEC of 
SA(BXN)N mixture.  
A scaled-up separation was carried out to obtain SA(BXN)3 for use in complexation with M13-
biotin. Although the SA(BXN)0 – SA(BXN)2 species were well-resolved, the SA(BXN)3 and 
SA(BXN)4 species were not well separated from each other (Figure 3.25A). Despite this, fractions 
could still be isolated that would correspond to SA with either no or one biotin-binding site open 
(Figure 3.25B). Several approaches to improve the resolution were attempted including: shallower 
elution gradients and cleaning the column; however, the best resolution obtained was that shown in 
Figure 3.25. Given that it was still possible to obtain SA(BXN) with a single biotin-binding site using 






Figure 3.25: IEC separation of SA(BXN)N species on a MonoQ® anion exchange column in 10 mM Tris pH 8.0 and eluted 
with a gradient of 0 – 200 mM NaCl.  A) Chromatogram of SA(BXN) prepared at a SA:BXN ratios of 1:2. Peak 4 indicates the 
elution time of SA(BXN)3 species. B) B4F fluorescence (490 nm excitation, 525 nm emission) titration of SA(BXN)3 and 
SA(BXN)4 isolated from IEC. The x-axis is reported in terms of B4F added per SA monomer concentration (average, n = 3). 
Possible future improvements to this methodology can be easily conceived. When mixing BXN 
and SA, a wide distribution of SA(BXN)N forms – with only a fraction of this being SA(BXN)3. This is 
due to the rapid binding of biotin to SA and slow off-rate, which results in a non-equilibrium 
distribution of species (Jones and Kurzban 1995). However, over time the distribution of SA(biotin) 
species would shift to one that better reflects the relative quantities of biotin and SA in the solution. 
Therefore, it should be possible to favour formation of a particular species by incubation of SA/BXN 
mixtures at higher temperature, followed by separation by IEC. As noted in Section 3.3.1.2, at 
increased temperatures there was considerable unbinding and rebinding of biotin-analogues observed. 
Following from the observations of Jones and Kurzban then, a better approach might involve 
preparation of SA:BXN at a 1:3 ratio, followed by a short incubation at 50 oC to bias the distribution of 
species toward the desired SA(BXN)3.  
In summary, this method was the most promising approach toward preparing SA(Cel8A) 
complexes with a defined stoichiometry. SA(BXN)3 was isolated here as a precursor to preparing 
Cel8A complexes of defined stoichiometry via the Co(III)-mediated interaction. Prior to complexation 
with Cel8A, however, the capability of M13-biotin to bind this scaffold was explored first. Following 
complexation onto M13, the resulting nanoscale scaffold would have NTA moieties (three per SAtet) 
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presented along the length to allow further complexation of the His6-tagged Cel8A and subsequent 
oxidation with H2O2 to form the final complex. Next the efficiency of preparing a purified 
“monomeric” SA(NTA)3 onto M13-biotin was explored. 
3.3.3 Preparation of M13/SA(NTA)3 scaffold 
 
Following from the experiments which led to the isolation of an NTA-displaying SA 
component with a single free biotin-binding site (SA(BXN)3), the ability to efficiently bind this 
component to M13-biotin was explored next. First, some considerations regarding the possible loading 
capacity and possible steric limitations relating to the total number of SA that could be theoretically 
loaded onto the phage scaffold will be discussed. Next, TEM evidence showing the resulting 
M13/SA(NTA)3 complexes will be presented and discussed. This will be followed last by the 
experimental results from further complexation of these M13/SA(NTA)3 scaffolds with Cel8A under 
the Co(III)-mediated complexation conditions. 
 Estimating optimal packing of SA on M13-biotin 
 
In order to better assess the TEM images in the following section, the approximate sizes of the 
components were compared. Estimation of the maximal loading of protein onto M13 has been done for 
a protein of ~26.8 kDa (GFP); the maximum loading was based on the number of labelling sites 
occluded by attachment of a single GFP and was estimated to be ~385 GFP/M13 (Hess et al. 2012). It 
was expected to be useful to determine the theoretical maximum possible loading of SA onto M13 
based on its geometry. M13 and SA (52 kDa) were approximated as a cylinder of ~7 nm diameter and a 
sphere of ~6 nm diameter respectively (Figure 3.26). For the M13-PEG12-biotin scaffold, the length of 
the PEG12 linker will depend on how extended it is. For comparison, a relaxed PEG12 linker extended 
out ~2.6 nM from the biotin-binding site of SA while fully extended it measures ~3.8 nm from the 
binding site (Figure 3.26). The distance of SA from the surface of M13 would therefore fall somewhere 
below this when assembled. For simplicity, the following approximations consider the relative spacing 
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of N-termini on M13 to estimate the spacing of biotin moieties in M13-biotin, though it should be noted 
that Lys8 can also be modified by chemical acylation (K. Li et al. 2010). Thus, in the real biotinylated 
M13 particles, the actual spacing of biotin moieties would likely be shorter in some areas where Lys8 
was labelled as well. Regardless, the simplified consideration of N-termini spacing will be suitable for 
an initial estimate of biotin spacing – which is expected to translate to how SA(BXN)3 would be spaced 
on biotinylated phage. 
 
Figure 3.26: Approximating SA and M13 diameters as geometric shapes and the expected length of PEG12-biotin bound to SA.  
(Left) SA was approximated as a 6 nm sphere, and M13 was approximated as a 7 nm cylinder. (Right) The biotin-PEG12 linker 
length estimates were measured from PEG12 built out from SA with biotin bound (PDB: 3RY2) using Maestro (Schrödinger). 
The linkers were measured and presented using UCSF Chimera. 
The majority of the M13 viral coat is formed by the major coat protein p8 which provides a 
surface with regularly spaced amines that can be functionalized. In the preparation of M13-biotin, these 
amines were reacted with TFP-PEG12-biotin. From literature data, the positioning of each p8 subunit 
can be approximated as stacks of planes, each with five subunits positioned and rotated ~36o between 
planes with spacing of 1.66 nm between each plane (Figure 3.27A)(Morag et al. 2015). This 
information gives one an approximate idea of the expected spacing of TFP-PEG12-biotin reacted to p8. 
Knowledge of the symmetry of the subunits therefore gives an indication of how the biotin moieties 
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might be spaced in assembled M13, and where SA might bind. Down the length of the bacteriophage, 
one can estimate that the approximate spacing between subunit functional groups is about 3.3 nm 
(Figure 26B). Therefore, binding of SA (recall, 6 nm diameter sphere), would block binding of SA to a 
directly adjacent p8 subunit, however, it would permit binding to the next subunit. This enables a 
prediction of what the spacing of SA on the bacteriophage coat might look like and how they might be 
spaced. This information will be useful to draw on when interpreting the TEM data. 
 
Figure 3.27: Estimating the probable spacing of PEG12-biotin moieties reacted to M13 p8 viral coat proteins.  A) Schematic 
highlighting the approximate spacing and symmetry of p8 subunit and how bound SA might be oriented. B) Diagram showing 
possible spacing of SA on the surface of M13 and how many adjacent subunits of p8 might be blocked. 
First, M13-PEG12-biotin on its own was analyzed by TEM to obtain a baseline diameter that 
could be later compared to the samples complexed with SA(BXN)3. M13-PEG12-biotin was adhered to 
TEM grids and stained with PTA as a negative stain (Figure 3.28). The diameters at multiple points 
along the length of multiple M13 were chosen and manually measured using image analysis tools. From 
these measurements, a histogram was prepared showing the distribution of measured diameters (Figure 
3.29). The estimated mean diameter of M13-PEG12-biotin was 7.6 nm. This was slightly higher than 
typical literature estimates of M13 diameter which are around 6 – 6.5 nm (Cao, Xu, and Mao 2011; D. 
Marvin 1998). The slightly expanded diameter measured might be from the attached PEG12 molecules 
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forming a zone that somewhat excludes the PTA heavy metal negative stain. Regardless, this gave a 
baseline measure of diameter with which to compare M13 complexed with SA. 
 
Figure 3.28: Representative TEM images of M13-PEG12-biotin negatively stained with 1% phosphotungstic acid (PTA). 
 
Figure 3.29: Histogram with density plot of M13-PEG12-biotin diameters estimated from TEM images.  Estimated using 
ImageJ image analysis software (n = 67).  
A good test of the predicted spacing of SA based on the above discussion regarding the M13 
major coat protein geometry is to use a monovalent SA (single biotin-binding site) and observe the 
apparent packing of SA by TEM. In this case, the monovalent SA was the SA(BXN)3 prepared in 
Section 3.3.2.3. Here are the results from complexing M13-PEG12-biotin with SA(BXN)3 collected 
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from IEC. In this discussion, the spacing and apparent packing of the SA molecules are noted, 
measured and compared to the expected spacing based on the theoretical estimate of optimal packing 
discussed above. Two main variations of this experiment were done: one with excess SA(BXN)3 added 
and a second experiment with slightly less than a stoichiometric amount of SA(BXN)3 compared to the 
total amount of p8 subunits present. 
First, M13-PEG12-biotin with an excess of added SA(BXN)3 was imaged by TEM. M13-PEG12-
biotin at 1.2 µM p8 subunits was incubated with 2 µM SA(BXN)3 prepared from IEC. The diameter of 
M13-biotin incubated with excess SA(BXN)3 was visibly thicker than M13-PEG12-biotin on its own 
(Figure 3.30). The bound SA gave the surface of the bacteriophage a bumpy appearance, as the phages 
appeared to be almost uniformly coated with SA(BXN)3. Once again, the diameter of M13-PEG12-
biotin with bound SA(BXN)3 was measured at multiple points along the length of imaged phages to 
compare with the expected diameter increase for M13 with bound SA. This was once again represented 
as a histogram of diameter measurements (Figure 3.31). The mean diameter of these phages estimated 
by image analysis was 16.4 nm from 390 observations. This was slightly lower than the predicted 
diameter which would have been 19 nm based on the approximate shapes laid side-by-side (7 nm for 
M13, 6 nm for SA; Figure 3.26). However, SA is not perfectly spherical and the estimate above of 6 
nm may overestimate the true diameter along some of the axes of SA. Overall the observations were 




Figure 3.30: Representative TEM images of M13-PEG12-biotin and bound SA(BXN)3 negatively stained with 1% PTA.  M13 
complexes were prepared at a p8:SA(BXN)3 ratio of 1:2. 
 
Figure 3.31: Histogram with density plot of M13 complex (M13-PEG12-biotin mixed with SA(BXN)3 at a ratio of 1:2 
p8:SA(BXN)3) diameters estimated from TEM images.  Estimated using ImageJ image analysis software (n = 390). 
 Secondly, M13-biotin incubated with a nearly stoichiometric amount of SA(BXN)3 was also 
imaged. There was greater variation in the diameter of these M13 phages, though they were still clearly 
of a greater thickness than M13-PEG12-biotin on its own (Figure 3.32). The diameters were measured 
at various points along the length of phages and showed two populations of phage widths (Figure 
3.33). The histogram density plot showed one population with a mean around 16 nm, and another 
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population around 11 nm (106 observations). The wider diameter population, as seen above, likely 
corresponded to M13-biotin with SA bound on both sides. The smaller width population likely 
corresponded to areas where SA was bound on only one side of the phage.  
 
Figure 3.32: Representative TEM images of M13-PEG12-biotin and bound SA(BXN)3 negatively stained with 1% PTA.  M13 
complexes were prepared at a p8:SA(BXN)3 ratio of 1:1. 
 
Figure 3.33: Histogram with density plot of M13 complex (M13-PEG12-biotin mixed with SA(BXN)3 at a ratio of 1:1 
p8:SA(BXN)3) diameters estimated from TEM images.  Estimated using ImageJ image analysis software (n = 106). 
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Lastly, since the quality of the TEM data was good enough to resolve individual SA tetramers, 
a comparison was made to the SA packing model proposed at the start of this section. Where the SA 
molecules were well-resolved on M13, one gets a good impression of the well-ordered spacing between 
adjacent SA (Figure 3.34A). In particular, it was possible to measure the end-to-end distance of 
individually resolved, adjacent SA molecules to compare with what would be expected for optimal 
packing. After measuring this distance multiple times, the mean end-to-end distance of adjacent SA 
molecules was about 12.4 nm (Figure 3.34B). The range of these measurements was consistent with 
the predicted spacing of SA where each bound SA blocked binding to the directly adjacent biotin 
moiety. As the spacing of biotin moieties was estimated to be roughly 3.3 nm and the diameter of SA 
itself was ~6 nm, each SA along the length of the phage should be packed almost directly against its 




Figure 3.34: Determining approximate longitudinal spacing of SA tetramers packed on M13-PEG12-biotin.  A) Schematic 
showing how distance was measured: end-to-end distance of adjacent SA tetramers. B) Examples of areas of ordered 
SA(BXN)3 on M13-PEG12-biotin (TEM, 1% PTA negative stain). White arrows point to individual SA tetramers; red arrow 
points to gap in SA packing. C) Histogram with density plot longitudinal end-to-end distances of adjacent SA tetramers (n = 
12).  
To better explain this, the potential packing arrangement observed was modeled coarsely in 3D. 
The model was built using the measurements made from structural data on M13 p8 symmetry (Morag 
et al. 2015). In particular, based on the authors’ explanation of p8 symmetry, 6 nm spheres were 
arranged with 5-fold symmetry around a 7 nm cylinder (Figure 3.35A). Three stacks of rings with 5-
fold symmetry were shown to give an idea of how such dense packing may be possible. For 
comparison, a well-resolved section of SA(BXN)3 loaded M13 is shown as well, showing a packing 
pattern of SA reminiscent of the 3D model (Figure 3.35B). As a single adjacent site for SA binding 
appears to be occluded when a single SA binds, the optimal loading density appears to be ~1 SA for 
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every 2 p8 subunits – giving a possible loading of ~1350 SA per M13. This would be one of the highest 
loading capacities observed for binding of a protein onto an M13 scaffold thus far. For reference, SA 
loaded with GFP was estimated to have a theoretical maximal loading of 385 GFP/M13, with ~91 
GFP/M13 actually measured (Hess et al. 2012). As the GFP was reacted to M13 enzymatically (using 
sortase), there could conceivable be steric limitations for reaction with the enzyme. Given that the M13-
biotin scaffold used here was not uniformly biotinylated, the actual loading would likely be lower than 
the estimated 1 SA per 2 p8. In the TEM images; this was observed as the occasional “missing SA” in 
an otherwise densely packed phage (see red arrow in Figure 3.34). Regardless, these experiments were 
able to give a semi-stochastic snapshot of how these SA are loaded onto biotinylated M13 scaffolds.  
 
Figure 3.35: Visualizing the possible packing of SA tetramers onto the surface of M13-biotin.  A) A 3D model of 15 spheres (d 
= 6 units) stacked in three layers (5 spheres per layer) with 5-fold symmetry around a cylinder (7 units). Each layer is spaced 
3.3 units and rotated 36o to roughly represent symmetry of p8 coat proteins highlighted in figure 3.27. B) TEM image showing 
highly ordered packing of SA(BXN)3 on M13-PEG12-biotin (stained with 1% PTA). 
In summary, the packing of monovalent SA onto biotinylated M13 was assessed by TEM. 
From the TEM observations, loading of monovalent SA onto biotinylated M13 occurred very 
efficiently. The resulting complexes were anticipated to have ~3 NTA moieties per SA for a maximum 
of ~4000 NTA per M13. This was expected to be particularly useful for further complexation to His-
tagged protein using the Co(III)-mediated approach (Wegner and Spatz 2013). In the following section, 
some of the efforts to detect complexed Cel8A using this approach will be presented.  
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 Further complexation of Cel8A with M13/SA(NTA)3 scaffold 
 
After demonstrating that SA(BXN)3 could be uniformly bound to M13-PEG12-biotin to prepare 
an NTA-bearing nanoscale scaffold, further complexation was tested. Initially this was done by 
negative staining of TEM grids with PTA as done in the previous section; however, any differences in 
diameter of M13 complexes were not easily observed. An immuno-gold labelling approach was devised 
to attempt to detect Cel8A complexed to the phage. Lastly, some considerations regarding the kinetics 
and expected equilibrium kinetics of Cel8A bound to NTA via coordination complex with Co(II) will 
be discussed. 
Binding of His6-tagged Cel8A was initially assessed by negatively stained TEM to see if there 
might be a noticeable diameter increase from the binding of Cel8A. SA(BXN)3 was bound to M13-
biotin as done in the previous section. These were subsequently incubated with a stoichiometric amount 
of Co(II), and 3 Cel8A for every SA(BXN)3. The complexes were oxidized for 10 min with 10 mM 
H2O2. These samples were adhered to TEM grids and negatively stained with PTA. Under these 
conditions, the M13 complexes looked very similar to the M13 bound to SA(BXN)3 in the previous 
section (Figure 3.36). The adhered layer of protein appeared uniformly wide with few obvious 
“bulges” or nodules that might indicate the presence of bound Cel8A (expected diameter of cellulase 
domain is ~5 nm based on the crystal structure). Overall, multiple measures of the diameter of these 
samples were consistent with the width of M13 with SA(BXN)3 bound (Figure 3.37). The mean 
diameter was measured to be 15.4 nm – consistent with the diameter of the M13/ SA(BXN)3 without 
any added Cel8A. Given the infrequent occurrence of irregularities along the length of the phages, it 
would be questionable to try and assign them as complexed Cel8A. Therefore, alternate means would 




Figure 3.36: Representative TEM images of M13-PEG12-biotin (1 µM p8) and bound 1 µM SA(BXN)3 reacted to 3 µM Cel8A 
via Co(III)-mediated approach.  Negatively stained with 1% PTA. The panels show different phage particles from the same 
TEM grid.   
 
Figure 3.37: Histogram with density plot of M13 Cel8A complex (M13-PEG12-biotin (1 µM p8) and bound 1 µM SA(BXN)3 
reacted to 3 µM Cel8A via Co(III)-mediated approach) diameters estimated from TEM images.  Estimated using ImageJ image 




To identify whether any Cel8A was associated with the M13 scaffold under the Co(III)-
mediated complexation conditions, immunostaining for TEM was attempted. A hapten was selected 
with which Cel8A would be modified and then bound with an appropriate antibody. Then, a secondary 
antibody conjugated to a 5 nm gold nanoparticle (GNP) was added to visualize Cel8A by TEM. 
TAMRA was selected initially, as Cel8A could be modified and then quantified easily by absorbance 
spectroscopy to confirm it was labelled efficiency (Figure 3.38A). Labelling of Cel8A with NHS-
TAMRA as described in the Methods resulted in a labelling efficiency of 97%.  
 
Figure 3.38: Anti-TAMRA detection of Cel8A-TAMRA bound to M13-SA(NTA) scaffold.  A) Absorbance spectrum of 80 µM 
Cel8A-TAMRA reacted to 5-fold NHS-TAMRA for 3 h at 23 oC. B) Representative TEM images of M13-PEG12-biotin (1 µM 
p8) and bound 1 µM SA(BXN)3 reacted to 3 µM Cel8A-TAMRA via Co(III)-mediated approach. Immunolabelled with anti-
TAMRA primary antibody and 5 nm GNP-conjugated secondary antibody and negatively stained with 1% PTA. The panels 
show different phage particles from the same TEM grid.   
Overall, this approach failed due to the high background from 5 nm GNPs bound to the grid. 
The M13 had a thickened width from the binding of SA(BXN)3 and could be clearly observed (Figure 
3.38B). However, the selectivity of the immunogold labelling method was poor as the secondary 
antibody GNPs could be observed spread throughout the grid. Additionally, the GNPs were only rarely 
imaged in the vicinity of M13 making it difficult to ascertain whether it was by chance or specific 
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binding of the primary antibody to Cel8A-TAMRA. In order to draw conclusions, the background noise 
needed to be reduced. 
Several controls were carried out to determine the reason for the high background and reduce it. 
First, the immunostaining procedure was done with M13-PEG12-biotin on its own to determine the 
extent to which there was non-specific binding of either the primary or secondary antibody. There was 
little non-specific binding of the GNPs on the grid (Figure 3.39A). From this it was apparent that the 
0.1% BSA was adequate to block non-specific binding of the antibodies or coated GNPs. Overall, non-
specific binding of the antibody to the grid after blocking was unlikely the reason for the high 
background. Additionally, a positive control using M13 covalently labelled with NHS-TAMRA was 
stained using the same protocol (Figure 3.39B). The immunolabelling protocol was clearly identified 
the dye covalently labeled to the phage showing the antibody pair was indeed capable of specifically 




Figure 3.39: Representative TEM images of anti-TAMRA immunolabelling protocol troubleshooting.  A) M13-PEG12-biotin 
negative control. B) M13 covalently labelled with NHS-TAMRA. C) M13-PEG12-biotin first added to the grid. Following a 
blocking step with 0.1% BSA, Cel8A-TAMRA (with 0.1% BSA) was added to grid for 30 min. D) M13-PEG12-biotin was first 
added to the grid. Following a blocking step with 0.1% BSA, TAMRA-COO- (with 0.1% BSA) was added to grid for 30 min. 
TEM samples adhered to grids as indicated were immunolabelled with anti-TAMRA primary antibody and 5 nm GNP-
conjugated secondary antibody and negatively stained with 1% PTA. 
A change to the immunostaining protocol was made to account for the possibility that the high 
background came from Cel8A-TAMRA adsorbed to the grid prior to blocking and staining. The grid 
was incubated with M13-biotin first, blocked with 0.1% BSA, then incubated with Cel8A-TAMRA and 
finally subjected to the immunostaining protocol. M13 could be observed here at a width consistent 
with naked M13 (no coat of SA present; Figure 3.39C). There was a heavy background of GNPs 
observed here despite first blocking the grid with BSA before adding Cel8A-TAMRA. This blocking 
step should have prevented the non-specific binding of Cel8A, but clearly some non-specific interaction 
of Cel8A-TAMRA with the grid was possible. 
 An alternative possibility is that there was some free TAMRA present in the Cel8A-TAMRA 
preparation. While the Cel8A-TAMRA was extensively dialyzed, TAMRA is quite hydrophobic and its 
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removal may not have been complete. Consider a 3 µM TAMRA-Cel8A solution: even if one assumes 
1% unreacted TAMRA that was not adequately removed by dialysis, that would result in ~30 nM free 
dye. Any unreacted TAMRA present in the preparation may in fact be quite significant. To test this, the 
grids were first incubated with M13, blocked with BSA and then incubated with a 30 nM TAMRA-
COO- prior to immunostaining. There was considerable background from including the grid with as 
little as 30 nM TAMRA-COO- (Figure 3.39D). When imaged by TEM, the secondary antibody GNPs 
showed up ubiquitously.  
It seems apparent that non-specific binding of the dye molecule itself was the issue with this 
approach. It is possible that unreacted TAMRA binds first to the layer of BSA on the grid, and then 
primary antibody is binding to that. There are known interactions between hydrophobic dyes and BSA 
where a specific binding between the two components can be measured (Jameson et al. 2016). BSA has 
several high-affinity binding sites for anionic lipids which might also bind dye molecules (Kragh-
Hansen et al. 2001). The exact number of detergent binding sites depends on the nature of the 
hydrophobic molecule that interacts with BSA. A dye related to TAMRA, rhodamine B (which has 4 
ethyl groups rather than 4 methyl groups) has specific binding to a particular detergent binding site on 
BSA (Cai et al. 2010). The hydrophobic properties of certain fluorescent dyes are a known potential 
problem in experiments that rely on stochastic measurement, such as single molecule tracking 
experiments (Zanetti-Domingues et al. 2013). Thus, TAMRA as a hapten molecule to use in 
immunostaining procedures should be carefully considered as it was observed here to result in 
considerable background noise. An alternate primary/secondary antibody pair would have been a 
possible solution; however, the Co(III)-mediated approach to complex Cel8A to the M13 scaffold was 
not pursued further for the reasons highlighted below. 
 Despite the high efficiency of loading SA(BXN)3 onto M13-biotin, the subsequent loading step 
of His-tagged protein would likely not be efficient enough. In particular, a key part of this strategy was 
the oxidation of Co(II) to Co(III) to form a stable complex with a slow off-rate (Wegner and Spatz 
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2013). Prior to oxidation there must be complexation of Co(II), NTA and the His-tagged protein. 
Unfortunately, the interaction between NTA:Co(II) and His6 peptides is weak – the association 
constant (Ka) is about 2290 M-1 (Mehlenbacher et al. 2015). Using this Ka, the amounts of 
NTA:Co(II):Cel8A expected to form under typical conditions tested were modelled with a simple 
protein ligand binding equilibrium (Figure 3.40). Specifically, the concentration of NTA (found in 
SA(BXN)3) was set to 3 µM and the amounts of complex that would be expected to form at a range of 
Cel8A concentrations were calculated. For the typical conditions used in preparing samples for TEM, 3 
µM Cel8A was used. In the model, only ~1 % of the NTA present on M13 would be expected to be 
complexed under these conditions and was consistent with the lack of obvious change to the width of 
M13 complexes in the TEM images.  
 
Figure 3.40: Simulated binding equilibria between Cel8A and Co(II):BXN at a range of Cel8A concentrations.  Co(II):BXN 
was treated as a single component due to its presumed tight binding (kD = 4 x 10-11 M for Co(II) and NTA (Anderegg 2009)). 
The simulation assumed a [L] = 3 µM and association constant of 2290 M-1 (from (Mehlenbacher et al. 2015)). The purple 
line indicates typical concentrations of Cel8A used for preparing Cel8A bound to SA(BXN)-coated M13 (3 µM). 
Due to the weak association constant expected for Co(II), a very large excess of Cel8A would 
be necessary to load appreciable amounts of the enzyme on the M13-SA(BXN)3 scaffold. This was not 
ideal from a modularity and applicability point of view, as this would necessitate further purification 
after complexation. While this is not a problem from the point of view of characterizing the system, in 
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developing a nanoscale scaffold with broad applicability, the low efficiency of this step would reduce 
the potential utility of this platform.  
3.4 Conclusions 
 
It became apparent that efficient interactions would be necessary at each step in order to 
prepare a nanoscale scaffold densely loaded with a particular protein of interest. Consider that one of 
the big advantages of using a viral scaffold is the exact and reproducible positioning of functional 
groups with known and predictable symmetry. This was seen with the efficient loading of SA(BXN)3 
onto M13-biotin – the SA was positioned with regular and dense packing, following the symmetry of 
p8 subunit packing. The subsequent complexation of His-tagged protein and NTA:Co(II) was 
unfortunately not efficient and by utilizing an interaction that results in poor coverage of the phage 
scaffold, the platform is not being used to its greatest advantage. In the ideal case there would be near 
complete complexation, producing a multi-enzyme construct with precisely positioned enzymes, ready 
for characterization.  
There may however be modifications to this approach that may improve the efficiency of the 
His6-protein loading step. The standard NTA:Ni(II) interaction with a His6-tagged protein has a 
dissociation constant of around 10 µM (Bartoschik et al. 2018). While better than the interaction with 
Co(II), this would still be unlikely to produce an efficiently loaded, multi-enzyme construct. Several 
groups have developed modified NTA analogues with either improved binding with His-tagged 
proteins, or cleverly make use of a subsequent covalent reaction with the His-tagged protein (Figure 
3.41). In one example of this, the NTA reagent is photo-reactive – after complexation, exposing the 
complex to light results in covalent reaction with the probe of interest (Hintersteiner et al. 2008). In a 
second example, an NTA analogue with a reactive tosyl group was observed to react over the course of 
12 h only with protein containing a His-tag (Uchinomiya et al. 2009). It was thought that the nearby 
coordinated Ni(II) enhanced the reaction with the tosyl group.  
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A different type of analogue is an NTA variant with tighter binding through avidity effects. 
This molecule had three NTA moieties, and resulted in a noncovalent interaction with a <1 nM 
dissociation constant (Lata et al. 2006). While this would be a non-covalent interaction, the enhanced 
binding from avidity affects would be expected to make interaction with the resulting M13 scaffold 
much more efficient and long-lived (Vauquelin and Charlton 2013). In particular, the use of a 
biotinylated tris-NTA would likely be an improvement over the design used here, by virtue of its low 
dissociation constant with His-tagged proteins and potential to interface with SA (Reichel et al. 2007). 
These potential improvements would be more likely to result in a generalized approach to binding His-
tagged proteins to a M13 scaffold that could be carried out more efficiently. 
 
Figure 3.41: NTA-based molecules for forming A, B) covalent and C) non-covalent interactions with oligo-His-tags on 
proteins.  A) Photoreactive NTA analogue (Hintersteiner et al. 2008). B) Reactive NTA analogue mediated by proximity of 
chelated Ni(II) (Uchinomiya et al. 2009). C) Tris-NTA with improved binding from avidity effects (Bartoschik et al. 2018). 
In characterizing the SA(BXN:Co(II):Cel8A) complexes by SEC, a biotinylated Cel8A was 
used as a positive control to aid in interpreting the chromatograms. It was apparent from the shift to 
increased mass and subsequent disappearance of the SA peak that complexation occurred very well. 
Also, from TEM analysis of SA bound to M13-biotin, it was found that SA packed efficiently onto the 
surface of M13. The size of SA matched well with the anticipated spacing of biotin moieties on M13-
biotin. Thus, given the efficient binding of SA to M13-biotin and apparent efficient binding of Cel8A-
biotin to SA, the use of directly biotinylated enzymes bound to M13 via a SA adaptor molecule was 
pursued as a follow-up strategy. 
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Chapter 4 Multi-enzyme assembly using streptavidin as an adaptor 




Given the positive results seen when using Cel8A covalently biotinylated with TFP-PEG12-
biotin as a positive control in Chapter 3, it became apparent that it would be more efficient to bind 
Cel8A-biotin directly to SA. When used as a positive control in troubleshooting the His-tag mediated 
approach, complexation was particularly clear. In the following section, methodologies to prepare 
complexes of biotinylated protein onto M13 using SA as an adaptor molecule will be discussed.  
First, in order to aid the interpretation of results, Cel8A-biotin was characterized by a 
fluorescence-based assay, to assess the extent of biotinylation, and mass spectrometry, to assess the 
distribution of Cel8A-biotin species present (Figure 4.1). Given the multivalent nature of the 
components, M13-biotin (maximum of 2700 biotin) and SA (four ligand binding sites), there was the 
potential for the formation of aggregates without defined control of the positioning of components – the 
methods were designed such that loading of enzyme could be done in a controllable manner while 
reducing random aggregation. Two different approaches were taken to prepare the complexes: 1) 
Cel8A-biotin was complexed with SA to form a mixture of SA(Cel8A-biotin)N complexes with some 
free biotin-binding sites to allow complexation to M13-biotin in a second step, and 2) M13 with a 
coating of SA (SA-coated M13) was pre-formed in an initial step, and complexation of Cel8A-biotin 




Figure 4.1: Chapter topic overview for the formation of Cel8A multienzyme complexes on M13 using SA as an adaptor 
molecule.  The topics in the mind map diagram will be presented in order from left-to-right. 
From experimentation with SA/Cel8A-biotin complexes in Section 3.3.2, it was apparent that 
SEC would be incapable of isolating SA/Cel8A-biotin with defined stoichiometry. Therefore, an 
approach using an ensemble of SA/Cel8A-biotin species with average stoichiometry determined by the 
ratio of SA and Cel8A-biotin used was first tested. This ensemble of SA/Cel8A-biotin species would 
then be mixed with M13-biotin to form a nanoscale arrangement of the Cel8A components on M13 
(Figure 4.2). As discussed in Section 3.3.1.1, directly binding biotin to SA can result in a distribution 
that is skewed toward fully bound and full unoccupied SA(biotin) species. Therefore, desthiobiotin-
saturated SA was used throughout this section to slow the binding of biotin to SA when mixing Cel8A-
biotin species to SA. The ratios of SA and Cel8A-biotin should furthermore be prepared in such a way 
that on average SA(Cel8A-biotin) species have some free biotin-binding sites for further complexation 
onto M13-biotin. A fluorescence assay utilizing B4F was devised to indirectly monitor the 




Figure 4.2: Schematic representation of multi-enzyme complex assembly using biotinylated enzyme and SA as an adaptor 
molecule. 
 For the second approach, where M13-biotin was first coated with SA, it was found that there 
were certain conditions under which SA and M13-biotin could be mixed without unwanted crosslinking 
and aggregation. The different conditions for preparing SA-coated M13 were assessed by TEM and will 
be discussed first, followed by the results of further complexation of SA-coated M13 with Cel8A-
biotin. Additionally, factors that impacted the stability of the formed complexes on M13 will be 
presented. In the last section, the results of activity assays against cellulosic substrates utilizing the 
formed M13/Cel8A complexes will be shown. In some of these assays, a cellulose binding module-
cohesin fusion protein (CBM-Coh) was included to bind to the free dockerin domains of Cel8A to 
furthermore add a targeting component to the assembled complexes. 




SA (>95% purity according to the supplier; Cedarlane, Burlington, Canada) was supplied as a 
lyophilized protein (from 10 mM potassium phosphate buffer pH 6.5) and was resuspended up to 5 
mg/mL in MQH2O. The concentration of SA was determined by its estimated monomer extinction 
coefficient at 280 nm of 41940 M-1 cm-1 (ProtParam, ExPASy). Low viscosity carboxymethylcellullose 
(CMC) sodium salt (Millipore Sigma, Oakville, Canada) was prepared freshly as a 1% solution (w/v) in 
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0.1 M sodium citrate pH 5.8 and α-cellulose (Millipore Sigma, Oakville, Canada) was similarly 
prepared freshly as a 2% (w/v) solution in 0.1 M sodium citrate pH 5.8. 
4.2.2 Protein expression and purification 
 
 General statement 
 
 Details on purification of the following relevant components can be found in Chapter 3 
methods: Cel8A and M13KE. 
 CBM-Coh expression and purification 
 
CBM-Coh was expressed from pET28a-ybbR-HIS-CBM-CohI (Addgene plasmid # 58709) 
from Hermann Gaub (Otten et al. 2014). Briefly, the plasmid was cloned into BL21 E. coli which was 
grown to ~0.8 OD at 37 oC in LB media with 50 µg/mL kanamycin. Protein expression was induced at 
37 oC with 1 mM IPTG for 3 h, at which point the cells were collected by centrifugation at 5000 g for 
15 min at 4 oC. 
To cell pellet from 1 L of culture, 30 mL of lysis buffer (25 mM Tris, 137 mM NaCl, 2.7 mM 
NaCl, 5 mM imidazole) supplemented with 0.5 mM PMSF was added. The resuspended pellet was 
passed three times through a high-pressure (>10,000 psi) homogenizer to lyse the cells. The lysate was 
incubated at 60 oC for 30 min and then centrifuged at 20,000 g for 30 min at 4 oC. The protein was 
purified by IMAC. The cleared lysate was loaded onto a 1 mL HisTrap™ (GE Healthcare, Chicago, 
USA), washed with 5 mL of wash buffer (25 mM Tris, 137 mM NaCl, 2.7 mM NaCl, 10 mM 
imidazole), and eluted over a 5 mL gradient from 5 to 250 mM imidazole. The sample was dialyzed 
against 50 mM sodium acetate pH 6 using a 12400 Da MWCO dialysis membrane (Millipore Sigma, 
Oakville, Canada). The purified protein was flash frozen in liquid nitrogen and stored at -80 oC. CBM-
Coh was quantified by measuring its absorbance at 280 nm and using its theoretical extinction 
coefficient of 48485 M-1 cm-1 calculated by ProtParam (Gasteiger et al. 2005). 
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4.2.3 Bioconjugation methods 
 
 Preparing Cel8A-PEG12-biotin (variable) 
 
 Cel8A was diluted to 110.8 µM in 100 mM sodium phosphate buffer pH 7.46. To this solution, 
either 110.8, 277, or 554 µM TFP-PEG12-biotin was added to initiate the reaction. The total amount of 
DMSO present in each reaction was 10% (v/v). The reaction was carried out for 18 h at 23 oC. After 
reaction, labeled Cel8A samples were dialyzed for a total of three 2 L dialysis exchanges (6 h 
minimum, 23 oC) employing 12400 kDa MWCO dialysis tubing (Millipore Sigma, Oakville, Canada) 
against 1x PBS pH 7.4. 
 Labelled Cel8A-PEG12-biotin samples were prepared for ESI-MS by employing filtration 
through C18 ZipTips (Millipore Sigma, Oakville, Canada). Sample preparation by spin filtration (with 
10 kDa MWCO filters) was unsuccessful, as samples were poorly recovered after several spins, 
resulting in insufficient material to obtain good spectra. The Cel8A-PEG12-biotin samples were at ~60 
µM and were spiked to a formic acid (FA) concentration of 0.5% (v/v) prior to binding to the ZipTip. 
With a pipette set to 10 µL, the tip was aspirated: in 100% ACN 7 times, 0.1% FA 7 times, the sample 
15 times, 0.1% FA 7 times (discarding into waste each time), and finally aspirating into 50 µL 1:1 
MeOH:H2O with 0.1 % FA. The desalted sample was directly infused into a ThermoFisher™ Q-
Exactive ESI-MS Orbitrap in positive mode.   
 Preparing M13-PEG4-biotin 
 
Tetrafluorophenyl-PEG12-biotin (TFP-PEG4-biotin) was first prepared at a 10 mM 
concentration in anhydrous dimethyl formamide (DMF). The final reaction concentrations were 100 
µM p8, 1 mM TFP-PEG4-biotin in 1x PBS pH 7.46 with 20% DMF. Reactions were carried out over 18 
h at 4 oC. These were then dialyzed 6 times against 2 L of 1x PBS pH 7.46 in 12.4 kDa MWCO 
regenerated cellulose dialysis tubing (Millipore Sigma, Oakville, Canada). M13-PEG4-biotin were flash 
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frozen with liquid nitrogen and stored at -80 oC. The concentration of M13-PEG4-biotin was determined 
according to its A269 absorbance as described in Section 3.2.2.1. 
4.2.4 Preparation of Cel8A-biotin complexes on M13 
 
 Preparation of SA(Cel8A-biotin) complexes onto M13-biotin 
 
 This method describes the general approach and conditions for preparing SA(Cel8A-biotin) 
complexes followed by subsequent complexation onto M13-PEG12-biotin. All steps were carried out at 
23 oC. Saturated SA was first prepared at 25 µM SA and 100 µM desthiobiotin and equilibrated for 10 
min in 1x PBS pH 7.4. Cel8A-biotin was added to desthiobiotin-saturated SA as indicated; typical 
concentrations were, Cel8A-biotin (0.74 biotin/Cel8A) added to a concentration of 33.8 µM Cel8A (25 
µM biotin moieties) and equilibrated for 60 min. M13-PEG12-biotin was added to a final p8 
concentration as indicated; typical concentrations were 16 µM p8 subunits added to 1.48 µM 
SA(Cel8A-biotin)N complexes to ensure complete binding of SA(Cel8A-biotin)N species over the 
course of 1 h. 
 Where CBM-Coh was added to these complexes, an additional step where the complexes were 
diluted down to 350 nM Cel8A subunits and incubated with 700 nM CBM-Coh in 0.1 M citrate pH 5.8 
supplemented with 2 mM EDTA and 12 mM CaCl2 for 2 h at 37 oC was carried out. 
 Preparation of SA-coated M13 and complexation with Cel8A-biotin 
 
 This method describes the general approach taken to coat M13-PEG4-biotin with SA, followed 
by subsequent complexation with Cel8A-biotin. SA-coated M13 was typically prepared with M13-
PEG4-biotin at 2 µM p8 subunits and SA at 2 µM in MQH2O. M13-PEG4-biotin was added to the 
solution first and mixed before adding SA which was further mixed immediately by pipetting. 
For complexation with Cel8A-biotin, prepared SA-coated M13 was first pre-bound to 
desthiobiotin. Typically, desthiobiotin was added to a final concentration of 8 µM to the complexes to 
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saturate biotin-binding sites and given 15 min to equilibrate. After, Cel8A-biotin (0.74 biotin/Cel8A) 
was added to 3.2 µM Cel8A (2.36 µM biotin) to SA-coated M13 at a SA tetramer concentration of 1.6 
µM unless otherwise indicated. These were allowed to interact for 1 h at 23 oC before further 
manipulation. 
 Drop dialysis of SA-coated M13 complexes 
 
 Clean-up of SA-coated M13 complexes was tested with two approaches: by drop dialysis and 
by differential centrifugation. SA(Cel8A-biotin) complexes with M13-biotin were prepared as 
described. Drop dialysis was carried out on MF-Millipore Membrane filters with 0.05 µM pore size 
(Millipore Sigma, Oakville, Canada). Filters were floated onto MQH2O or 1x TBS (25 mM Tris, 137 
mM NaCl, 2.7 mM KCl pH 7.4). The sample (100 µL) was pipetted gently onto filters that were floated 
on MQH2O or 1x TBS pH 7.4 and allowed to dialyze at 23 oC for up to 4 h (Figure 4.3). Small aliquots 
of MQH2O or 1x TBS pH 7.4 were added over time to bring up the volume to 100 µL with some gentle 
mixing by pipetting. The final volume was brought back to 100 µL by mass. The change in SA 
concentration over time was determined by monitoring the biotin-binding activity of the solution using 
B4F. Briefly, samples containing SA were diluted into 400 nM B4F in 1x PBS pH 7.4 and the change 
in fluorescence, when compared to a B4F fluorescence standard curve, was used to determine biotin-
binding activity of the sample. The biotin-binding activity was proportional to the amount of SA in 
solution and used to calculate the relative concentrations of SA over time. Where M13 was monitored, 
the concentration was too low to monitor spectrophotometrically; M13 was instead monitored by its 
titer (PFU/mL). M13 was diluted up to 109-fold in sterile MQH2O and plated on a lawn of E. coli 
ER2738 plated on LB agar supplemented with 12 µg/mL tetracycline. These were incubated overnight 




Figure 4.3: Drop dialysis setup showing membrane filter with a solution to be dialyzed floating on buffer in a Petri plate. 
4.2.5 Analysis methods 
 
 Estimating Cel8A biotinylation by mass spectrometry 
 
It is possible to determine the labelling efficiency of a multiply labelled protein by treating 
reactive amine observed to be labelled (m) with a probability (p) of being labelled and fitting to a 
binomial distribution as shown in Equation 4.1 (Wojcik et al. 2008). The relative intensities of 
biotinylated Cel8A peaks in deconvoluted mass spectra were fit to a binomial distribution using a least 
squares minimization approach to obtain an estimate of the extent of biotinylation of Cel8A-biotin 
samples. Absolute quantitation by MS would require running each component separately to determine 
relative ionization efficiencies – this method is simplified in that it assumes the ionization efficiency of 
each Cel8A-biotin species is similar. 
𝑃(𝑛; 𝑚; 𝑝) =
𝑚!
𝑛!(𝑚−𝑛)!
𝑝𝑛(1 − 𝑝)𝑚−𝑛        (4.1) 
 
In this distribution, m represents the total number of Lys residues that can be labelled, p is the 
probability of a Lys being labelled (value to be fitted), and n is the number of amines observed to be 
labelled. The value of m was determined from the maximumly labelled species observed (m = 3). The 
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peaks that were used in fitting were the parent peaks (with no ion adducts). For Cel8A(biotin)0, this was 
the peak at 50276 Da with each subsequently-labelled peak have an additional mass of 827.02 Da.  
Each peak intensity was divided by the sum of all peak intensities to obtain a relative frequency 
(0 – 1) for each Cel8A(biotin)N species. The value of p that best fit the relative frequencies of each 
Cel8A(biotin)N species to a binomial distribution was determined by least squares minimization. 
Analysis was performed in R (version 3.5.1). 
 Estimating Cel8A biotinylation by B4F titration 
 
A B4F titration was carried out as described in Chapter 3 in order to determine the total biotin 
per Cel8A in bioconjugate preparations. First, the concentration of Cel8A was determined by its 
estimated extinction coefficient at 280 nm of 104420 M-1 cm-1 calculated by ProtParam (Gasteiger et al. 
2005). The concentration of SA was determined by its estimated monomer extinction coefficient at 280 
nm of 41940 M-1 cm-1. Biotin-4-fluorescein (B4F) was diluted 250-fold from a DMSO stock into 1x 
PBS pH 7.4 and standardized using its extinction coefficient of 68000 M-1 cm-1 at 495 nm (Ebner et al. 
2008). For the titration, Cel8A-biotin samples were first mixed with SA at a concentration of 2.5 µM 
SAtet and 2.5 µM Cel8A-biotin in 1x PBS pH 7.4. The complexed protein was further diluted: 5 µL into 
495 µL 1x PBS pH 7.4 to a SAtet concentration of 25 nM. The fluorescence of this mixture was 
measured at 490 nm excitation and 525 nm emission with a 515 nm cut-off filter after each 5 µL 
addition of 1 µM B4F. B4F was added until a breakpoint was clearly observed. A control titration with 
just SA to determine the number of open biotin-binding sites in the absence of biotinylated protein was 
also carried out as described above. 
 Monitoring complexation of SA(Cel8A-biotin)N to M13-biotin using B4F 
 
This assay was devised to monitor complexation of SA (and SA(Cel8A-biotin) complexes) to 
biotinylated M13 indirectly by monitoring the total number of free biotin-binding sites before and after 
adding SA(Cel8A-biotin) to M13-biotin. The total amount of free biotin-binding sites at each step was 
141 
 
determined by adding a known amount of B4F to SA; B4F is quenched upon binding to SA, therefore 
the difference in B4F fluorescence before and after adding a SA-containing sample is proportional to 
the number of biotin-binding sites present. The absolute molar amount of free B4F before and after was 
determined using a fluorescence standard curve. A fluorescence standard curve was made using the 
same prepared buffers used for each experiment. 
First, the SA(Cel8A-biotin)N complexes are prepared. SA was first pre-saturated with an 
equivalent amount of desthiobiotin (25 µM SAtet and 100 µM desthiobiotin) in 1x PBS pH 7.4. Cel8A-
biotin (0.74 biotin/Cel8A) was added to a final concentration of 33.78 µM Cel8A (equivalent to 25 µM 
biotin). After the addition of desthiobiotin, the mixture was incubated 15 min at room temperature. 
After the addition of Cel8A-biotin and 1x PBS, the mixture was incubated for 1 hour at room 
temperature. At this stage, the complexes with varying amounts of Cel8A-biotin (and residual 
desthiobiotin) bound to SA will be referred to generally as “SA(Cel8A-biotin)”. As these species are 
likely to be an ensemble of SA(Cel8A-biotin)N species, the specific ratios or concentrations of SA and 
Cel8A-biotin used in preparing SA(Cel8A-biotin) complexes will be referred to where relevant. 
 The ensemble of SA(Cel8A-biotin)N species, as prepared above, were diluted to 2 µM of SAtet 
and then bound to an M13-PEG12-biotin concentration such that 16, 8 or 4 µM of p8 subunits were 
present (assuming 2700 p8/M13 particle). Controls with SA(Cel8A-biotin) diluted an equivalent 
amount in 1x PBS pH 7.4 were also prepared. This complexation mixture was also incubated for 1 hour 
to allow time for the desthiobiotin to be displaced by the biotin on the M13. Lastly, the complex was 
diluted to 75 nM of SAtet (expected free biotin-binding sites 225 nM) and mixed with 350 nM of B4F in 
1x PBS pH 7.4. These solutions were equilibrated for 2 hours at room temperature prior to measuring 
the retained fluorescence at 490 nm excitation, 525 nm emission with a 515 nm cut-off. Fluorescence 
data was collected on a SpectraMax® M5 (Molecular Devices, San Jose, USA) with the photomultiplier 
tube sensitivity set to high. 
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 PEG precipitation of SA(Cel8A-biotin)N complexes prepared on M13-biotin 
 
PEG precipitation of M13 phages was carried out to qualitatively assess the presence of 
SA(Cel8A-biotin) complexes bound to M13. Complexation of Cel8A-biotin (attached to SA) to M13 
was carried out in two steps: first Cel8A-biotin was complexed to SA to form an ensemble of 
SA(Cel8A-biotin) complexes, followed by complexation to the M13-biotin scaffold. SA at a 
concentration of 15 µM was bound to 60 µM desthiobiotin in 1x PBS pH 7.4. After 30 min, Cel8A-
biotin (2.04 biotin/Cel8A) was added to a final concentration of 15 µM Cel8A (30.6 µM biotin) and 
incubated for 60 min at 23 oC in 1x PBS pH 7.4. The prepared SA(Cel8A-biotin) ensemble was further 
diluted to 1.5 µM SAtet in 1x PBS pH 7.4. For the M13-biotin containing sample, M13-biotin was added 
to a final concentration of 36 µM p8 subunits. For the control without M13-biotin an equal quantity of 
buffer was added. PEG/NaCl (20% PEG-8000, 2.5 M NaCl) was added at 200 µL PEG/NaCl per 1 mL 
of SA(Cel8A-biotin) with or without M13-PEG12-biotin. This was precipitated for 1 hour at 23 oC and 
then centrifuged at 15000 g for 10 min. The pellet fraction was brought back to its original volume with 
1x PBS pH 7.4. 
Initial aliquots of SA(Cel8A-biotin) (with or without M13-biotin) before centrifugation, as well 
as aliquots of the pellet and supernatant fractions were assayed for endocellulase activity. The aliquots 
taken were diluted such that the final concentration of Cel8A would be 50 nM if one were to assume 
that the total amount of Cel8A added was retained in that respective fraction. The reactions were carried 
out with 0.5% CMC in 0.1 M citrate pH 5.8 at 50 oC for 10 min. Reducing ends produced were detected 
with DNS reagent (as prepared in section 3.2.4.1.) and compared to a glucose standard curve to convert 
the values to a molar quantity of reducing ends produced. Briefly, aliquots of the reaction were mixed 
1:1 with DNS reagent and boiled 5 min. The resulting absorbances were read at 540 nm. 




 This assay was carried out to confirm that association between CBM-Coh and the biotinylated 
Cel8A could occur. Phosphoric acid-swollen cellulose (PASC) was produced for this assay according 
to literature methods (Hsieh et al. 2015). First, 4 g Avicel® PH101 was incubated with 100 mL of ice-
cold 85% phosphoric acid. Mechanical disruption with a glass stir rod was used to break up the 
cellulose and after 2.5 h the syrupy solution was poured into 1.9 L of ice-cold distilled deionized water. 
The cellulose fibres were allowed to settle and the water carefully decanted off for a total of 4 x 2L 
water washes. Similarly, the fibres were washed with 2 x 2 L of NaHCO3 (10 g/L, not pH adjusted). 
Three more 2 L water washes were carried out and the final volume was brought down to about 100 
mL. The PASC was quantified gravimetrically by evaporating the water in vacuo.  
This procedure was carried out according to literature methods for cellulose-based pull-down 
assays (Yael Vazana et al. 2012). However, rather than analyze bound and unbound fractions solely by 
SDS-PAGE, the fraction of unbound protein was assessed by its activity against CMC. Additionally, 
PASC was used as it has a higher binding capacity for cellulose-binding proteins than other forms of 
insoluble cellulose (Lamed et al. 1985). Mixtures of Cel8A-biotin were prepared with CBM-Coh at 350 
nM Cel8A and corresponding ratios of CBM-Coh. Solutions were equilibrated for 2 h at 37 oC in 0.1 M 
citrate pH 5.8 supplemented with 2 mM ethylenediaminetetraacetic acid (EDTA) and 12 mM CaCl2. 
These solutions were further incubated with PASC at a final concentration of 0.12 % w/v on ice for 1 h. 
The solutions were centrifuged at 12700 g for 5 min. 
Supernatants were diluted down to 10 nM Cel8A (based on the initial concentration of Cel8A-
biotin in the solution prior to centrifugation) and reacted with 0.5 % CMC (w/v) in 0.1 M sodium citrate 
pH 5.8 at 65 oC for various time intervals. Endpoints were analyzed by mixing aliquots of the reaction 
1:1 with DNS reagent (as prepared in Section 3.2.5.1) and boiling for 5 min. The absorbance of the 
solution was read at 540 nm and compared to a D-glucose standard curve reacted with DNS in the same 
way. The initial rates were determined from time points taken during the linear portion of the reaction. 
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 Endocellulase assays 
 
 For assays against CMC, complexes were diluted such that there was either 100 nM Cel8A for 
reactions at 23 oC, or 10 nM Cel8A for reactions at 50 oC unless otherwise noted. Reactions were 
carried out with 0.5 % CMC in 0.1 M citrate pH 5.8. These concentrations were chosen such that the 
linear range of the reaction could be monitored over 20 – 30 min. Aliquots were removed and mixed 
with 1:1 with DNS reagent (prepared as described in Section 3.2.5.1.) and boiled 5 min. The 
absorbance of the resulting solution read at 540 nm and compared to a D-glucose standard curve to 
determine the produced reducing ends. 
 For assays against α-cellulose, reactions were carried out in test tubes floated in a jacketed 
beaker attached to a water bath to maintain the temperature at 50 oC. The jacketed beaker was set on a 
stir plate to allow stirring of the reactions to ensure dispersion of α-cellulose particles throughout the 
reaction. Complexes were diluted such that there was 100 nM Cel8A. Reactions were carried out with 1 
% w/v α-cellulose in 0.1 M citrate pH 5.8 at 50 oC with constant stirring. Due to the insolubility of the 
substrate, removing equal aliquots by pipette was inconsistent; thus, each endpoint represents a single 
test tube which was mixed 1:1 with DNS reagent and boiled for 10 min. Tubes were cooled for 1 min 
before centrifuging at 15000 g for 5 min to remove α-cellulose particles and the absorbance of the 
supernatant was read at 540 nm and compared to a glucose standard curve to determine reducing ends. 
 TEM staining conditions (regular staining with PTA) 
 
Phosphotungstic acid (PTA) was prepared fresh before each experiment by diluting PTA in 
water to 1% (w/v) and then adding 1.12 mL 2 M NaOH per 1 g of PTA that was weighed out to 
neutralize the stain (Phillips 1950).  
M13 phage containing samples were typically adhered to TEM grids at a concentration of 1.5 – 
4.5 x 1011 M13 particles/mL in sterile MQH2O (M13 typically exchanged into MQH2O from 1x PBS 
buffer by dilution of ~100-fold). Grids used were carbon/formvar 400 mesh (Ted Pella, etc.) or ultrathin 
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carbon film supported by lacey carbon 400 mesh (Ted Pella, etc.) where indicated. Grids were prepared 
by placing grids onto prepared drops of sample/wash solution. A typical grid preparation is as follows: 
a 10 µL drop of M13 was adhered to the grid for 1 min, followed by two brief washes (a few seconds) 
on 50 µL drops of sterile MQH2O, and lastly, staining for 20 sec on a 20 µL drop of 1% PTA. Excess 
solution was wicked away with filter paper after each step. Grids were dried overnight. 
 TEM staining conditions (TEM immunostaining procedure) 
 
This staining procedure was carried out to specifically bind 5 nm gold nanoparticles (GNP) to 
the His6-tag of Cel8A present on M13 scaffolds. The primary antibody used to bind the His6-tag was a 
6x-His tag monoclonal mouse IgG antibody (ThermoFisher Scientific, Waltham, USA). The stock 
solution was at 1 mg/mL. The secondary antibody was goat anti-mouse IgG 5 nm GNP conjugate 
(Cytodiagnostics, Burlington, Canada). The stock solution was at 3 OD (~1.64 x 1014 particles/mL 
according to the manufacturer). 
The protocol for immunogold staining was adapted from literature methods with some changes 
(X. Li et al. 2016). The TEM grids used were carbon/formvar 400 mesh. In order to adhere phage 
samples to the grid, M13 was diluted down to 1.5 – 4.5 x 1011 M13 particles/mL in sterile MQH2O, and 
a 10 µL droplet to each grid and let sit for 1 min before removing the excess with filter paper. The grid 
was touched to 50 µL water droplets (~2 sec) to wash and the excess was removed with filter paper. 
The grid was blocked by incubation of the grid with 50 µL droplet of blocking buffer (0.1 % BSA in 1x 
TBS pH 7.4) for 10 min to prevent non-specific binding of antibodies. The excess solution was 
removed with filter paper. The grid was incubated on 50 µL droplet containing primary antibody 
(diluted 1:20 into blocking buffer) for 60 min. This was washed 5 x 3 min on 50 µL droplets of 
blocking buffer. The grid was incubated on 50 µL droplet containing the secondary antibody GNP 
conjugate (diluted 1:30 into blocking buffer) for 60 min. This was washed 3 x 3 min on 50 µL droplets 
of blocking buffer, followed by 3 x 3 min on 50 µL droplets of 1x TBS pH 7.4, and lastly, with 4 x 30 s 
on 50 µL droplets of sterile MQH2O. The excess solution was removed with filter paper. Lastly, the 
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grids were stained on 20 µL droplets of 1% (w/v) PTA for 1 min and then the excess stain was removed 
with filter paper. 
 
4.3 Results and discussion 
 
 There were two main approaches taken to complexing biotinylated Cel8A (referred to generally 
as Cel8A-biotin) to M13-biotin using SA as an adaptor protein. The main difference in these two 
approaches was whether or not Cel8A-biotin was complexed to SA before further complexation onto 
M13-biotin, or if M13-biotin was first bound to SA followed by complexation with the biotinylated 
enzyme. There were benefits and drawbacks to both approaches that will be highlighted in this section. 
Furthermore, each approach highlights different aspects and considerations that are generally applicable 
to the formation of a high density, multi-enzyme complex on an M13 scaffold, and perhaps for other 
filamentous phages. 
4.3.1 Estimated extents of biotinylation of Cel8A-biotin 
 
 Characterization of Cel8A-biotin will be discussed here prior to discussing the results of 
complexation onto M13-biotin. The results here are relevant to all of the approaches used to prepare 
Cel8A/M13 complexes using SA as an adaptor molecule in this chapter, and thus will be presented first. 
Specifically, the method used to biotinylate Cel8A was expected to produce a mixture of Cel8A-biotin 
species. Therefore, the characterization in this section covers the estimation of the total extent of 
biotinylation of Cel8A-biotin samples and the distribution of Cel8A(biotin)N (multiply labelled) species 
by mass spectrometry. Here, Cel8A(biotin)N refers to the total number of times a particular Cel8A was 
modified with biotin. 
Cel8A-biotin was prepared by reacting free amines on the protein with the activated ester TFP-
PEG12-biotin. After reaction, excess reagents and hydrolyzed side product were removed by dialysis 
with 12400 Da MWCO dialysis tubing. About 40 % of Cel8A was lost over the course of the dialysis 
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step for each sample (Table 4-1). This was possibly due to association of the cellulase with the 
regenerated cellulose dialysis membrane; some affinity to cellulose-based membranes might be 
expected. However, the recovered yields after dialysis were acceptable. 











Cel8A-biotin (1 eq TFP-
biotin) 
111 111 64.8 ± 2.5 58.5 ± 2.3 
Cel8A-biotin (2.5 eq 
TFP-biotin) 
111 277 63.0 ± 3.0 56.9 ± 2.7 
Cel8A-biotin (5 eq TFP-
biotin) 
111 554 63.8 ± 2.4 57.6 ± 2.2 
 
One of the methods used to estimate the extent of biotinylation was by competitive titration 
with the fluorescent biotin analogue, biotin-4-fluorescein (B4F), against streptavidin (SA). From three 
different concentrations of TFP-PEG12-biotin initially added to Cel8A, a range of labelling efficiencies 
from 32 – 171 % labelling were estimated (Table 4-2). The extent of biotinylation increased as the 
equivalents of TFP-PEG12-biotin in the reaction increased. An example of the calculations used to 
estimate the extent of biotinylation from a competitive B4F titration are highlighted in Table 4-2. The 
maximum sites per SA were determined from a control (SA at the same concentration), titrated with 
B4F to determine the total biotin-binding sites present in the absence of Cel8A-biotin. From the 
breakpoint of the titration, one can estimate the number of biotin present in the unknown samples from 
which the biotin per Cel8A is calculated (described in more details in Methods 4.2.5.2.).  
Table 4-2: Summary of B4F fluorescence titration breakpoint estimates (mean and SD; n=3).  From left-to-right the columns 













0.754 ± 0.045 0.835 0.0813 8.13 0.32 ± 0.18 
Cel8A:TFP-
biotin 1:2.5 
0.650 ± 0.017 0.835 0.185 18.5 0.74 ± 0.07 
Cel8A:TFP-
biotin 1:5 





0.832 ± 0.018 0.835 0.003 0.3 0.01 ± 0.070 
*Total concentration of biotin binding sites was 100 nM; the fraction of occupied sites multiplied by 100 nM gives [biotin]. 
҂Concentration of Cel8A-biotin added was 25 nM. 
 
In the initial survey of ESI-MS of Cel8A-biotin, it was possible to resolve the individual 
biotinylated species of Cel8A-biotin. The expected average isotopic mass of unlabeled Cel8A is 
50276.70 Da and corresponds well to the measured mass (Figure 4.4A). The increase in mass expected 
for the aminolysis reaction was 827.02 Da (Figure 4.4B). The species detected at 51102.06, 51928.13 
and 52753.03 Da correspond well to Cel8A(biotin), Cel8A(biotin)2 and Cel8A(biotin)3 respectively. As 
there are several surface-exposed Lys residues present, multiply labelled Cel8A is expected (19 surface-
exposed Lys residues on cellulase domain; Figure 4.5), though, many of the Lys residues appear to be 
interacting as salt bridges according to the crystal structure (PDB: 1CEM; (Alzari, ne Souchon, and 
Dominguez 1996)). It is commonly the case for thermostable proteins to have a network of ionic 
bonding on the surface of the protein (Chan, Yu, and Wong 2011). At pH 7.46, these salt bridges mean 
that it is possible that only a small subset of these Lys residues is reactive. 
 
Figure 4.4: Typical ESI-MS of Cel8A-biotin samples.  A) Deconvoluted ESI mass spectrum of Cel8A-biotin (0.74 
biotin/protein) run in 1:1 MeOH:H2O + 0.1% FA on a Thermo Q-Exactive ESI mass spectrometer and deconvoluted using 
BioPharma Finder™ (ThermoScientific, v.3.0). B) Fragment of TFP-PEG12-biotin showing expected mass increase upon 




Figure 4.5: Crystal structure of Cel8A (cellulase domain) highlighting Lys residues (blue) and potential ionic interactions with 
acidic residues, Asp and Glu (red).  PDB: 1CEM (Alzari, ne Souchon, and Dominguez 1996)). 
If one assumes that the ionization efficiency is the same for each of the multiply biotinylated 
Cel8A species, and the reactive Lys residues are equivalent in their reactivity, then the data should fit 
well to a binomial distribution. The main peak for each Cel8A(biotin)N species (parent ion; no adducts) 
was taken from the deconvoluted spectra and then fit to a binomial distribution (Figure 4.6). The 
spectra fit reasonably well to the binomial distributions, indicating that the reacted Lys residues are 
likely similar in their reactivity. More practically, the fitted values for p could be used to determine the 
percent labelling of each Cel8A-biotin sample. The estimates of percent labelling from the mass spectra 
ranged from 57 – 189 % labelling. Though it was possible to estimate percent labelling from the B4F 
competitive titration experiment, knowledge of the distribution of multiply biotinylated species is 
important for understanding complexation to SA and M13 downstream. The batch of biotinylated 
Cel8A-biotin (unless otherwise indicated) used in subsequent experiments in this chapter was the 




Figure 4.6: Estimating extent of biotinylation from mass spectra of Cel8A-biotin.  Deconvoluted ESI mass spectra of Cel8A-
biotin (left column) from reactions of Cel8A (110.8 µM) with increasing equivalents of TFP-PEG12-biotin: A) 110.8 µM, B) 
277 µM, and C) 554 µM TFP-PEG12-biotin. Peak intensity (bars) from mass spectra were fit to a binomial distribution (fitted 
line) as described in the Methods (middle column). The value of p fitted from the binomial distribution was multiplied by total 
reactive residues (m) to obtain the average biotin per Cel8A (right column). Single spectra (n = 1) were fit to obtain values. 
The estimations of extent of biotinylation of Cel8A by ESI-MS were higher than by the B4F 
titration method discussed above. If the ionization efficiencies being different was the reason for the 
difference between the ESI-MS estimates and the B4F estimates, one would expect the estimates to be 
lower by ESI-MS. It should be considered that the spectrum is run in positive ion mode and each 
subsequent labelling would reduce the overall positive charge on the protein surface, and hence it is 
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likely that this would reduce the ionization efficiency of the biotinylated species and hence 
underestimate their true amount. It is possible that the B4F titration method underestimates the total 
biotin present. Since the assay relies on binding analyte to SA, if not all of the biotin is capable of 
binding to SA (due to steric factors), the total amount could be underestimated by this method.  
In summary, Cel8A-biotin prepared through the acylation of primary amines with an activated 
biotin ester was characterized by fluorescence titration and ESI-MS. From this, an estimate of the extent 
of biotinylation and distribution of Cel8A(biotin)N species was determined. Further studies could 
employ tandem mass spectrometry sequencing to specifically localize the position(s) of the biotin; 
however the purpose of demonstrating that multienzyme complexes could be controllably fabricated on 
a filamentous phage, determination of the exact location(s) of the biotin modification(s) were not 
pursued at this stage. 
4.3.2 Method 1: complexation of SA(Cel8A-biotin)N species to M13-biotin 
 
This section covers analysis and results of preparing an ensemble of SA(Cel8A-biotin) species 
with relative amounts of SA and Cel8A-biotin, such that the resulting mixture of SA(Cel8A-biotin)N 
species would have, on average, one or more open biotin-binding sites on each SA. In a subsequent 
step, these SA(Cel8A-biotin)N species were adhered to biotin-M13 (Figure 4.7). Successful 
complexation was indirectly confirmed using PEG precipitation followed by monitoring Cel8A activity 
in supernatant or pellet fractions. Additionally, B4F was utilized as a probe to follow complexation by 
monitoring loss of free biotin-binding sites upon addition of M13-biotin – allowing binding of 
SA(Cel8A-biotin) complexes to M13 to be inferred. While Cel8A was confirmed to be bound to the 
M13 scaffold, the arrangement of Cel8A components were not as designed or intended. Analysis of the 
results of TEM experiments demonstrated that SA(Cel8A-biotin) complexation occurred in a non-
uniform fashion and it was likely that aggregates of SA(Cel8A-biotin) formed that were incapable of 
binding to the M13-biotin scaffold. However, this section highlights some factors and considerations in 
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assessing the successful formation of multi-enzyme complexes on a nanoscale scaffold – and some 
useful methodologies for assessing and monitoring the binding of enzymes to this scaffold. 
 
Figure 4.7: Schematic representation of methodology whereby SA(Cel8A-biotin) complexes are first formed and then further 
complexed onto M13-PEG12-biotin. 
 Confirming complexation of Cel8A by indirect methods (PEG precipitation) 
 
Assessing the success of complexation of Cel8A onto M13 using the approach outlined in 
Figure 4.7 was accomplished employing two different methodologies. One was to determine whether 
cellulase activity could be found associated with M13 scaffolds after separating M13 from other 
components. The second approach was to use the fluorescent biotin analogue, B4F, to probe the 
average free biotin-binding sites on SA before and after complexation with M13-biotin. This was 
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furthermore used to estimate the number of SA(Cel8A-biotin) complexes that could be bound per M13-
biotin scaffold.  
Initially, complexation to M13-biotin was assessed by determining whether endocellulase 
activity followed the separation of M13 from other components. This experiment took advantage of the 
ability to precipitate M13 by incubation with PEG-8000/NaCl followed by centrifugation. In this way, 
binding of SA(Cel8A-biotin)N complexes to M13-biotin could be confirmed by the presence of 
endocellulase activity in the pellet and loss from the supernatant. An excess amount of M13-biotin was 
added to prepared solutions of SA(Cel8A-biotin) to ensure complete binding to the M13 scaffold and so 
that binding of SA(Cel8A-biotin) would be unlikely to be limited by available M13 surface area to bind 
to. As a control, this was compared with the same SA(Cel8A-biotin) complexes in the absence of M13-
biotin to confirm that M13 was indeed necessary for fractionation of SA(Cel8A-biotin) to the pellet 
fraction. 
The activity of Cel8A was monitored using carboxymethyl cellulose (CMC), a soluble 
cellulose substrate useful for monitoring the activity of endocellulases. This cellulose derivative 
contains carboxymethyl (-CH2-COOH) groups attached to a subset of the hydroxyl groups of the 
glucose residues in the cellulose biopolymer. Cleavage of the substrate over time was monitored via the 
dinitrosalicylic acid (DNS) assay for detecting reducing ends of sugars – with each additional reducing 
end produced corresponding to a single cut by Cel8A. In order to assess the presence of the enzyme in 
either the supernatant fraction or pellet fraction following PEG-8000 precipitation of M13, activity in 
the pellet and SN fractions was compared to the total activity prior to PEG precipitation. Samples were 
diluted such that the final concentration of enzyme would be equal if 100% of the Cel8A were found in 
that fraction. Thus, the activity in each fraction would be proportional to the amount of Cel8A. 
First, Cel8A on its own did not precipitate under the conditions used to precipitate M13 
(Figure 4.8). However, after preparing Cel8A-biotin with SA the properties might be expected to 
change; therefore, samples with all components except for M13-biotin were tested as well to determine 
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that they would not also precipitate. This control was run alongside the same sample containing M13-
biotin as well for a direct comparison. In comparing the pellet fractions, endocellulase activity was 
found in the pellet only when M13-biotin was added to SA(Cel8A-biotin) mixtures (Figure 4.8). Given 
that endocellulase activity was in the pellet only with added M13-biotin, it was inferred that this activity 
comes from SA(Cel8A-biotin) associated with M13-biotin. 
 
Figure 4.8: M13-specific PEG precipitation of SA(Cel8A) complexed bound to M13-biotin.  SA(Cel8A-biotin)N complexes 
were first prepared and precipitated as described in the Methods section (Section 4.2.7). Endocellulase activity was monitored 
with 0.5% CMC reacted for 10 min with end-point analysis of produced reducing ends with DNS at 65 oC (mean and SD; n = 
3). The percent of recovered activity was determined from the initial activity of the solution before precipitation. “SN” refers 
to the supernatant fraction. 
Some additional information might also be inferred from this experiment. First, not all of the 
endocellulase activity was fractionated to the pellet in the presence of M13-biotin. One possibility was 
that there may have been incomplete precipitation of any M13-SA(Cel8A-biotin) complexes that 
formed. The efficiency of recovering M13-biotin after PEG precipitation was tested and found to be 
dependent upon the concentration of M13. M13 phages were titered before and after PEG precipitation 
and the amount of M13-biotin recovered from a single round of PEG precipitation was 89 % for M13 at 
1011 particles/mL and 16 % for M13 at 1010 particles/mL. The concentration of M13 with complexed 
SA(Cel8A-biotin) was at ~8 x 1012 particles/mL – it is therefore expected that the majority of M13 
could be precipitated under these conditions. A second possibility considers the labelling efficiency of 
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the Cel8A-biotin (74% labelled) used in preparing the solutions of SA(Cel8A-biotin). From ESI-MS 
estimations of the distribution of Cel8A(biotin)N species presented earlier, 21% in this sample exists as 
Cel8A(biotin)0. This should account for a portion of the endocellulase activity found in the supernatant.  
 Confirming complexation of Cel8A by indirect methods (Fluorescence assay) 
 
It was determined that Cel8A was associated with M13 by following Cel8A activity after PEG 
precipitation. However, this was unable to answer how many SA(Cel8A-biotin) complexes might be 
bound to M13-biotin. To explore this question, a fluorescence assay using B4F was devised to probe for 
unoccupied biotin-binding sites on SA(Cel8A-biotin) complexes before and after the addition of M13-
biotin.  
This assay directly measures the amount of free B4F by its fluorescence, which is quenched 
when bound to SA. In this experiment, SA is present among the various SA(Cel8A-biotin)N species in 
solution. Therefore, analyzing the amount of biotin-binding sites initially present in a solution of SA 
and Cel8A-biotin using B4F would inform on the average free biotin-binding sites per SA tetramer. 
Upon adding M13-biotin, the change in the average number of free biotin-binding sites would inform 
on the extent to which those SA(Cel8A-biotin) were bound to the M13 scaffold. The biotin-binding 
sites present in each mixture were determined indirectly by the addition of a known quantity of B4F – 
quenching of B4F fluorescence is proportional to the number of biotin-binding sites. In this way, one 
can indirectly estimate the extent of loading of SA(Cel8A-biotin) onto M13-biotin. The fluorescence of 
the mixture is therefore inversely proportional to the quantity of SA(Cel8A-biotin) not bound to M13. 
By assaying several different ratios of SA(Cel8A-biotin):M13, the number of complexes that can be 
loaded onto M13 can be estimated. 
In presenting the results of preparing different ratios of SA(Cel8A-biotin) ensembles with M13-
biotin, M13 will be referred to in terms of p8 subunits (2700 p8/M13) and “SA(Cel8A-biotin)” refers to 
the total amount of SA tetramers in the solution. For example, a 1:8 mixture of SA(Cel8A-biotin):p8 
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would refer to a mixture of SA and Cel8A-biotin complexes where an amount of M13-biotin was added 
such that the concentration of p8 was 8 times the concentration of SA tetramers in the solution. In the 
1:8 SA(Cel8A-biotin):p8 mixture no biotin-binding sites were detected after adding M13-biotin (Figure 
4.9A, B). This suggests that the biotin present on M13-biotin was sufficient to fully bind all SA(Cel8A-
biotin) complexes in that mixture. This would correspond to roughly 340 SA(Cel8A-biotin) complexes 
loaded per phage. At lower concentrations of M13, it is apparent that there is not enough surface area to 
bind all SA(Cel8A-biotin) complexes (Figure 4.9C, E). For these samples the number of available 






Figure 4.9: Free B4F in mixtures of 1:1 SA:Cel8A (0.74 biotin/protein) complexes and M13-PEG12-biotin.  The y-axis 
indicates the amount of unbound B4F when 350 nM was mixed with assembled complexes (mean and SD; n = 3). In the 
different data sets, different amounts of M13-biotin (referred to in terms of major coat protein concentration assuming 2700 
p8/M13). SA(Cel8A-biotin)1 (75 nM) was mixed with A) 600 nM p8, C) 300 nM p8, or E) 150 nM p8. The interpretation of the 
fluorescence data is shown in panels B, D, F. 
The difference in free B4F between the B4F only controls and the SA(Cel8A-biotin) samples 
reflects the amount of available biotin-binding sites on the SA(Cel8A-biotin) complexes before adding 
M13-biotin. By dividing this value by the total number of SA tetramers (75 nM), one can obtain the 
average number of free biotin-binding sites per SA after complexing with Cel8A-biotin (Table 4-3). 
The difference between the B4F only control and the SA(Cel8A-biotin) complexes mixed with M13-
biotin reflects any open biotin-binding sites on SA(Cel8A-biotin) that have not been bound to M13-
biotin. By dividing this value by the average open biotin-binding sites per SA(Cel8A-biotin), one can 
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calculate the total number of unbound SA(Cel8A-biotin) in the mixture, which can then be used to infer 
the SA(Cel8A-biotin) complexes that are therefore bound to M13. By dividing this number by the total 
number of p8 subunits present in the mixture, the number of SA(Cel8A-biotin) complexes bound to 
M13 can be estimated as a percent ([SA]bound/[p8] x 100%).  
Table 4-3: Estimate of loading capacity of M13-PEG12-biotin for SA(Cel8A-biotin)N complexes prepared from 1:1 









bound to M13 
(nM) 
Loading capacity (% 
SA complexes/p8) 
1:8 0.598 ± 0.038 -1.23 ± 6.22 76.2 ± 6.22 12.7 ± 1.0 
1:4 0.700 ± 0.101 19.7 ± 7.7 55.2 ± 7.7 18.4 ± 2.6 
1:2 0.598 ± 0.038 33.4 ± 5.86 41.6 ± 5.86 27.8 ± 4.9 
 
Since the 1:8 SA(Cel8A)N:p8 sample was able to bind all SA(Cel8A-biotin), this gives a lower 
bound estimate of how many SA(Cel8A-biotin) complexes can be loaded onto M13-biotin. The other 
samples where not all complexes are bound can be used to calculate an upper bound for the loading 
capacity. If the SA(Cel8A-biotin)N species are uniform in steric size (size of SA(Cel8A-biotin)N 
complexes, number of biotin-binding sites per complex) then the estimate between the 1:4, and 1:2 
SA(Cel8A-biotin):p8 samples should be similar. However, the estimates were quite different, with the 
1:4 sample giving a lower estimate of 18% loading and the 1:2 sample giving a higher estimate of 28 % 
loading (Table 4-3). This is an indication that the SA(Cel8A-biotin) complexes are likely not uniform 
and exist in a distribution of different sizes and valencies, as might be expected. 
There are two important considerations in making sense of the differing loading capacity 
estimates: 1) that the off-rate of SA and biotin is very slow, and 2) if the SA(Cel8A-biotin)N complexes 
exist as a distribution of different sizes, these could reasonably be expected to have differing rates of 
diffusion. The first consideration predicts that once bound to M13, the SA(Cel8A-biotin) would be slow 
to rearrange to a more optimal packing. For the second consideration, the smaller configurations of 
SA(Cel8A-biotin) might be expected to bind the M13 first, leaving little space for the larger 
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configurations to then diffuse in and bind (Figure 4.10). There would unlikely be much difference 
between a SA with three versus two Cel8A bound; however, a proportion of Cel8A-biotin species are 
biotinylated >1 and therefore there is potential for complexes of SA and Cel8A-biotin with more than 
one SA molecule participating, resulting in a distribution of particle sizes. If the total number of biotin-
binding sites was skewed such that the smaller configurations of SA(Cel8A-biotin) have more open 
sites per complex, then binding of these smaller species would result in a higher estimate for the 
loading capacity, where M13 surface area is limited. Thus, as more M13-biotin is added, the change in 
the estimated number of complexes bound to M13, which was determined by the change in total biotin-
binding sites after adding M13-biotin, would not scale linearly with increasing M13 surface area.  
 
Figure 4.10: Illustration of complexes with varying size loading onto an M13 scaffold at higher, and lower loading ratios 
(complex:M13).  In the top of the figure, there is only limited space available on M13 and once bound to M13, the formed 
complex is kinetically stable. In the bottom of the figure, as more space opens on the M13 coat, larger complexes might bind – 
however, the packing becomes less efficient and hence, the estimate for the loading capacity decreases. 
In summary, it is possible to first prepare a mixture of SA(Cel8A-biotin) and in a subsequent 
step, bind to M13-biotin; though only a portion of the Cel8A activity can be associated to the phage 
scaffold in this way. When preparing M13/SA(Cel8A-biotin) complexes for PEG precipitation, an 
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excess amount of M13-biotin (~113 SA/Cel8A complexes per M13) was used to ensure maximal 
binding of SA(Cel8A-biotin). It was found that Cel8A activity could be found associated with the M13 
scaffold and indirectly suggested that complexation was occurring. In order to better quantitate the 
amount of SA(Cel8A-biotin) bound to M13, a fluorescence-based assay was devised to assess binding 
to M13. This assay was able to provide a lower limit for the loading capacity onto M13 of roughly 340 
complexes per M13 using this approach. This gives an idea of the minimum amount of M13-biotin that 
should be used to ensure that limited surface area on M13 is a negligible factor. Furthermore, the results 
suggest that there exists a distribution of SA(Cel8A-biotin)N species with differing valencies (ligand 
binding sites/molecule) and sizes. This would be confirmed by later experiments examining prepared 
complexes by TEM. 
 Visualization of SA(Cel8A-biotin) complexes by TEM 
 
The indirect assays in the previous section were able to confirm that SA(Cel8A-biotin) could be 
prepared and then be complexed onto the M13-biotin scaffold in a subsequent step. In order to further 
understand the arrangement of SA(Cel8A-biotin) complexes on M13, the resulting supramolecular 
complexes were analyzed by TEM. Cel8A was labelled with antibody-conjugated gold nanoparticles 
(GNPs) to make the localization of Cel8A on M13 scaffolds more obvious. A primary antibody that 
recognized the His6-tag on Cel8A was paired with a secondary antibody conjugated to a 5 nm GNP. 
This would be useful in determining the distribution of Cel8A along the length of M13 and would 
further confirm that SA(Cel8A-biotin) complexes were indeed bound.  
SA(Cel8A-biotin) was first prepared by mixing SA and Cel8A-biotin as described in the 
Methods and then subsequently bound to an excess of M13-PEG12-biotin; the resulting complexes were 
then analyzed by TEM. The appearance of M13-biotin after complexation with SA(Cel8A-biotin) was 
roughened and bumpy (Figure 4.11A). Additionally, it was apparent that there were some particles 
roughly 10 – 20 nm in diameter and irregularly shaped on the background of the grid. Staining with the 
antibody-conjugated GNPs revealed that the bumpy protrusions on the surface of M13 were indeed 
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complexes of SA(Cel8A-biotin) bound to the surface of the phage (Figure 4.11B). However, these 
were irregularly spaced along the length of M13 and the size of the protrusions varied. The background 
particles observed on the unstained grid were also reactive to the antibody-conjugated GNPs, indicating 
that Cel8A must be present (Figure 4.11C). The average area of the background particles was 130 nm2 
and seemed to be composed of at least two populations of ~190 and 80 nm2 (Figure 4.12). It was not 
unexpected that there would be some unbound Cel8A – from the ESI-MS estimates, ~23 % of the 
Cel8A in the Cel8A-biotin (0.74 biotin/Cel8A) sample was unlabeled. However, it is clear from the size 
of these particles in the non-immunostained image that they are composed of more than a single Cel8A 
molecule, as Cel8A is ~5 nm in diameter for the cellulase domain. These are therefore likely small 
aggregates of SA(Cel8A-biotin). 
 
Figure 4.11: Representative TEM images of SA(Cel8A-biotin)N complexes bound to M13-PEG12-biotin.  SA(Cel8A-biotin)N 
complexes were prepared at 1:1 Cel8A-biotin:SAtet and then bound to 16 µM M13-PEG12-biotin. Samples were stained for 
TEM either with A) 1% PTA, or B, C) immunogold antibody labelling against His6-tag as described in the Methods. White 




Figure 4.12: Particle analysis of background particles observed on TEM grids of SA(Cel8A-biotin)N complexes bound to M13-
PEG12-biotin.  A) Representative image of background particles in 1% PTA stained TEM sample. B) Outlines of particles 
detected using particle analysis tool in ImageJ (version 1.52n). C) Histogram of particle areas measured using ImageJ with 
associated density plot (n = 196). 
In combination with the results of the indirect assays in the previous section, a more complete 
picture of the M13-SA(Cel8A-biotin) complexes formed by this approach can be elucidated. The results 
obtained by TEM need to be reconciled with the results obtained from the PEG precipitation assays and 
the fluorescent B4F assay. First, the PEG precipitation assays were done in order to determine whether 
endocellulase activity could be found associated M13 phages. This is consistent with the visual 
evidence of clusters of SA(Cel8A-biotin) bound to the surface of M13 by TEM. Furthermore, it was 
found that not all the endocellulase activity was associated with M13, as the resulting SN after PEG 
precipitation still contained Cel8A activity. This would be consistent with the unbound Cel8A in the 
TEM images. 
Second, the B4F assays suggested that all biotin-binding sites present in solutions of 
SA(Cel8A-biotin) were occupied upon subsequent addition of M13-biotin. However, it is clear from the 
TEM that SA (in the form of SA(Cel8A-biotin) aggregates) remains unbound. In order to be consistent 
with the B4F results, these small aggregates of SA(Cel8A-biotin) which are not bound to M13-biotin 
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must therefore have no accessible biotin-binding sites. Additionally, an excess of M13 ([p8] = 16 µM, 
[SA]complexes = 1.48 µM) was added to the SA(Cel8A-biotin) complexes in preparing these samples for 
TEM. From the B4F fluorescence experiments, it was determined that a 1:8 ratio of SA(Cel8A):p8 was 
sufficient to occupy all detected biotin-binding sites. Inspection of the TEM images show much of the 
surface area of M13 unoccupied – it is unlikely that steric effects were preventing binding of the 
unbound SA(Cel8A-biotin). Therefore, it is inferred that upon preparing SA(Cel8A-biotin) complexes 
in the initial step that a mixture of SA(Cel8A-biotin) clusters with and without available biotin-binding 
sites form – though the relative concentrations of SA and Cel8A-biotin were such that each SA would 
have, on average, 3 open biotin-binding sites. 
In summary, though the indirect methods of assaying the nature of complexes formed from first 
preparing SA(Cel8A-biotin) followed by subsequent addition of M13-biotin were promising – imaging 
of the M13-SA(Cel8A-biotin) complexes by TEM revealed the complexes were not formed as 
anticipated. Loading Cel8A-biotin onto M13 in this way was inefficient, with much of the Cel8A bound 
up in small aggregates of SA/Cel8A-biotin that were not capable of binding to M13-biotin. For the 
Cel8A-biotin batch with 0.74 biotin/Cel8A, though the most abundant species was singly biotinylated 
Cel8A, ~30% of the Cel8A-biotin species according to the mass spectra have two or more biotin per 
Cel8A. Future directions taking this approach should carefully consider the extent of biotinylation of 
the protein of interest. In particular, methods of labelling that can ensure only a single biotin per protein 
would be preferable. Possible alternative methods that could be recommended are maleimide labeling 
of free Cys (if a single Cys can be added to the protein of interest) or enzymatic labelling methods that 
utilizes an incorporated biotinylation recognition peptide sequence.  
4.3.3 Method 2: binding Cel8A-biotin to SA-coated M13 scaffold 
 
 In a second approach to preparing multi-enzyme scaffolds on M13, the phages were first coated 
with SA. In the subsequent step, Cel8A-biotin would be bound to the SA-coated M13 scaffold (Figure 
4.13). Highlighted in this section are some of the factors found to be important in preparing complexes 
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of M13 with bound SA (referred to generally in this section as SA-coated M13). Notably, since both 
the SA and M13-biotin were capable of forming multiple affinity interactions, there was the potential 
for a crosslinking side reaction between two or more M13-biotin with SA as a “crosslinker”. This was a 
particularly obvious concern – surprisingly, directly adding SA to biotinylated M13 under the 
appropriate conditions was found to form SA-coated M13 with a low degree of crosslinking observed. 
Two main factors were explored in preparing SA-coated M13: the ratio of SA:p8 subunits and total 
concentration of SA/p8 subunits used. These two factors were critical in forming SA-coated M13 
without considerable crosslinking “side reactions”. The subsequent binding of Cel8A-biotin to this 
scaffold was demonstrated via TEM analysis to be quite uniform. Further design considerations 
regarding the stability and dynamic nature of the formed complexes will also be discussed.  
 
Figure 4.13: Scheme showing assembly of SA onto M13-PEG4-biotin to produce SA-coated M13 followed by assembly of 
biotinylated Cel8A onto the resulting scaffold. 
 Preparation of SA-coated M13: SA-coating protects from crosslinking 
 
 Based on the geometry and symmetry of SA, it seemed possible to prepare M13-biotin in such 
a way that SA was only capable of binding at the adjacent cis biotin-binding sites, leaving the opposing 
two (trans) biotin-binding sites for further loading with Cel8A-biotin. This was predicted based on the 
relative positioning of the biotin-binding sites on SA: two pairs of approximately adjacent ligand-
binding sites exist on opposite sides of the molecule (Figure 4.14A). A shorter PEG4 linker (as opposed 
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to the PEG12 linker used in all previous experiments with biotinylated M13) was used in preparing 
biotinylated M13 (Figure 4.14B). This was to reduce the chance of p8-biotin binding to all four biotin-
binding sites on SA, as the shorter PEG linker would be expected to restrict the SA to a greater extent. 
 
Figure 4.14: Geometrical and size considerations for SA and expected relative lengths of PEG linkers on M13.  A) Relative 
positioning of biotin-binding sites on SA with bound biotin molecules (PDB: 3RY2 (Le Trong et al. 2011)). The arrows show 
where the openings to the ligand-binding sites are. B) Comparison of relative lengths and spacing expected for M13-PEG12-
biotin and M13-PEG4-biotin with a SA molecule bound to biotin moiety (PDB: 1PFI (D. J. Liu and Day 1994)). The PEG 
linkers were built out from biotin bound to SA using Maestro (Schrödinger). 
It was hypothesized that with an excess of SA, M13-PEG4-biotin would bind to free SA at a 
higher probability than SA already bound to M13-PEG4-biotin – which would be expected to diffuse 
more slowly in solution. This was considered from the fact that SA binds to free biotin with an on-rate 
near the limit of diffusion (~130 x 106 s-1 M-1; (Deng, Kitova, and Klassen 2013)). Furthermore, the 
slow off-rate of SA was predicted to allow a solution containing SA-coated M13 to be stable once 
formed. In this way, it might be possible to mix SA and M13-biotin without significant aggregate 
formation, in contrast to what might be intuitively expected when mixing two multivalent components 
(SA: 4 ligand-biotin sites, M13: 2700 p8 subunits). Additionally, it was earlier observed that packing of 
SA onto M13 is quite efficient and has a theoretical optimal packing density of roughly one SAtet for 
every two p8 subunits (based on TEM observations; Section 3.3.3.1). Therefore, if sufficient SA is 
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added such that M13 is completely coated with SA, there would be little free biotin-p8 to form inter-
M13 crosslinks after the initial formation of SA-coated M13. However, if not enough SA is provided to 
fully cover the surface area of M13, exposed p8-biotin on one M13 could bind to a different SA-coated 
M13 and aggregate. 
 Based on this initial hypothesis, if the concentration of SA must indeed be high enough to 
protect M13-biotin from crosslinking, then at lower ratios of SA:p8, one should expect to see a higher 
degree of crosslinking and hence phage aggregate formation. At a ratio of 0.25:1 SA:p8, there was poor 
dispersion of singly SA-coated M13 on the TEM grid (Figure 4.15A). Furthermore, where M13 could 
be found, they existed in large dense aggregates. Indeed, before even spotting the samples to the TEM 
grids, the solutions had formed aggregates that precipitated out of solution. However, at a 1:1 ratio of 
SA:p8 (recall, ~1 SA can optimally fit for every two p8 coat proteins), SA-coated M13 were found to 
be well-dispersed throughout the grid (Figure 4.15B). Occasional small aggregates were visible, but the 
SA-coated M13 visualized on the grid were clearly more dispersed here. Furthermore, no visible 
aggregation could be seen in solution by visual inspection. Samples were also prepared at a 0.5:1 ratio 
of SA:p8 (the amount of SA that could be maximally loaded onto M13 with no excess); however, this 
was similarly prone to aggregation as with the 0.25:1 loading ratio (not shown). Aggregation was seen 




Figure 4.15: Representative TEM micrographs of SA-coated M13 prepared at different ratios of SA:p8.  Complexes were 
prepared at a final concentration of 2 µM p8 and A) 0.5 µM SAtet and, B) 2 µM SAtet. Stained with 1% PTA. White scale bars 
represent 1 µm. The insets show a 500 x 500 nm area of the same grid. 
Interestingly, when preparing SA-coated M13 at even higher ratios of SA:p8 (2:1) an additional 
side pathway was observed. It was found that preparing SA-coated M13 with too much of an excess of 
SA resulted in an apparent deformation of the assembled virus itself. When these samples were 
observed by TEM, there were several instances where the M13 particles appeared to collapse and twist 
in upon themselves (Figure 4.16). Several representative species along this apparent pathway were 
captured in a series of TEM images from this grid. First, the coat toward one of the ends of the phage 
was observed to curve and separate from the rest of the phage (Figure 4.16, panel 1). The following 
steps give the impression that as additional p8-biotin become exposed, the SA is able to bind and 
further force the phage into an arrangement that is more compact. It has been observed that under 
certain solvent conditions, chloroform in particular, that the major coat protein adopts a very different 
packing structure referred to as open-form phage (Griffith, Manning, and Dunn 1981; D. A. Marvin, 
Symmons, and Straus 2014). While unlikely that the mechanism is the same, this example does 
highlight that p8 subunits have been observed to radically change their packing structure under specific 
conditions. Something analogous might be occurring here, but instead of a change in solvent conditions 
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inducing a different packing structure of the major coat protein, the tight binding of SA might force the 
biotinylated p8 coat proteins into a different conformation. Importantly, these altered phage were 
infrequently observed where the ratio of SA:p8 was 1:1 and so these conditions were used in future 
preparations of SA-coated M13. 
 
Figure 4.16: Representative TEM images showing SA-coated M13 (prepared from M13-PEG4-biotin at 2 µM p8 subunits and 
4 µM SAtet) with altered packing structure.  Stained with 1% PTA. Each panel is 200 by 200 nm. 
If the complexes were able to form as predicted – with two cis-facing biotin-binding sites 
attached to M13-biotin, and two outward facing – then, upon adding Cel8A-biotin, the enzyme should 
be able to bind to the SA-coated M13 complex. After preparing these complexes with an approximately 
stoichiometric amount of Cel8A-biotin (according to number of biotin and expected biotin-binding sites 
in the SA-coated M13 sample), they were adhered to TEM grids and were immunostained with GNPs 
against the His6-tag on Cel8A. The surface of the phage was rough with very obvious “nodules” which 
protruded from the phage (Figure 4.17A). When these were labelled with antibody GNPs, Cel8A was 
detected ubiquitously along the length of SA-coated M13 (Figure 4.17B). Notably, the Cel8A was 
detected uniformly distributed along the entire length of the phage. Though it was apparent that there 
was a considerable amount of Cel8A unbound to the SA-coated M13 scaffold, this was anticipated, 
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given that an excess of SA was used in preparing SA-coated M13. Therefore, upon adding Cel8A-
biotin, some would bind the scaffold, and some would bind SA that was free in solution. This 
demonstrated that after coating with SA there still existed available biotin-binding sites with which to 
further complex with biotinylated enzyme. Importantly, being able to produce a multi-enzyme complex 
on M13 that was extensively and uniformly loaded was one of the main goals of this work.  
 
Figure 4.17: Representative TEM images of Cel8A -biotin bound to SA-coated M13 nanoscale scaffold.  SA-coated M13 was 
prepared with 2 µM p8-PEG4-biotin and 2 µM SAtet and then mixed with 8 µM desthiobiotin. Cel8A-PEG12-biotin (0.74 
biotin/Cel8A) was added to a final concentration of 3.2 µM. TEM samples were stained with A) 1% PTA, and B) 
immunostained with anti-His6 primary antibody, and 5 nm secondary antibody GNP followed by staining with 1% PTA. 
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Studies on the binding of SA to biotinylated lipid surfaces is relevant to the discussion of this 
SA-coated M13 complex. While dissolved in solution, M13 can be thought of as a high curvature 
surface. A comprehensive study of the residual valency to a lipid surface demonstrated several 
important considerations for the binding of SA to a surface (Dubacheva et al. 2017). One relevant result 
in particular was the relationship between packing density (of SA on a biotinylated surface) and the 
resulting valency of SA binding to that biotinylated surface. A residual valency (free biotin-binding 
sites on SA) of two was favored in the likely case where steric interactions between surface-bound SA 
may have prevented binding to a third site. Or in other words, a high density of SA bound to a surface 
sterically prevents neighboring SA from binding more than twice to that surface. Considering that the 
SA-coated M13 produced here was able to further bind to Cel8A-biotin and that SA were densely 
packed suggests a residual valency of two in SA-coated M13.  
Furthermore, there was a recommendation that a binding valency of two be made in order to 
ensure stable interaction of SA with a surface. It was found that SA bound by two or more biotin to the 
surface could not be washed away easily, showing increased stability and lifetime of SA on the surface 
(Dubacheva et al. 2017). This consideration is also relevant here, as it is desirable to have a long-lived 
interaction of SA with the biotinylated surface of M13 to ensure stable binding in subsequent steps after 
adding biotinylated enzyme to the scaffold. In summary, the idea to directly bind SA to M13-biotin was 
initially counterintuitive based on the potential for crosslinking and aggregation. Interestingly, the fast 
binding of SA to the surface of M13, and dense packing that can be achieved made this a viable 
strategy for decorating the surface of M13 with “sticky” ligand binding sites for the binding of 
additional components. Some additional considerations and potential challenges with this system are 
presented in the following sections. 
 Low concentration of SA and M13-PEG4-biotin are required to reduce crosslinking behavior 
 
 It was anticipated that the concentrations of SA and M13-biotin would be an important factor in 
forming SA-coated M13 without too much aggregation. In particular, at higher concentrations of M13-
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biotin, the chance of a “crosslink” occurring would likely be higher, as the average distance between 
M13 particles in solution would be reduced and this might translate to a higher degree of aggregation 
when SA is added. This was tested by preparing 1:1 ratios of SA:p8 at 2, 10 and 20 µM (for each 
component) and qualitatively assessing the mixtures by TEM. For SA-coated M13 prepared at the 
lowest concentration tested (2 µM), M13 phages were overall well-dispersed and uniformly bound to 
the TEM grid (Figure 4.18A). In the samples prepared at either of the higher concentrations, M13 was 
poorly dispersed on the grid (Figure 4.18B, C). Large, dark aggregates were also visible, though the 
electrons penetrated poorly due to the thickness of these aggregates – these could only be visualized as 
dark shapes, sometimes with the ends of phage visible at the periphery. Though this approach to 
characterizing the extent of aggregation was only qualitative, it does seem to indicate the importance of 
preparing SA-coated M13 at lower concentrations.  
 
Figure 4.18: TEM micrographs of SA-coated M13 at a 1:1 ratio of SA:p8 at different concentrations.  Samples were further 
complexed with Cel8A-PEG12-biotin (0.74 biotin/cel8A) so that the samples could be stained with immunogold as described. 
A) SA-coated M13 prepared at 2 µM SA and 2 µM p8. B) SA-coated M13 prepared at 10 µM SA and 10 µM p8. C) SA-coated 
M13 prepared at 20 µM SA and 20 µM p8. SA-coated M13 complexes were diluted down to 2 µM SA, and Cel8A-PEG12-biotin 
(0.74 biotin/Cel8A) was added to a final concentration of 3.2 µM. M13 were highlighted individually using ImageJ image 
analysis software to aid visibility. Scale-bars represent 1 µM. 
Analysis of the results in terms of expected average distance between M13 particles at different 
concentrations can aid in understanding these interactions. As the concentration of the two components 
is increased, there is a higher likelihood that two M13-biotin(SA)N (M13 with some amount of SA 
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bound) to meet and form a crosslink. As the concentrations decrease, the average distance between any 
M13 increases and the likelihood of two particles meeting would be expected to decrease. There is 
likely an interplay between the rate at which diffusing SA can quickly and efficiently coat the M13-
biotin (covering up any “sticky” p8 biotin patches), and the rate at which two M13 phages come into 
contact resulting in some crosslinking side product. This unfortunately does preclude the possibility of 
preparing SA-coated M13 at higher concentrations initially. However, given the tight binding of SA 
and biotin, it is quite possible to get complete complexation with biotinylated target without having to 
employ high concentrations. 
 Dynamic behavior and stability at higher temperature 
 
 It is expected based on the increased off-rate of SA/biotin at higher temperatures (half-life of 
~46 min at 44.8 oC, compared to 35 h at 22 oC (Deng, Kitova, and Klassen 2013)) that some dynamics 
will occur at higher temperatures. This was also seen in Section 3.3.1.2 where SA(BXN)4 was found to 
exchange BXN molecules for B4F molecules over time at elevated (50 oC), but not at ambient (23 oC) 
temperatures. In particular, those dynamics could include potential unbinding and rebinding of Cel8A-
biotin, or even SA from the surface of M13-biotin. It was conceivable then, that at higher temperatures, 
complexes of Cel8A-biotin prepared on the surface of SA-coated M13 might tend to aggregate over 
time as these components rearrange themselves. This aggregation could occur either via a) p8-biotin 
binding to a different SA-coated M13 or, b) Cel8A-biotin forming a crosslink between two SA-coated 
M13. The effects of incubation at 50 oC were tested to see whether and how this affected the overall 
structure of the M13/Cel8A complexes over time. This was further relevant to reactions carried out with 
Cel8A which are typically carried out at temperatures at or greater than 50 oC for efficient hydrolysis of 
cellulose. 
 SA-coated M13 with Cel8A-biotin bound were visualized by TEM to make a comparison of 
how quickly they might tend toward larger aggregates over time when incubated at 50 oC. Samples 
were observed after 0, 1 and 4 h incubation at 50 oC. Over the timeframe observed, Cel8A-biotin was 
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observed to be ubiquitously bound to M13 particles (Figure 4.19). The appearance of individual phages 
with Cel8A-biotin bound were similar between the incubation times used. In order to give a 
representative overview of these TEM grids, several images were taken at low magnification (13,000x) 
in order to qualitatively assess the extent of aggregation of these samples (Figure 4.20). There did seem 
to be a larger number of electon-dense aggregates that formed at 4 h incubation time, but surprisingly, 
the dispersion of SA-coated M13 with bound Cel8A-biotin was still quite good. Given the dynamic 
nature of the components expected at 50 oC, and the number of possible interactions (mediated by SA 
and biotin) that could potentially form between two phages, it is remarkable that the extent of 
aggregation overtime is not more noticeable. 
 
Figure 4.19: Effect of incubation of SA-coated M13 with Cel8A-biotin at 50 oC.  SA-coated M13 was prepared with 2 µM p8-
PEG4-biotin and 2 µM SAtet and then mixed with 8 µM desthiobiotin. Cel8A-PEG12-biotin (0.74 biotin/Cel8A) was added to a 
final concentration of 3.2 µM. These were incubated at 50 oC for A) 0 h, B) 1 h, and C) 4 h. Samples were labelled with 




Figure 4.20: Effect of incubation of SA-coated M13 with Cel8A-biotin at 50 oC (wide view).  SA-coated M13 was prepared 
with 2 µM p8-PEG4-biotin and 2 µM SAtet and then mixed with 8 µM desthiobiotin. Cel8A-PEG12-biotin (0.74 biotin/Cel8A) 
was added to a final concentration of 3.2 µM. These were incubated at 50 oC for A) 0 h, B) 1 h, and C) 4 h. Samples were 
labelled with primary antibody against His6-tag and 5 nm secondary antibody GNP. M13 phages were highlighted 
individually using ImageJ image analysis software to aid visibility. Scale bars represent 1 µM. 
 It was expected that there would be some dynamic behavior among the components used to 
prepare a multi-enzyme complex on M13, and all the possible interactions expected to occur in this 
mixture of components are quite complex. There are three different components (M13-biotin, SA and 
Cel8A-biotin) which are all capable of binding to each other in various configurations. It is because of 
this complexity that the observations made in this data set were so surprising. One aspect of these 
findings that should be considered is the idea of avidity; that the same SA molecule is capable of 
binding at two of its biotin-binding sites on the same biotinylated M13 surface. It is typically found that 
avidity interactions can greatly increase the lifetime of a protein ligand interaction through rebinding 
(Vauquelin and Charlton 2013). The idea is that forced proximity can promote rebinding of a protein to 
a nearby ligand, and thereby increase resident time. While a single biotin bound to SA may be expected 
to dynamically exchange, SA bound “bivalently” to the biotin-M13 surface could exhibit a longer-lived 
interaction. Recall from Section 3.3.3.1 that the expected spacing of two adjacent biotin on the surface 
of M13 would be  ~3 nm, which is certainly short enough distance for bivalent binding to SA (diameter 
of SA is ~6 nm). This could have a very significant impact on the lifetime and stability of a single, 
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particular SA bound to the surface of biotinylated M13. While the off-rate of biotin/SA increases at 
higher temperature, for SA to be liberated from the surface of M13 when in such a configuration both 
biotin would need to dissociate before rebinding occurs.  
A second consideration is that free SA (or SA(Cel8A-biotin) in solution plays a protective role. 
Upon forming SA-coated M13, there is an excess of free SA in solution (recall from Section 4.3.3.1 
that this is necessary for forming SA-coated M13 without aggregation). This free SA may be playing a 
protective role, quickly replacing any SA displaced from the surface of M13-biotin. Consider what 
might occur when a SA or SA(Cel8A-biotin) dissociates from the surface of M13-biotin; the exposed 
patch of M13-biotin would either encounter another SA-coated M13, or one of the free SA present in 
the solution. If the exposed patch binds to SA present on a separate phage, aggregation may occur. 
Thus, the excess SA may protect from aggregation by quickly binding to any exposed p8-biotin patches 
before the formation of a crosslink with another SA-coated M13.  
If having an excess of SA is required for the stability of formed SA-coated M13 multi-enzyme 
complexes, it would be expected that this would make removal of unbound components (excess SA, 
and Cel8A) detrimental. However, it should be noted that in cellulosomal arrangements of enzymes, 
there is expected to be considerable dynamics, as the cohesin-dockerin interaction is itself non-covalent. 
Thus, it might be sufficient that a proportion of Cel8A exists bound to the designed nanoscale scaffold 
with a defined lifetime – with individual cellulases docking and releasing back into solution 
dynamically. In this way, there would be an increased concentration of cellulase localized on the 
surface of phage on average. This would of course depend on a number of parameters, such as the 
lifetime of residence of a single docked enzyme. Regardless, the apparent stability of SA-coated M13 
with complexed enzyme at increased temperature was an interesting phenomenon, though the potential 
requirement for excess SA to be present could be a potential challenge in some applications.  




 Lastly, it was discovered that the ionic strength of the solution used when preparing SA-coated 
M13 from M13-PEG4-biotin and SA affected the stability of the resulting SA/M13 complex. When 
prepared in water, the SA-coated M13 formed with the expected dimensions (Figure 4.21A). 
Furthermore, the phages were well-dispersed on the grid and easy to locate. However, when preparing 
SA-coated M13 in a buffered solution, the samples had a few notable differences when observed by 
TEM. Even though the samples were prepared at the same concentrations, there were few phages 
observed on the grid. Furthermore, phages that were found on the grid had a “bushy” appearance – as if 
they were falling apart (Figure 4.21B, C). The appearance of these “damaged” phages could be 
consistent with the lack of phage observed on the grid, as they degrade over time. The conclusion was 
that the phages prepared in 1x TBS were not stable and peeled apart into smaller particles.  
 
Figure 4.21: Representative TEM images showing the effect of ionic strength in structure of SA-coated M13.  Complexes were 
prepared at a final concentration of 2 µM p8 and 2 µM SAtet in A) water, and B, C) 1x TBS pH 7.4. Stained with 1% PTA. 
Firstly, though designed to only bind bivalently to one side of SA at the adjacent cis ligand-
binding sites, it is feasible that adjacent p8-biotin might be capable of binding to ligand-binding sites of 
SA in the trans configuration. If this occurs, it could force or restrict the flexibility of the M13 particle 
in a way that starts to destabilize the intermolecular interactions between p8 subunits. This is 
reminiscent of the collapsing phage observed in Section 4.3.3.1 where it was hypothesized that SA 
bound more than twice to the same M13-biotin surface could start to deform or destabilize the packing 
of p8 coat proteins. The binding of SA to three or more p8-biotin on the same phage SA could act as an 
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initial trigger for this “collapse”, as it could force curvature which in turn could position additional p8-
biotin to re-bind to SA on the same phage particle further pulling the subunits apart. 
Given that one difference between preparing the SA-coated M13 in 1x TBS versus water would 
be the ionic strength of those solutions, it is reasonable to consider possible electrostatic effects. The 
overall charge on the surface of M13 is negative (pI of 4.2 (Zimmermann et al. 1986)) and SA has a 
theoretical pI of 6.09 (negative at neutral pH; calculated using ProtParam (Gasteiger et al. 2005)). It is 
therefore conceivable that in low ionic strength solutions there is an electrostatic barrier (repulsion) to 
SA orienting in such a way that allows binding to one of the trans biotin-binding sites. However, upon 
switching to a solution with greater ionic strength, the range of that electrostatic repulsion could be 
reduced by charge screening, allowing SA bound to the surface of M13 to re-orient such that 
neighboring p8-biotin can bind to the trans biotin-binding sites, triggering the process leading to the 
degradation observed in the TEM images above. This leads to an additional design consideration that 
was not initially apparent: that of potential electrostatic contributions to the stability of the formed 
complexes on M13. Though it might be possible that binding of an additional component (i.e., Cel8A-
biotin) might “cap off” the phage and have a stabilizing effect on the entire structure. Consider the SA-
coated complexes with Cel8A-biotin in Section 4.3.3.3 at 50 oC; despite the higher dynamics that occur 
at this temperature, the complexes remained stable for at least 4 h. While there is instability apparently 
present with SA-coated M13, further complexation with Cel8A-biotin may be stabilizing. 
 Attempts to purify SA-coated M13 from other components 
 
Due to the multi-component nature of the M13 complexes, a gentle method was sought to 
remove unbound components (SA and Cel8A-biotin) from Cel8A-biotin mixtures complexed to SA-
coated M13. In particular, a method that utilizes a small surface area would hopefully reduce the loss of 
materials from non-specific binding. Due to the requirement of low µM SA and p8 concentrations when 
assembling SA-coated M13, typical separation methods such as chromatography were expected to 
result in a considerable loss of any material applied to a column. Drop dialysis, a method analogous to 
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conventional dialysis, was tested as a purification procedure. In drop dialysis, a filter membrane is 
floated on a dialysis buffer and solution to be dialyzed is pipetted on top of the filter. This method has 
been reported to be useful for dialyzing small volumes of biomolecules, with DNA and protein 
recovery being reported as high at 98% (Marusyk and Sergeant 1980). This approach has been used to 
desalt proteins for mass spectrometry (Cancilla et al. 2000; Lehmann Renato Zenobi and Vetter 1999) 
and for removal of reactants in reactions with biomolecules (Brin et al. 2000). In particular, there is 
evidence that over time, proteins will also be removed by drop dialysis (Görisch 1988). A half-life of 
about 85 min was reported for ribonuclease by drop dialysis. Thus, if the relatively small SA could be 
removed at a rate faster than M13, this approach could be suitable. 
The envisioned clean-up procedure was as follows: SA-coated M13 would be first prepared as 
described, followed by removal of excess SA. The resulting solution would be expected to contain only 
biotin-binding sites associated with M13 and thus, would be used as the base material for stoichiometric 
complexation of Cel8A-biotin. This procedure was initially tested with the individual components SA 
and M13. An exponential decrease over time (t½ ~ 1.3 h) was observed with SA on its own (Figure 
4.22A). The loss of M13KE titer was slower than the loss of SA over the course of 4 h. While complete 
removal of free SA would be unlikely, the resulting drop-dialyzed solution would be enriched with 
M13. To further test this, SA either in the presence of M13KE (no interaction) or with M13-PEG4-
biotin (to prepare SA-coated M13) was monitored overtime by drop dialysis. The decrease in biotin-
binding sites over time when SA was mixed with biotinylated M13 was slower than with the 
nonbiotinylated control (Figure 4.22B). This suggested that perhaps the fraction of SA that was bound 
to M13-PEG4-biotin might dialyze out at a slower rate than free SA. A time point of 3 h was chosen to 
examine dialyzed solutions, as this seemed a good compromise between removing SA and retaining 
some M13 particles. Since the concentrations of components were low in these mixtures, the samples 
which were drop dialyzed were immediately adhered to TEM grids and analyzed by TEM. However, no 
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recovered samples were visible on any of the TEM grids – typically, at this order of magnitude of phage 
concentration (~1011 particles/mL), phage particles uniformly coat the grids. 
 
Figure 4.22: Testing the suitability of drop dialysis for cleaning up SA from SA-coated M13 preparations.  A) Recovered 
M13KE (no biotin) and SA from a mixture of SA and M13KE applied to drop dialysis over 1x TBS pH 7.4. The percent 
recovery for M13 was based on the titer (plated twice per time point) of a single trial. The percent recovery for SA was 
determined from its biotin-binding activity using B4F (determined three times per time point) for a single trial. B) Recovered 
SA mixed with either M13KE (no biotin) or M13-PEG4-biotin and applied to drop dialysis over 1x TBS pH 7.4. The recovered 
SA was determined according to its biotin-binding activity using B4F (determined three times per time point) for a single trial. 
Mean values and SD are shown. 
 As it was observed that ionic strength was detrimental to the stability of SA-coated M13 
particles (Section 4.3.3.4.), drop dialysis procedures were briefly tested in MQH2O. Drop dialysis of 
SA over MQH2O was carried out and SA concentration was observed to decrease at a similar rate to SA 
in 1x TBS pH 7.4 (not shown) and so it was expected that 3 h of drop dialysis would still be appropriate 
before analyzing the resulting mixtures by TEM. SA-coated M13 with complexed Cel8A-biotin was 
dialyzed over water for 3 h and then the resulting solutions analyzed by TEM. An aliquot of the 
prepared SA-coated M13 with Cel8A-biotin was removed prior to drop dialysis as a control. The 
control was consistent with the appearance of other SA-coated M13 with bound Cel8A-biotin that were 
shown in previous sections (Figure 4.23A). The M13 particles had a roughened surface from bound 
Cel8A and unbound SA(Cel8A-biotin) particles were observed as well. Additionally, these were well-
distributed on the TEM grid as seen previously. However, after 3 h of drop dialysis there were far less 
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M13 particles that could be imaged (Figure 4.23B). The M13 that could be found were typically 
bundled together in small aggregates. One possibility is that too many M13 particles were lost over the 
course of drop dialysis – possibly due to adsorption to the membrane used for drop dialysis, as the 0.05 
µM pore diameter should have prevented transfer through the membrane. A second possibility is that 
some amount of excess SA is necessary for the stability of the SA-coated M13 particles. If a SA were to 
dissociate from the surface of M13-biotin, having an excess of SA would make it more likely that a 
different SA diffuses in to bind to the empty spot, rather than it encountering a second SA-coated M13. 
Regardless of the reason, this was found to be unsuitable for cleaning up preparations of SA-coated 
M13. 
 
Figure 4.23: SA-coated M13 with bound Cel8A-biotin recovered from drop dialysis.  SA-coated M13 complexes with Cel8A-
biotin were prepared as described in the methods and subjected to drop dialysis on water for A) 0 h, and B) 3h. After that time, 
the samples were removed and adhered to TEM grids which were stained with 1% PTA. 
 A second approach was tested to clean up SA-coated M13 preparations. Given the difference in 
size between SA-coated M13 and individual SA(Cel8A-biotin) particles, differential centrifugation was 
attempted. This was carried out at 4 oC in order to reduce the chance of SA/biotin dissociation, followed 
by potential inter-phage links forming. Prepared SA-coated M13 were centrifuged at 15000 g for 3 h. 
When the resulting pellet was resuspended and analyzed by TEM, phage that were observed were in 
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large aggregates (Figure 4.24A). M13 particles that were tangled together were of a diameter consistent 
with that expected for SA-coated M13 (Figure 4.24B). Given that centrifugation would ultimately 
cause the average distance between SA-coated M13 to decrease as they form a pellet, it is not surprising 
that they ultimately aggregated together in this way.  
 
 
Figure 4.24: TEM of SA-coated M13 recovered from the pellet after differential centrifugation.  A) Wide view of tangled M13 
particles. B) Higher magnification image of a section of M13 tangle. The black arrows show the lacey carbon from the grid 
itself. 
 In summary, two methods were tested to try to remove unbound SA from SA-coated M13 
preparations: drop dialysis and differential centrifugation. Neither of these approaches were successful; 
however, the drop dialysis results did ultimately highlight some factors that appeared to be important to 
phage stability. The apparent instability of SA-coated M13 in salt-containing solutions was first noticed 
when analyzing samples drop dialyzed over buffered solution (discussed more in Section 4.3.3.4). 
However, even when carried out in water, there were few recovered phages to be imaged – perhaps due 
to adsorption to the membrane, or some other factor involving lowered stability in the absence of some 
amount of free SA. Despite the unfortunate difficulties here, recall that SA-coated M13 with bound 
Cel8A-biotin was stable at 50 oC for up to at least 4 h (Section 4.3.3.3.). Given that SA-coated M13 
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with bound Cel8A-biotin remains stable without removal of unbound particles, it would potentially be 
worth testing the activity of these complexes against cellulose substrates. 
4.3.4 Cellulase activity assays SA(Cel8A-biotin) complexes on M13-biotin 
 
Despite the difficult in purifying the M13 complexes from the unbound components, it was 
desired to at least evaluate what kind of activity these complexes had against cellulosic substrates. It has 
been observed that a good proportion of Cel8A-biotin exists bound to the phage scaffolds produced by 
the two methods used in this chapter (SA(Cel8A-biotin) bound to M13-biotin in Section 4.3.2; SA-
coated M13 with bound Cel8A-biotin in Section 4.3.3). If there is a considerable rate enhancement 
from Cel8A-biotin complexed onto phage scaffold, this might be observed even in the presence of 
unbound components. Furthermore, since the SA-coated M13 was shown to maintain its structure over 
the course of at least 4 hours at 50 oC when in the presence of unbound SA(Cel8A-biotin), it might be 
beneficial to the stability of SA-coated M13 particles to carry out reactions without removal of those 
excess components. Thus, the mixture of components would be likely to exist as a dynamic system with 
SA(Cel8A-biotin) dissociating and rebinding over the course of a reaction. Considering that the off-rate 
for SA/biotin at 44 oC is ~2.5 x 10-4 s-1 (Deng, Kitova, and Klassen 2013), it is still expected that docked 
Cel8A-biotin would have a relatively long-lived interaction with the biotinylated M13-biotin scaffold. 
Indeed, extensive consideration on the necessary interactions in the native cellulosome suggest 
a conformationally flexible arrangement of cellulases where considerable dynamics of the cellulase-
laden scaffold occurs (S. P. Smith and Bayer 2013). For example, with type 1 cohesin-dockerin 
interactions (Section 1.4) binding can occur in two modes (oriented ~180o to each other) and it has been 
speculated that the ability of the cellulases to dock in a way that allows flexibility in orientation over 
the course of degrading cellulose could be important for efficient activity. As it is unlikely that the 
cellulosome itself is a static system, it is potentially worth exploring the cellulolytic activity of these 
nanoscale complexes, where a dynamic equilibrium likely exists between docked and free cellulase. 
Therefore, the systems explored here and the results should be considered within the context that these 
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comprise scaffolded as well as some proportion of freely diffusing complexes of SA(Cel8A-biotin) or 
Cel8A-biotin. 
For some of the reactions in this section, an additional component was included. As the Cel8A 
used here contains a C-terminal dockerin (Doc) domain, it is possible to bind this to a cohesin (Coh) 
from the same organism (Section 1.4). CBM-Coh was obtained, expressed and purified as described in 
the Methods. The CBM domain binds strongly to cellulose and has furthermore been shown to enhance 
activity against cellulose (Mansfield, Mooney, and Saddler 1999). Furthermore, using an affinity pull-
down assay, the interaction between CBM-Coh and Cel8A was confirmed (Yael Vazana et al. 2012). 
By incubating CBM-Coh with Cel8A, the extent of the interaction can be determined by assessing the 
fraction of cellulase activity that associates with cellulose. The cellulose was removed by centrifugation 
and the activity of the supernatant is assessed. At increasing concentrations of CBM-Coh, less Cel8A 
activity was recovered in the supernatant when incubated with phosphoric-acid swollen cellulose 
(PASC; Figure 4.25A). At a 1:1 ratio of CBM-Coh to Cel8A, 80 % of Cel8A activity was lost from the 
supernatant fraction, and at a 3:1 ratio (excess CBM-Coh), 90% removal of activity was the maximum 
decrease observed. The initial rates correspond to the fraction of Cel8A associated with CBM-Coh. 
SDS-PAGE on the pelleted PASC showed a trend of increasing Cel8A-biotin associated at higher 
concentrations of CBM-Coh (Figure 4.25B). There was some association of Cel8A to the PASC 
fraction observed in the absence of CBM-Coh. This was consistent with the observed loss of activity in 
the supernatant fraction of Cel8A-biotin mixed with PASC compared to the activity of Cel8A-biotin on 
its own. However, the trend clearly shows association under the conditions later used for binding CBM-
Coh to Cel8A in some of the assays. PASC pull-down assays were tried for SA(Cel8A-biotin) 
complexes as well; however, there was so much binding of these complexes to PASC in the absence of 




Figure 4.25: PASC pull-down assay to confirm association of Cel8A-biotin with CBM-Coh.  A) Endocellulase activity 
measured against 0.5 % CMC at 65 oC of diluted supernatant after removal of PASC/CBM by centrifugation (mean and SD 
shown; n = 3). B) SDS-PAGE of PASC pellets after incubation with CBM-containing complexes. Control lanes with purified 
Cel8A and CBM-Coh run separately. 
The activity against a simple cellulose substrate, CMC, and a complex cellulose substrate, α-
cellulose, were investigated utilizing complexes produced by either 1) preparing SA(Cel8A-biotin) 
followed by docking onto M13-PEG12-biotin, or 2) preparing SA-coated M13 (biotin-PEG4 linker) and 
binding Cel8A-biotin to it, without further removal of unbound components. Initially, activity against 
the soluble substrate, CMC, was tested to confirm that mixtures with the phage scaffolds were active. 
Specifically, activity against CMC was measured at two temperatures – 50 oC, where considerable 
dynamics would be expected, and 23 oC, where little rearrangement of SA/biotin affinity interactions 
would be expected. Typically, at 23 oC there was a loss of activity observed compared to free cellulase 
(Figure 4.26A, C). This was observed in samples from both approaches to preparing complexes on 
M13-biotin. As the orientation of complexed Cel8A-biotin was not known here, it is possible that the 
loss of activity compared to free Cel8A-biotin comes from occlusion of the enzyme active site. For 
complexes of SA(Cel8A-biotin) bound to M13-biotin, further binding of CBM-Coh was also tested – 
this was found to hinder the mixtures of enzymes to a greater extent (Figure 4.26A, B). It is possible 
that the presence of the additional CBM-Coh component hindered access of the CMC to the Cel8A 
active sites without offering further enhancement to rate. This might be due to the simple nature of the 
substrate – it is soluble and therefore has no real surface with which the CBM domain might bind. 
Conversely, at high temperature, the difference between free Cel8A-biotin and complexed Cel8A-biotin 
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was minimal (Figure 4.26B, D). The similarity in rate of CMC hydrolysis to free Cel8A at 50 oC, 
which was present in solution at the same concentrations that were present in all assembled complexes, 
likely reflects the rearrangement of SA/biotin affinity interactions allowing a greater fraction of 
complexed Cel8A to make their active sites accessible to the substrate. 
 
Figure 4.26: CMC hydrolysis of Cel8A-biotin bound to SA/M13 scaffolds.  SA/M13 scaffolds were prepared either by A, B) 
first preparing SA(Cel8A-biotin) and binding to M13-PEG12-biotin or C, D) preparing SA-coated M13 and adding Cel8A-
biotin. The reactions were carried out at A, C) 23 oC or B, D) 50 oC against 0.5% CMC in 0.1 M citrate pH 5.8. The reducing 
ends produced were measured using the DNS assay described in the Methods (mean and SD shown; n = 3). Additional 
complexation with CBM-Coh was done as described in the Methods. 
Given that assemblies of Cel8A onto M13 had activity against the simple substrate, activity 
against a complex substrate, α-cellulose was tested. This substrate was insoluble and required that 
reaction mixtures be individually stirred over the course of the reaction to ensure complete dispersal of 
the substrate. Detection of hydrolysis activity was done by measuring the total reducing ends produced 
over time using DNS detection. Total reducing ends were measured on whole α-cellulose particles, and 
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therefore would include both solubilized reducing ends in solution, and hydrolysis on the surface of the 
cellulose particles. To determine a reasonable endpoint for the reactions with the complexes, the 
substrate was initially reacted with free Cel8A over the course of 48 h at 50 oC (Figure 4.27A). There 
was little hydrolysis beyond 24 h. Based on the results of this initial survey, the endpoints at 8 and 24 
hours were used to compare different arrangements of Cel8A.  
 
Figure 4.27: Endocellulase activity against 1% (w/v) α-cellulose in 0.1 M sodium citrate pH 5.8.  A) Time course of reducing 
ends produced when α-cellulose was reacted with 100 nM Cel8A-biotin. B) Survey of 8 and 24 h endpoints of α-cellulose 
reacted to 100 nM Cel8A complexed to SA and M13 as described in the Methods. The reducing ends produced show SD from n 
= 2 trials (or n = 4 for SA-coated M13). 
Overall, between Cel8A, SA(Cel8A-biotin) bound to M13, and Cel8A-biotin bound to SA-
coated M13, there was very little difference in activity between these arrangements (Figure 4.27B). 
Given the insoluble nature of the substrate, these assays were unfortunately prone to high variability 
between reactions set up in separate test tubes. This makes determination of whether there was any true 
difference between activity of free Cel8A and complexed Cel8A difficult. The further complexation of 
a second component, CBM-Coh, was also carried out. CBM domains are known to enhance activity by 
two means: through affinity of the CBM domain with the cellulose surface, and by making individual 
cellulose chains more accessible to enzymes (Mansfield, Mooney, and Saddler 1999). The most 
noticeable rate enhancement came from inclusion of this additional component. For free Cel8A, 1.5-
fold more reducing ends were produced at 24 hours when CBM-Coh was included (Figure 4.27B). For 
the complexed arrangement of cellulases there were 1.8-fold more reducing ends produced when CBM-
Coh was added. Still, these were only modest enhancements to the rate.  
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Overall, the activity was quite low – consider that for a 1% solution of α-cellulose (10 mg/mL), 
and at a monomer MW of 162.14 g/mol per glucose unit in the polymer, there would be 62 mM of 
potential reducing ends that could be produced at maximum. Among all the configurations of Cel8A 
tested, only 4 – 7% of total hydrolysis of α-cellulose was observed. The activity of Cel8A was 
estimated to be 5 µmol/min/(µmol Cel8A) against other insoluble cellulose substrates (Schwarz, 
Gräbnitz, and Staudenbauer 1986). Based on this activity, ~0.7 mM reducing ends might be expected at 
24 h. Within the context of this known activity of Cel8A, production of 2.5 mM reducing ends at 24 h is 
reasonable. 
Enhancement of cellulase activity via complexation onto the nanoscale scaffolds used here was 
not observed. It has been noted already that without purification the total activity comes from a mixture 
of docked and free cellulases – even so, if complexation were to enhance activity, some increase still 
may have been observed here. Therefore, there are additional considerations that relate more directly to 
the nature of the scaffold and cellulase used here. In research on artificial cellulosomes, it was found 
that a simple two-component mixtures of CBM and endocellulase (Cel5A from Thermobifida fusca) 
complexed on a DNA scaffold did exhibit synergy together (Mori et al. 2013). There were some key 
differences that might account for the lack of synergy observed here. Firstly, the cellulase was 
covalently reacted to the DNA scaffold and the CBM domain was expressed as a fusion to the 
endoglucanase (Mori et al. 2013). The covalent and defined position of the CBM relative to the 
endoglucanase could be a critical factor to the observed synergy upon complexation. Additionally, the 
flexibility of the scaffolds would be expected to be quite different. The persistence length gives a 
measure of flexibility, with smaller values being more flexible: the persistence lengths of M13 and 
DNA are 1265 and 34 nm respectively (Gross et al. 2011; Khalil et al. 2007). Conformational flexibility 
is likely a critical factor to the high cellulosome activity seen in nature (S. P. Smith and Bayer 2013). 
Thus, the M13 scaffold may not be flexible enough to allow the optimal positioning of docked 
cellulases. Furthermore, in the Cel5A/CBM system mentioned above, there existed an optimal density 
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of Cel5A on the DNA scaffolds for rate enhancement to be observed (Mori et al. 2013). At densities in 
excess of this, there was a decrease in activity. With that in mind, it may be that this nanoscale 
arrangement of cellulases were too densely loaded onto the M13 scaffold. 
Lastly, it might be that the use of a single enzymatic component was too simplistic to truly 
observe rate enhancement against a complex substrate such as cellulose. Typically, true cellulosomal 
activity requires additional components, such as exoglucanases (Artzi, Bayer, and Moraïs 2017). 
Initially, a single enzyme was used due to there being literature examples of synergy with endocellulase 
and CBM domains through proximity effects (Honda, Tanaka, and Yoshino 2015; Mori et al. 2013; Q. 
Sun et al. 2014). This would therefore have been a simple proof of concept; however, inclusion of an 
exoglucanase as well, while increasing the complexity of the scaffold, would test whether co-
complexation of the two types of cellulases resulted in endo-/exo- synergy observed in cellulosomes 
(Mansfield, Mooney, and Saddler 1999). However, the use of a single component initially was 
important as it allowed more facile characterization of binding and complexation. It is conceivable that 
the application of a mixture of biotinylated Cel8A and a biotinylated exo-cellulase to the SA-coated 
scaffold could be carried out based on the principles learned here. 
4.4 Conclusions 
 
 In this chapter, SA was used as an adaptor protein between biotinylated M13 and biotinylated 
Cel8A. While simple in concept, there were several subtleties that revealed more complex interactions 
between the components. The initial goal was to devise a nanoscale scaffold and methodology for 
preparing large, multi-enzyme complexes and use the endocellulase, Cel8A, to form an artificial 
cellulosome as a proof-of concept; the process of characterizing the complexation methodology has led 
to some subtle and interesting characteristics of this system. 
 The challenge addressed initially was how one might take a defined arrangement of SA and 
Cel8A-biotin and bind this to M13-biotin without unwanted crosslinking between the M13 and SA. 
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This challenge was approached in two different ways. The first methodology was to first prepare 
SA(Cel8A-biotin) in such a way that there would be biotin-binding sites available for complexation 
onto M13-biotin. However, this is complicated by the fact that binding of biotin to SA is rapid, and 
results in the formation of a non-equilibrium distribution of SA(biotin) species (Jones and Kurzban 
1995). However, as highlighted in Chapter 3, SA pre-saturated with desthiobiotin could be used to bias 
the distribution of SA(biotin)N species toward a more statistically predictable one by slowing down the 
binding of biotin to SA. This was used extensively here in the preparation of SA(Cel8A-biotin) 
complexes to avoid biasing the distribution toward SA with biotin-binding sites fully occupied with 
Cel8A-biotin. Using this method, cellulase activity could be detected associated with M13 particles – 
however, they were found to be non-uniformly loaded with SA(Cel8A) upon analysis by TEM. The 
main drawback was that mixing SA with Cel8A-biotin where multiply biotinylated species were present 
(recall that ~30% of Cel8A-biotin species in the 0.74 biotin/Cel8A batch were biotinylated twice or 
more) resulted in aggregates that could not bind to M13-biotin. Thus, this approach might be more 
suitable for singly biotinylated components via maleimide labeling or a specific recognition peptide, 
such AviTag for E. coli biotin ligase labelling (Y. Li and Sousa 2012). In this way, the number of 
possible interactions that might occur between components would be simplified. 
 Of particular interest was the discovery that directly mixing M13-biotin with unmodified SA, 
rather than resulting in highly disordered aggregates, could form uniformly coated M13 under the right 
conditions. This scaffold, referred to throughout as SA-coated M13, was prepared using a shorter PEG4-
linker that was thought to restrict SA binding to the two cis-facing biotin-binding sites. In support of 
this, SA-coated M13 were capable of binding Cel8A-biotin in a subsequent step – supporting the 
existence of unoccupied trans-biotin binding sites. Initially, this appeared to be a very good way to 
prepare a nanoscale arrangement of SA with biotin-binding activity for subsequent binding of enzymes 
– as binding of Cel8A-biotin was uniform when observed by TEM. Furthermore, when directly 
subjected to incubation at higher temperature, the filamentous ordering of components persisted. 
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Careful observation led to the discovery of an instability in the assembled structures whereby SA 
binding could destabilize p8 monomer packing. It was speculated that this process was triggered by 
binding of SA at its trans-ligand binding sites to the same phage, putting strain on attached p8 subunits. 
Since this degradation process was enhanced when SA-coated M13 were prepared at higher ionic 
strength, it was further speculated that the charge repulsion between SA and the M13 surface might act 
as a barrier to binding at the trans-biotin binding site. This strained configuration might then further 
cause the shedding or rearrangement of packed p8 subunits as observed. 
 Possible strategies for improving upon the SA-coated M13 scaffold would seek to resolve the 
instability. Given the likely role of electrostatics in this process, engineering p8 to be more negative 
might provide a higher barrier to unfavorable binding configurations. Numerous p8 variants exist with 
additional glutamates for the purpose of binding cations or otherwise placing greater negative charge on 
the coat of M13 for device applications (Jeong et al. 2013; B. Y. Lee et al. 2012; Nam 2006). By 
tailoring the surface of M13 in this way, the resulting SA-coated M13 might be stabilized better in 
buffered solutions. Another possibility is to use a SA variant with even tighter binding to biotin, such as 
traptavidin (Chivers et al. 2011). In this variant, the off-rate is 10-fold slower than wildtype SA. By 
increasing the lifetime of the SA-biotin interaction on the scaffold, the chance for a particular SA to 
unbind from the M13-biotin surface, followed by a neighboring SA binding in a configuration that 
destabilizes the p8 packing structure, should be reduced. Lastly, by using a bifurcated biotin analogue 
to bind additional components to the SA-coated M13 scaffold, the entire assembly might be better 
stabilized. Such an analogue should space the biotin moieties such that they span the distance between 
two cis-binding sites. First, given the multivalent nature of such a reagent, there would be avidity 
effects making attachment particularly stable; furthermore, this might essentially “cap” off any 
remaining biotin-binding sites, preventing any destabilizing binding configurations between the biotin-
binding sites opposite to the ones bound to p8-biotin.  
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The initial goals set out were to design a scaffold that would form multi-enzyme complexes 
utilizing a nanoscale scaffold. Through exploring different methodologies for preparing multi-enzyme 
complexes on M13 design principles important to preparing this scaffold were learned, and 
furthermore, complexes with endocellulolytic activity were successfully prepared. Though several 
possible improvements to this system were highlighted in this chapter summary, it is encouraging that 
the complexes do indeed have activity against cellulose.
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Chapter 5 Conclusions and future research 
 
 Over the course of this thesis research several strategies were explored for preparing densely 
loaded multi-enzyme complexes on M13. This goal was not a simple one; in particular, positioning 
multiple biological components in a controlled way by manipulating their properties, concentrations 
and the interactions that can form between them is a real challenge. Furthermore, there were several 
characteristics that were desired in the resulting complex: that it was densely and uniformly loaded with 
enzyme, retained enzymatic activity, could be prepared using a methodology that could be broadly 
applicable and not specific to a particular enzyme, and utilized the properties of the phage scaffold 
itself. In the end, M13 particles densely loaded with enzyme were observed. In this summary, some of 
the notable aspects of this work and challenges that became apparent will be highlighted. 
 A range of designs were conceived and modified throughout the course of this work and these 
touched on the above-mentioned desirable properties, while having their own subtleties and challenges. 
By highlighting these challenges and discussing them, even where designs were unsuccessful, concepts 
that were found to be important or improvements to design methodologies could be highlighted in a 
way that pushes the field further and helps in the design and preparation of multi-enzyme complexes in 
a general sense. Initially, an M13 platform with Coh2 domains conjugated to p8 to controllably bind 
dockerin-bearing enzymes was designed. An advantage of using such an adaptor was that it would 
control the orientation of the docked proteins via engineering of a dockerin-domain either at the N- or 
C-terminus of the protein of interest as needed. The Coh2 would be attached to the M13 scaffold via 
literature methods for enzyme-mediated conjugation to M13 (Hess et al. 2012). However, it was found 
that the application of this technique was somewhat protein-dependent as efficient cyclization was 
observed to occur with Coh2, rather than formation of the desired p8 adduct. The cyclization side 
reaction is known to occur and modification to the N-terminus of the protein to prevent it is 
recommended (Guimaraes et al. 2013); however, these side-reactions were still observed. Furthermore, 
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it was determined that an enzyme-mediated approach would be unlikely to produce a densely loaded 
scaffold, likely due to steric effects creating an upper limit for the total protein per M13 that could be 
achieved. Thus, after consideration, a redesign was pursued where the first step involved efficient 
modification of the viral coat directly by chemical means followed by protein complexation. 
 For the second broad approach, M13 particles were labelled with biotin molecules with 
different spacer lengths (PEG4 and PEG12) and an “adaptor” molecule, SA, was used. Importantly, this 
would ultimately allow for high capacity loading of the adaptor molecule – up to ~1350 SA per M13 
was estimated. In terms of extending the methodology to be broadly applicable, the initial design 
involved further complexation of the protein of interest by utilizing a His6-tag. To have the resulting 
complexes form stably, a methodology for oxidizing Co(II) to Co(III) coordinated with His-tagged 
proteins was utilized (Wegner and Spatz 2013). In this thesis, SA tetramers with three bound NTA 
moieties for binding the His6-tagged protein and a single open biotin-binding site to bind to 
biotinylated M13 were realized. However, it was later found that the loading step was not very efficient, 
and high loading of the biotinylated protein was not observed. Interestingly, the positioning and spacing 
of the adaptor molecule followed from the symmetry and packing of p8 monomers. One of the 
interesting aspects with respect to utilizing viral particles in assembling components on the nanoscale 
are the well-defined positioning of functional groups via the symmetry of the viral coat itself. This has 
been noted as one of the attractive aspects of viruses as nanoscale scaffolds (L. A. Lee and Wang 2006). 
Thus, the data demonstrating the nearly ideal packing of the SA adaptor on the surface of M13 particles 
reflects this concept well – importantly, the size of SA was well-suited to its positioning with the ~5-
fold symmetry of p8, and allowed it to be positioned almost directly adjacent to neighboring SA 
molecules. 
 This nearly ideal packing later led to the conception of an approach whereby M13-biotin could 
be directly mixed with SA under appropriate conditions producing SA-coated M13 with residual 
valency for further complexation of a biotinylated biomolecule. This approach was particularly 
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attractive for several reasons: 1) this led to M13 uniformly loaded with Cel8A, 2) the core scaffold was 
composed of two core components, SA and M13-biotin – which are straightforward in their 
preparation, and 3) this was anticipated to be highly modular. For the first point, of the methods 
explored in this thesis, the highest loading density was achieved using this SA-coated M13 scaffold as 
indicated by TEM micrographs. This was only possible with efficient interactions at each step in 
assembling the complexes – in this case, the tight binding between biotin and SA. The second point 
relates to the idea of accessibility – the core scaffold, SA-coated M13, is prepared from two highly 
accessible components which has good implications for potential applicability. Lastly, as the core 
scaffold is essentially a filamentous array of biotin-binding sites, the modularity comes down to 
whether a particular biomolecule can be biotinylated.  
As discussed in the summary of Chapter 4, there are many ways to biotinylate biomolecules – 
for proteins, particular expression systems even obviate the need for bioconjugate techniques entirely 
by biotinylating the protein as it is expressed (Y. Li and Sousa 2012). Thus, the requirement that the 
biomolecule be biotinylated is any easy one to meet. As carried out here, biotinylation of reactive 
amino acids is another straightforward method of preparing a component to be docked onto this 
scaffold. However, this can lead to multiply biotinylated proteins (depending on the chemistry utilized), 
increasing the number of potential interactions with the SA adaptor protein. This system was 
characterized using a biotinylated enzyme with multiply biotinylated species present (though the most 
abundant species was singly labelled Cel8A, ~30% of species had ≥2 biotin per Cel8A), representing 
this more challenging case; with multivalence comes the potential for crosslinking side reactions and 
aggregation. Yet it was found that even with such a component here, the resulting enzyme-laden M13 
were still well-dispersed, and not observed to aggregate. This may be due to the high-density of biotin-
binding sites presented to a multiply biotinylated molecule as it approaches this highly curved SA-
coated M13 surface: once bound at one of its biotin moieties, the rest are likely to find a place to bind in 
neighboring SA molecules bound to the phage surface, rather than bind to a separate phage particle. 
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 The observations made in this thesis have important implications for the use of biotinylated 
viruses and SA-conjugated components in general. The utilization of SA/biotin interactions are 
common in approaches where specificity and stable interactions are desired, as highlighted in Section 
1.5. With reference specifically to filamentous viruses, there have been examples of biotinylated phages 
utilizing the SA/biotin interaction for the purpose of signal enhancement (ELISA; (Brasino, Lee, and 
Cha 2015; S. Williams, Schulz, and Sierks 2015)) or sensor signal enhancement (field effect biosensor; 
(Poghossian et al. 2018)). In these applications, the biotinylated virus served as a mediator with which a 
particular sensing component conjugated to SA was bound after the phage was first adhered to a solid 
phase. These differ from the designs explored in this thesis in which M13-biotin in solution was 
complexed with SA and other components forming complexes which were soluble and dispersed; 
however, the concepts learned in this thesis are likely still applicable.  
In particular, where a tight-binding, multivalent component such as SA is used to interact with 
a biotinylated multi-subunit scaffold (i.e., viruses), it is important to confirm that the resulting 
structures are indeed formed as intended, as it was highlighted that there is potential for the packing 
structure of multi-subunit viruses to be destabilized by SA binding (i.e.. SA-coated M13; Section 
4.3.3.4). This is unlikely to impact the utilization of biotinylated viruses where monovalent SA are used 
to build onto the scaffold (i.e.. SA(BXN)3 bound to M13-biotin; Section 3.3.4); however, this is likely 
to be an important consideration for SA conjugates (with multiple biotin-binding sites), where there 
exists the potential for multiple interactions to form. Indeed, it was demonstrated that the interactions 
that lead to these degradation pathways can be quite subtle, where factors such as the ionic strength of a 
solution may lead to destabilization when a multivalent component is bound. Whether this is a 
phenomenon specific to M13 would be an interesting fundamental avenue to explore, as this could 
highlight the way in which subunit packing and symmetry of a multi-subunit scaffold translates to the 
relative stability of a complex formed with a multivalent component such as SA. It is predicted that if 
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binding to more than two of the biotin-binding sites of SA by the same biotinylated scaffold is limited 
due its geometry and spacing of biotin moieties, the resulting complex may exhibit better stability.  
In summary, multi-subunit particles such as viruses are an important part of the nanoscale 
toolbox – however, just as any single tool may not be optimal in all applications, one should consider 
that each naturally-occurring, or designed, multi-subunit scaffold may have different strengths. This 
thesis research focused particularly on methods for preparing large, multi-enzymes on a particular viral 
scaffold, M13, using tight-binding interactions. Among the various design considerations highlighted 
above, a particularly novel methodology that was devised was the rapid coating of M13-biotin with SA, 
forming arrays of SA with residual biotin-binding capability. In characterizing this, there was potential 
for high density loading of biotinylated enzymes, but also some challenges to be overcome with respect 
to the instability introduced to coat protein packing under certain conditions. It is expected that this 
methodology is not specific only to M13 and might be employed elsewhere with appropriately spaced 
biotin-binding moieties. Furthermore, the results here hint at the potential value of a thorough 
characterization of different multi-subunit scaffolds with varied geometries and spacing of reactive 
groups. Given the wealth of stable, multi-subunit structures that exist in nature there is much to be 
explored and it is hoped that the challenges highlighted in this thesis illustrate the value in building up a 
toolbox of carefully characterized nanoscale scaffolds.
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